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Hypertensive Disorders in Pregnancy 
In some mystenous way the presence of chononic villi in certain women mates vasospasm and hypertension Moreover to effect a cure 
the chononic villi must be expelled or surgically removed The vasospastic hypertensive state and related pathological changes somehow 
induced by the presence of chononic villi may not be so great that pregnancy need be termmated prematurely (Pntchard, 1978) 
Pregnancy may induce hypertension in previously normoten-
sive women or aggravate hypertension in women who have 
underlying hypertension Generalized edema, proteinuna, or 
both, often accompany hypertension induced or aggravated by 
pregnancy Convulsions also may develop in association with 
hypertension, especially if hypertension is ignored 
Hypertensive disorders complicating pregnancy are com-
mon and form one of the great tnad, along with hemorrhage 
and infection, that continues to be responsible for a large num-
ber of maternal deaths in the United States Kaunitz and col-
leagues (1985) reported that 20 percent of 2,067|»aternal deaths 
from 1974 to 1978 were caused by hypertensivs^diseases With 
improved prenatal care and a rational approach tVthe manage-
ment of hypertensive disorders complicating pregnancy, dra-
matic declines in maternal mortality rates have been reported 
more recently (Lehmann and colleagues, 1987, Rochat and co-
workers, 1988, Sachs and associates, 1987) Hypertensive disor-
ders are also an important cause of perinatal mortality and 
severe morbidity 
How pregnancy per se incites or aggravates hypertensive 
vascular disease remains unsolved despite decades of intensive 
research, and these disorders remain among the most important 
unsolved problems in obstetncs The large toll of maternal and 
infant lives that may be taken by hypertension induced or ag-
gravated by pregnancy is most often preventable Good prena-
tal supervision followed by appropriate treatment will 
ameliorate many cases sufficiently that the outcomes for both 
fetus-infant and mother are satisfactory 
GENERAL CONSIDERATIONS 
CLASSIFICATION AND 
DIFFERENTIAL DIAGNOSIS 
TERMINOLOGY 
The unsatisfactory term toxemia of pregnancy has been applied 
variably to any or all disorders in which hypertension, protein-
una, or edema was present dunng pregnancy or the puerpe-
num, and to other disorders, as well The Amencan College of 
Obstetricians and Gynecologists (1986) proposed the following 
definitions and classification of hypertension that develop dur-
ing pregnancy or the puerpenum Hypertension is defined as a 
diastolic blood pressure of at least 90 mm Hg or a systolic 
pressure of at least 140 mm Hg, or a nse in diastolic pressure of 
at least 15 mm Hg or in systolic pressure of 30 mm Hg The 
blood pressure readings cited must be obtained on at least two 
occasions 6 hours or more apart Preeclampsia is the develop-
ment of hypertension with proteinuna, edema, or both, in-
duced by pregnancy after the 20th week of gestation, and 
sometimes earlier when there are extensive hydahdiform 
changes in the chononic villi (see Chap 31, p 544) Eclampsia is 
diagnosed when convulsions, not caused by anv coincidental 
neurological disease such as epilepsy, develop in a woman who 
also has clinical cntena for preeclampsia Superimposed pre-
eclampsia or eclampsia is defined as preeclampsia or eclampsia 
that develops in a woman with chronic hypertensive vascular or 
renal disease Chronic hypertensive disease is defined as persistent 
hypertension, of whatever cause, antedating pregnancy o- de-
tected before the 20th week of gestation in the absence of hy-
dahdiform mole or extensive molar change, or hypertension 
that persists beyond 6 weeks postpartum 
Unfortunately, not all women can be categorized neatly as having 
one of these syndromes Earlier, the Committee on Terminology of 
the Amencan College of Obstetncians and Gynecologists (Hughes, 
1972) sought to improve the diagnosis of preeclampsia It defined 
gestational hypertension as elevated blood pressure that develops 
dunng the latter half of pregnancy or dunng the first 24 hours 
following delivery It is not accompanied by other evidence for 
preeclampsia or chronic underlying hypertension, and it disap-
pears within 10 days of delivery It is unclear whether this is mild 
or incipient preeclampsia forestalled by delivery or if it is a marker 
for latent chronic hypertension, but we agree with Chesley (1985) 
that it is probably the latter If so, then it is certainly inappropnately 
classified Gestational edema is characterized by abnormal fluid re-
tention that regresses after delivery, hypertension never develop-
ing Rarely, so-called gestational proteinuria exceeds 300 mg per day 
m the absence of hypertension, edema, renal infection, or other 
known renovascular disease These terms are not used by many 
teaching centers in the United States 
Because of the confusion that has ansen from these classi-
fications of hypertensive disorders complicating pregnancy, we 
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have made the modifications shown in Table 35-1. Our princi-
pal reason was to separate hypertension that is in some way 
induced by pregnancy from hypertension that merely coexists 
with it. At the same time it needs to be emphasized that chronic 
underlying hypertension will increase the frequency and inten-
sity of superimposed preeclampsia. 
PREGNANCY-INDUCED HYPERTENSION 
As shown in Table 35-1, pregnancy-induced hypertension is 
divided into three categories: (1) hypertension alone, (2) pre-
eclampsia, and (3) eclampsia. The diagnosis of preeclampsia is 
based on the development of hypertension plus proteinuria or 
of edema that is generalized and overt, or both. Eclampsia is 
characterized typically by the abnormalities just cited with the 
addition of convulsions that are precipitated by the pregnancy-
induced hypertension. Only rarely does preeclampsia develop 
earlier than 20 weeks gestation, and then usually in cases of 
hydatidiform mole or appreciable molar degeneration (see 
Chap. 31, p. 544). As emphasized by Chesley (1985), preeclamp-
sia is almost exclusively a disease of nulliparous women. Al-
though it more commonly affects the woman who is at the 
extremes of reproductive age, that is, teenagers or those older 
than 35 years, preeclampsia in the latter usually reflects 
pregnancy-aggravated hypertension. Pregnancy-induced hy-
pertension is occasionally seen in the multipara with multifetal 
pregnancy or fetal hydrops. Pregnancy-aggravated hyperten-
sion is common in multiparas with vascular diseases, including 
chronic essential hypertension and diabetes mellirus, or those 
with coexisting renal disease. 
DIAGNOSIS 
The diagnosis of pregnancy-induced hypertension is usually 
straightforward and made when the blood pressure is 140/90 mm 
Hg or greater. Although it has been accepted in the past that an 
increase of 30 mm Hg systolic or 15 mm Hg diastolic over 
baseline values on at least two occasions 6 or more hours apart 
be considered as possibly diagnostic for pregnancy-induced hy r 
pertension, these vague criteria have little clinical value. Such 
findings, however, may increase the risk for pregnancy-induced 
TABLE 35-1. CLASSIFICATION OF HYPERTENSIVE DISORDERS 
COMPLICATING PREGNANCY 
Pregnancy-induced hypertension 
Hypertension that develops as a consequence of pregnancy, and re-
gresses postpartum 
1. Hypertension without proteinuria or pathological edema 
2. Preeclampsia—with proteinuria and/or pathological edema 
a. Mild 
b. Severe 
3. Eclampsia—proteinuria and/or pathological edema along with 
convulsions 
Pregnancy-aggravated hypertension 
Underlying hypertension worsened by pregnancy 
1. Superimposed preeclampsia 
2. Superimposed eclampsia 
Coincidental hypertension 
Chronic underlying hypertension that antecedes pregnancy or persists 
postpartum 
hypertension. Villar and colleagues (1988) reported that 31 per-
cent of young primigravidas with a 15 mm Hg rise in diastolic 
blood pressure developed pregnancy-induced hypertension. 
For those without such a rise, the incidence was 15 percent. For 
women in whom the systolic pressure rose 30 mm Hg or more, 
42 percent developed pregnancy-induced hypertension, com-
pared to an incidence of 17 percent in women without such a 
rise. If both systolic and diastolic pressure increased as defined, 
then 56 percent developed pregnancy-induced hypertension, 
compared to only 15 percent if there had not been a preceding 
elevation. Midpregnancy blood pressure elevations more likely 
forecast future chronic hypertension (Chesley and Sibai, 1988). 
Although the diagnosis of preeclampsia has traditionally 
required the identification of pregnancy-induced hypertension 
plus proteinuria or generalized edema, many authorities concur 
that edema, even of the hands and face, is such a common 
finding in pregnant women that its presence should not validate 
the diagnosis of preeclampsia any more than its absence should 
preclude the diagnosis. Indeed, Robertson (1971) reported that 
one third of women developed generalized edema by the 38th 
week of pregnancy, and he was unable to show a significant 
statistical correlation between edema and hypertension. In an-
other study, Friedman and Neff (1976) identified perinatal mor-
tality for women with edema alone to be 30 percent lower than 
for the general population. Thus, the edema of preeclampsia is 
pathological and not dependent, and it usually involves the face 
and hands and persists even after arising. A useful indicator of 
nondependent edema is the woman's complaint that her rings 
have become too tight. 
Proteinuria is an important sign of preeclampsia and Ches-
The combination of proteinuria and hypertension during 
pregnancy markedly increases the risk of perinatal mortality. 
McCartney and co-workers (1971), in their extensive study of 
renal biopsy specimens obtained from hypertensive pregnant 
women, invariably found that proteinuria was present when 
the glomerular lesion considered to be characteristic of pre-
eclampsia was evident. It is important to recognize, however, 
that both proteinuria and alterations of glomerular histology 
develop late in the course of pregnancy-induced hypertension. 
Actually, preeclampsia becomes evident clinically only near the 
end of an often protracted, covert pathophysiological process . 
that may begin 3 to 4 months before hypertension develops. 
The fact that perinatal mortality is increased by maternal 
hypertension is evident from an analysis of data collected from 
the Collaborative Perinatal Project conducted by the National 
Institute of Neurologic and Communicative Disorders and 
Stroke (Friedman and Neff, 1976). From this 13-year prospective 
study, 38,636 pregnancies were selected for analysis because 
they satisfied the following criteria: (1) antepartum care before 
the 28th week of pregnancy, (2) singleton fetus, (3) four or more 
antepartum visits, and (4) date of last menstrual period known. 
In Table 35-2 the fetal death rate for these pregnancies is pre-
sented in relation to the presence or absence of hypertension, 
proteinuria, or both. Hypertension alone, defined by diastolic 
blood pressure of 95 mm Hg or greater, was associated with a 
threefold rise in the fetal death rate. Worsening hypertension, 
ley (1985) rightfully concluded that the diagnosis is questionable 
in its absence. Proteinuria is defined as 300 mg or more of 
urinary protein during a 24-hour period or 100 mg per dL or 
more in at least frvo random urine specimens collected 6 hours 
or more apart. The degree of proteinuria may fluctuate wideT^" 
over any 24-hour period, even in severe cases. Therefore, a 
single random sample may fail to detect significant proteinuria. 
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TABLE 35-2. FETAL DEATH RATE PER 1,000 BIRTHS ANALYZED 
ACCORDING TO DIASTOLIC PRESSURE AND PROTEINURIA 
COMBINATIONS 
Diastolic Blood 
Pressure 
(mm Hg) 
<65 
65-74 
75-84 
85-94 
95-104 
105 + 
Total 
None 
15 5a 
93 
62 
87 
19 2a 
20 5a 
86 
Trace 
136 
81 
74 
93 
17 4a 
27 9a 
95 
Proteinuria 
r+ 
62 
56 
62 
23 6a 
26 7a 
62 6a 
129 
2+ 
— 
32 9a 
19 2a 
— 
55 8a 
68 8a 
23 2a 
3+ 
— 
41 5 
— 
22 3 
115 3a 
125 2a 
42 0a 
4+ 
— 
__ 
— 
— 
143a 
111a 
57a 
Totat 
136 
88 
68 
102 
25 2 
41 5a 
aP< 0 01 
Modified from Friedman and Nefi In Lmdheimer Katz and Zuspan (eds) Hyper-
tension in Pregnancy New York Wiley 1976 
especially if accompanied by proteinuria, was more ominous 
Conversely, proteinuna without hypertension had little overall 
influence on the frequency of fetal death 
In an evaluation of the causes of perinatal deaths in this 
same study population, Naeye and Friedman (1979) concluded 
that 70 percent of the excess deaths were due to three disorders 
large placental infarcts, markedly small placental size, and 
abruptio placentae They further stated, "All three [disorders] 
display microscopic placental lesions [that] are the consequence 
of reduced uteroplacental perfusion " Uteroplacental per-
fusion is considered in detail on page 671 
When the blood pressure nses appreciably during the latter 
half of pregnancy it is dangerous, to the fetus especially, not to 
take action simply because proteinuna has not yet developed 
As Chesley (1985) emphasizes, 10 percent of eclamptic seizures 
develop before overt proteinuna Thus, from pathophysiologi-
cal and epidemiological perspectives it is clear that hypertension 
is the sine qua non of preeclampsia and that from the moment 
blood pressure begins to nse, both mother and fetus are at 
increased nsk Once the blood pressure exceeds 140/90 mm Hg, 
pregnancy-induced hypertension is diagnosed and the woman, 
treated accordingly Proteinuna is a sign of worsening hyper-
tensive disease, specifically preeclampsia, and when it is overt 
and persistent, the maternal and fetal nsks are increased even 
more 
SEVERITY OF PREGNANCY-INDUCED 
HYPERTENSION 
The seventy of pregnancy-induced hypertension is assessed by 
the frequency and intensity of those abnormalities shown in 
Table 35-3 At the ouset it is appreaated that many women 
have clmical syndromes that are somewhere between those two 
extremes Importantly, the differentiation between mild and 
severe preeclampsia cannot be rigidly pursued since appar-
ently mild disease may rapidly become severe. 
Blood pressure alone is not always a dependable indicator 
of seventy For example, an adolescent woman may have 3 + 
proteinuna and convulsions while her blood pressure is 140/85 
mm Hg, whereas most women with blood pressures as high as 
180/120 mm Hg do not have seizures Convulsions usually are 
preceded by an unrelenting severe headache or visual distur-
bances, thus, these symptoms are considered ominous 
TABLE 35-3. INDICATORS OF SEVERITY OF 
PREGNANCY-INDUCED HYPERTENSION 
Abnormality Mild Severe 
Diastolic blood pressure 
Proteinuria 
Headache 
Visual disturbances 
Upper abdominal pain 
Oliguria 
Convulsions 
Serum creatinine 
Thrombocytopenia 
Hyperbilirubinemia 
Liver enzyme elevation 
Fetal growth retardation 
Pulmonary edema 
< 100 mg Hg 
Trace to 1 + 
Absent 
Absent 
Absent 
Absent 
Absent 
Normal 
Absent 
Absent 
Minimal 
Absent 
Absent 
110 mm Hg or higher 
Persistent 2+ or more 
Present 
Present 
Present 
Present 
Present (eclampsia) 
Elevated 
Present 
Present 
Marked 
Obvious 
Present 
Proteinuna is an important indicator of severity, since, as 
discussed, it usually develops late in the course of the disease 
Certainly, persistent proteinuna of 2+ or more, or 24-hour 
unnary excretion of 4 g or more, is indicative of severe pre-
eclampsia With severe renal involvement, glomerular filtration 
may be impaired and the plasma creatinine concentration be-
come abnormally high, or it may begin to nse 
Epigastnc or nght upper quadrant pain is presumed to 
result from hepatocelluar necrosis and edema that stretches 
Glisson's capsule The charactenshc pain frequently is accom 
panied by elevation of serum liver enzymes, and usually 
prompts definitive therapy Rarely, the pain presages liver rup-
ture, or more correctly, catastrophic rupture of an hepatic sub-
capsular hematoma 
Thrombocytopenia is charactenshc of worsening pre-
eclampsia and is probably caused by microangiopathic hemol-
ysis engendered by severe vasospasm Whatever the cause 
evidence of gross hemolysis from hemoglobmemia, hemoglobi 
nuna, or hyperbilirubinemia is indicative of severe disease 
Other factors indicative of severe hypertension most often 
are seen in association with pregnancy-aggravated hyperten 
sion These factors include cardiac dysfunction with pulmonary 
edema as well as fetal growth retardation 
The more profound the frequency and intensity of these 
aberrations, the more severe the disease and the greater the 
need for pregnancy termination 
ECLAMPSIA 
In neglected or, less often, fulminant cases of pregnancy -
induced hypertension, eclampsia may develop The seizures are 
grand mal and may first appear before labor, dunng labor, or 
postpartum Any seizure that develops more than 48 hours 
postpartum is more likely to be the consequence of some other 
lesion of the central nervous system However, we have en 
countered otherwise typical eclampsia up to 10 days postpar 
rum (Brown and colleagues, 1987). 
COINCIDENTAL (CHRONIC) HYPERTENSION 
All chronic hypertensive disorders, regardless of their cause, pre 
dispose to the development of supenmposed preeclampsia or 
eclampsia These disorders can create a difficult problem or 
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diagnosis and management in women who are not seen for 
prenatal care until after midpregnancy. The diagnosis of coin-
cidental or chronic underlying hypertension is suggested by the 
following: (1) hypertension (140/90 mm Hg or greater) anteced-
ent to pregnancy, (2) hypertension (140/90 mm Hg or greater ) 
detected before the 20th week of pregnancy (unless there is 
gestational trophoblastic disease), or (3) persistent hypertension 
long after delivery. Additional historical factors that help sup-
port the diagnosis of coincidental hypertension are multiparity 
and hypertension complicating a previous pregnancy other than 
the first one. 
When the woman is not seen until the latter half of preg-
nancy, the diagnosis of chronic hypertension may be difficult to 
make, because blood pressure usually decreases during the sec-
ond and early third trimester in chronically hypertensive 
women. Thus, a woman with chronic vascular disease who is 
seen for the first time at 20 weeks frequently will have a normal 
blood pressure. During the third trimester, however, the blood 
pressure returns to its former hypertensive level, presenting a 
diagnostic problem: is this chronic (coexistent) hypertensive dis-
ease or is it pregnancy-induced hypertension? 
There are many diseases and syndromes associated with 
underlying hypertension that may be encountered during preg-
nancy. Sims (1970) proposed the modified classification pre-
sented in Table 35-4. As is true for the general population of the 
same age group, essential hypertension is the cause of under-
lying vascular disease in more than 90 percent of pregnant 
women. McCartney (1964) studied renal biopsies from women 
with "clinical preeclampsia," and found chronic glomerulone-
phritis in 21 percent of the nulliparas and in nearly 70 percent of 
the multiparas. Fisher and co-workers (1969), however, did not 
confirm a high prevalence of chronic glomerulonephritis in their 
own patients. 
It must be remembered that chronic hypertension causes 
morbidity whether the woman is pregnant or not. Specifically, 
chronic hypertension may lead to premature cardiovascular de-
terioration and cause cardiac decompensation and cerebrovas-
TABLE 35-4. UNDERLYING CHRONIC HYPERTENSIVE 
DISORDERS UPON WHICH PREECLAMPSIA MAY 
BE SUPERIMPOSED 
Hypertensive diseases 
Essential familial hypertension 
(hypertensive vascular disease) 
Renovascular hypertension 
Coarctation of the aorta 
Primary aldosteronism 
Pheochromocytoma 
Renal and urinary tract disease 
Glomerulonephritis (acute and chronic) 
Nephrotic syndrome 
Chronic renal insufficiency 
Pyelonephritis 
Lupus erythematosus 
Scleroderma 
Periarteritis nodosa 
Acute renal failure 
Tubuler necrosis 
Cortical necrosis 
Polycystic kidney disease 
Diabetic nephropathy 
Modified from Sims: Am J Obstet Gynecol 107:154, 1970. 
cular accidents. Intrinsic renal damage also may result from 
chronic hypertensive disease, but more commonly in young 
women, hypertension develops as the result of underlying renal 
parenchymal disease. Dangers specific to pregnancy compli-
cated by chronic hypertension include the risk of pregnancy-
aggravated hypertension, which may develop in as many as 20 
percent of these women. Additionally, the risk of abruptio pla-
centae is increased substantively, and may be as high as 5 to 10 
percent. Moreover, the fetus of the woman with chronic hyper-
tension is at increased risk for growth retardation and intrau-
terine death. 
PREGNANCY-AGGRAVATED HYPERTENSION 
In some women with preexisting chronic hypertension there is 
worsening of hypertension, typically in later pregnancy. Such 
pregnancy-aggravated hypertension may be accompanied by 
proteinuria or pathological edema and is then termed superim-
posed preeclampsia. Frequently, superimposed preeclampsia has 
an onset earlier in pregnancy than pure preeclampsia, and it 
tends to be quite severe in many cases. Fetal growth retardation 
commonly accompanies these syndromes. 
Diagnosis includes documentation of chronic underlying 
hypertension. Pregnancy-aggravated hypertension is character-
ized by at least a 15 mm Hg increase in diastolic or a 30 mm Hg 
rise in systolic blood pressure, and preeclampsia is accompa-
nied by proteinuria or pathological edema, or both. Indicators of 
severity shown in Table 35-3 also are used to further character-
ize these disorders. 
INCIDENCE OF PREGNANCY-INDUCED 
HYPERTENSION 
Pregnancy-induced hypertension most often affects nulliparous 
women. Older women, who accrue an increasing incidence of 
chronic hypertension with advancing age, are at greater risk of 
pregnancy-aggravated hypertension or superimposed pre-
eclampsia. Thus, women at either end of the reproductive age 
in the past have been considered more susceptible. For exam-
ple, Duenhoelter and colleagues (1975) observed that very 
young teenage nulligravidas were at appreciably greater risk for 
preeclampsia. This traditional view is not supported by Guzick 
and associates (1987) who reported that younger-age women 
did not have a higher incidence of pregnancy-induced hyper-
tension when parity was considered. Spellacy and associates 
(1986) reported that women over 40 had a threefold (9.6 versus 
2.7 percent) increased incidence of hypertension compared to 
control women aged 20 to 30 years. Hansen (1986) reviewed 
several studies and reported a two- to threefold increase in the 
incidence of preeclampsia in nulliparas over 40 compared to 
those 25 to 29 years old. 
The incidence of preeclampsia is commonly cited to be 
about 5 percent, although remarkable variations are reported. 
The incidence is influenced by parity, it is related to racial—and 
thus to generic—predisposition, and environmental factors may 
have a role. From 1983 through 1986, 13 percent of 49,992 
women who were delivered at Parkland Hospital were identi-
fied as having pregnancy-induced or aggravated hypertension 
(Cunningham and Leveno, 1987). Almost 70 percent were 
nulliparous, but only half of these had proteinuria and thus 
preeclampsia according to Chesley. The effects of parity were 
striking, since nearly 20 percent of nulliparas had hypertension 
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antepartum, intrapartum, or in the puerperium, compared to an 
incidence of 7 percent in multiparas. 
Racial and genetic factors are important since they con-
tribute to the incidence ot underlying chronic hypertension. 
We analyzed pregnaricy outcomes of 5,622 nulliparas deliv-
ered at Parkland Hospital in 1986, and 18 percent of white, 20 
percent of Hispanic, and 22 percent of black women had hy-
pertension complicating pregnancy (Cunningham and Lev-
eno, 1987). Again, about half of these women had pre-
eclampsia defined as proteinuric hypertension. The incidence 
of hypertension in multiparas during pregnancy was 6.2 per-
cent in white, 6.6 in Hispanic, and 8.5 percent in black 
women, reflecting the increased incidence of underlying hy-
pertension in blacks. Slightly more than half of these mucip-
arous women with hypertension also had proteinuria and 
thus superimposed preeclampsia. 
The tendency for preeclampsia-eclampsia is inherited. 
Chesley and Cooper (1986) studied the sisters, daughters, 
granddaughters, and daughters-in-law of eclamptic women de-
livered at the Margaret Hague Maternity Hospital during the 
49-year period 1935 to 1984. They concluded that preeclampsia-
eclampsia is highly heritable and that the single-gene model, 
with a frequency of 0.25, best explained their observations; 
however, multifactorial inheritance also was considered possi-
ble (see Chap. 32, p . 574). 
Although Chesley (1974) disagrees, some have concluded 
that socioeconomically advantaged women have a lesser inci-
dence of preeclampsia, even after racial factors are controlled. 
Regardless, when a socially affluent woman develops pre-
eclampsia, it can be as severe and life-threatening as preeclamp-
sia in a ghetto teenager. 
In general, eclampsia is preventable, and it has become less 
common in the United States, since most women now receive 
"prenatal care. For example, in the seventeenth edition of 
Williams Obstetrics, the incidence of eclampsia at Parkland Hos-
pital was cited to be 1 in 700 deliveries for the past 25-year 
period. For the 4-year period 1983-1986 the incidence was 1 in 
1,150 deliveries. During this same time, there were proportion-
ally more nulliparous women delivered at our hospital, and this 
should favor an increased incidence of eclampsia rather than the 
decrease noted. 
THEORIES ABOUT THE CAUSE OF 
PREGNANCY-INDUCED HYPERTENSION 
Any satisfactory theory must take into account the following 
observations: pregnancy-induced or -aggravated hypertension 
is very much more likely to develop in the woman who (1) is 
exposed to chorionic villi for the first time, (2) is exposed to a 
superabundance of chorionic villi, as with twins or hydatidi-
form mole, (3) has preexisting vascular disease, or (4) is genet-
ically predisposed to hypertension developing during 
pregnancy. While chorionic villi are essential, they need not 
support a fetus nor be located within the uterus. 
The possibility that immunological as well as endocrine and 
genetic mechanisms are involved in the genesis of preeclampsia 
is intriguing. The risk of pregnancy-induced hypertension is en-
hanced appreciably in circumstances where formation of block-
ing antibodies to antigenic sites on the placenta might be im-
paired, such as during immunosuppressive therapy to protect a 
renal transplant during pregnancy; where effective immuniza-
tion by a previous pregnancy is lacking, as in first pregnancies; 
or where the number of antigenic sites provided by the placenta 
is unusually great compared to the amount of antibody, an 
example of which is multiple fetuses (Beer, 1978). Strickland 
and associates (1986) provided data that do not lend strong 
support to "immunization" by a previous pregnancy. They an-
alyzed the outcomes of 29,484 pregnancies at Parkland Hospital 
and reported that pregnancy-induced hypertension was only 
slightly decreased (22.3 versus 25.4 percent) in women who had 
previously aborted and now were having their first baby. How-
ever, supporting the immunization concept is the observation 
that preeclampsia develops in multiparous women impregnated 
by a new consort (Feeney and Scott, 1980) or in those pregnant 
as the result of donor insemination (Need and colleagues, 1983). 
As summarized by Chesley (1974), everyone from allergist 
to zoologist has proposed a theory and suggested "rational 
therapy" based upon that theory. Some schemes proposed 
included mastectomy, oophorectomy, renal decapsulation, 
trephination, alignment of the woman with the earth's mag-
netic field, and a myriad of medical regimens. Everything 
from watermelon season to infestation with a worm (Hydatoxi 
lualba) has been claimed to be of importance. The interested 
reader is urged to examine the scholarly and entertaining re-
view of various theories provided by Chesley (1978) in his 
elegant book, Hypertensive Disorders in Pregnancy. 
As discussed above, the tendency to develop preeclampsia 
is inherited. Cooper and Liston (1979) examined the possibility 
that susceptibility to preeclampsia is dependent upon a single 
recessive gene. They calculated the expected first-pregnancy 
frequencies of daughters of women with eclampsia; daughters-
in-law served as controls. The frequencies calculated by them 
and those actually observed by Chesley and co-workers (1968) 
in daughters and daughters-in-law of women with eclampsia 
are in remarkably close agreement. Subsequently, Chesley and 
Cooper (1986) reanalyzed Chesley's extensive data and con-
cluded that the single-gene hypothesis fits well, but multifacto-
rial inheritance cannot be excluded. 
Preeclampsia may be more common among indigent 
women; however, in the early 1900s eclampsia was believed to 
be most common in middle- and upper-class women. Indeed, 
that observation led to the ready acceptance of the hypothesis 
that dietary restriction of protein accounted for the reduction in 
the incidence of eclampsia in Germany during World War I. 
Although there are suggestions that dietary deficiencies might 
cause preeclampsia, this hypothesis also lacks supportive data. 
Since pregnancy "depletes" a woman nutritionally, preeclamp-
sia might be expected to be more common in multiparous 
women compared to nulliparas; however, the opposite is true. 
Moreover, in a number of studies in which dietary supplemen-
tation was provided, no reduction in the frequency of hyper-
tension was demonstrated (see Chap. 14, p. 263). Zlatnik and 
Burmeister (1983) provided convincing evidence that the inci-
dence of preeclampsia is not related to the level of dietary pro-
tein. Calcium deficiency has been implicated by some; however, 
appropriate clinical trials have not been done to test this hy-
pothesis (Belizan and colleagues, 1988). 
Carefully controlled epidemiological studies of pregnancy 
have been conducted in Aberdeen, Scotland, where for many 
years the relevant data have been available for most deliveries. 
Baird (1969) found that the incidence of preeclampsia did not 
differ significantly among the five social classes ranging from 
the professional and well-to-do (class I) through the unskilled 
laborers (class V), except for some slight increase in class III 
(skilled manual occupations). 
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rich foam cells Zeek and Assail (1950) extended these obser-
vations and concluded that in preeclampsia there is a 
pathognomonic lesion of the uteroplacental vessels that they 
termed acute atherosis Most investigators are now in accord 
that there is a lesion, but they do not necessarily agree on its 
prease nature Using electron microscopic studies of artenes 
at the uteroplacental implantation site, DeWolf and co-
CLINICAL FINDINGS 
The two especially important signs of preeclampsia— 
hypertension and proteinuria—are abnormalities of v\ hich the 
pregnant woman is usually unaware By the time svmptoms 
such as headache, visual disturbances, or epigastric pain de 
velop, the disorder is most always severe Hence the impor 
tance of prenatal care in the early detection and management of 
preeclampsia becomes obvious 
BLOOD PRESSURE 
The basic derangement in preeclampsia is arteriolar vasospasm, 
and it is not surprising, therefore, that the most dependable 
warning sign is an increase in blood pressure The diastolic 
pressure is probably a more reliable prognostic sign than the 
systolic, and any diastolic pressure of 90 mm Hg or more that 
persists is abnormal The fifth Korotkoff sound is used 
WEIGHT GAIN 
A sudden increase m weight may precede the development of 
preeclampsia, and indeed, excessive weight gain in some 
"women is the first sign Weight increase of about 1 pound per 
week is normal, but when weight gam exceeds much more than 
2 pounds m any given week, or 6 pounds in a month de\el 
oping preeclampsia must De suspected enaractenstic ot pre 
eclampsia is the suddenness ot the excessive weight gain rather 
than an increase distributed throughout gestation Sudden and 
excessive weight gam is attributable almost entirely to abnormal 
fluid retention and is demonstrable, as a rule, before visible signs 
of nondependent edema, such as, swollen eyelids and puffiness 
of the fingers In cases of fulminating preeclampsia or eclampsia, 
fluid retention may be extreme, and m such women a weight gain 
of 10 pounds or more within a week is not unusual 
PROTEINURIA 
The degree of proteinuria vanes greatly in preeclampsia not 
only from case to case but also in the same woman from hour to 
hour The variability points to a functional (vasospasm) rather 
than an organic cause In early preeclampsia proteinuria may 
be minimal or entirely lacking In the most severe forms protein 
una is usually demonstrable and may be as much as 10 g per L 
Proteinuna almost always develops later than hypertension and 
usually later than excessive weight gain 
HEADACHE 
Headache is unusual in milder cases but is increasingK frequent 
in more severe disease It is often frontal but may be occipital 
and it is resistant to relief from ordinary analgesics In women 
workers (1975) reported that early preeclamptic changes in-
clude endothelial damage, insudation of plasma constituents 
into the vessel wall, proliferation of myointimal cells, and me-
dial necrosis They also found that lipid accumulates first m 
the myointimal cells and then in macrophages Robertson and 
colleagues (1986) recently provided a careful review of these 
microscopic \ascular findings 
who develop eclampsia, severe headache almost invariably 
precedes the first convulsion. 
EPIGASTRIC PAIN 
Epigastric or right upper quadrant pain often is a symptom of 
severe preeclampsia and may be indicative of imminent con-
vulsions. It may be the result of stretching of the hepatic cap-
sule, possibly by edema and hemorrhage (p 667) 
VISUAL DISTURBANCES 
A spectrum of visual disturbances, ranging from slight blurnng 
of vision to scotomata to partial or complete blindness, may 
accompany preeclampsia These probably develop as the result 
of vasospasm, ischemia, and petechial hemorrhages within the 
occipital cortex (Brown and colleagues, 1988) In some women, 
visual symptoms may arise from retinal artenolar spasm, isch-
emia, and edema, and m rare cases, retinal detachment (p 670) 
In general, the prognosis for such detachments is good, and the 
retina usually reattaches spontaneously within a few weeks 
after delivery Hemorrhages and exudates are extremely rare m 
preeclampsia and when present, are almost invariably due to 
underlying chronic hypertensive vascular disease 
IMMEDIATE PROGNOSIS 
The prognosis for the mother and fetus is dependent to a con-
siderable extent on the gestational age of the fetus, whether 
improvement follows hospitalization, when and how delivery is 
accomplished, and whether eclampsia supervenes 
The perinatal mortality rate is vanably increased for preg-
nancies complicated by pregnancy-induced hypertension, as 
with the other hypertensive disorders It is dependent pnmanly 
upon the time of onset and the seventy of the disease Much of 
the loss is the consequence of prematurity, either from sponta-
neous labor or because of induced preterm delivery necessitated 
by severe preeclampsia 
PROPHYLAXIS AND EARLY TREATMENT 
EARLY DETECTION 
Because women are usually asymptomatic and seldom notice 
the signs of incipient preeclampsia, its early detection demands 
careful observation at appropriate,intervals, especially in 
women known to be predisposed to preeclampsia Major pre-
disposing factors are (1) nulhpanty, (2) familial history of 
preeclampsia-eclampsia, (3) multiple fetuses, (4) diabetes, (5) 
chronic vascular disease, (6) renal disease, (7) hydatidiform 
mole, and (8) fetal hydrops 
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Rapid weight gain any time during the latter half of preg-
nancy, or an upward trend in the diastolic blood pressure, even 
fohile still in the normal range, is worrisome. Every woman 
should be examined at least weekly during the last month of 
pregnancy and every 2 weeks during the previous 2 months. At 
these visits, the woman is weighed and careful blood pressure 
measurements made. Furthermore, all women should be ad-
vised verbally and preferably also by means of suitable printed 
mstructions to report immediately any ot the well-known symp~ 
toms or signs ot preeclampsia, such as headache, visual distur-
bances, and puhiness ot hands or face. The reporting of any 
#such symptoms calls tor an immediate examination to confirm 
or exclude preeclampsia. 
Weight Gain 
Obstetricians in the past often attempted to limit maternal 
weight gain to about 20 pounds, or even less, in the belief that 
preeclampsia could thereby be prevented. The total weight 
gained during pregnancy, however, probably has no relation to 
preeclampsia unless a large component of the gain is edema. 
Stringent restriction of weight gain is more likely to be detri-
mental rather than beneficial to both mother and fetus. The 
physician's scale, unfortunately, does not distinguish between 
the accumulation of edema fluid and the normal deposition of 
fetal and maternal tissue. 
DIURETICS AND SODIUM RESTRICTION 
Natriuretic drugs, such as chlorothiazide and its congeners, 
have been severely overused in the past. Although diuretics 
have been alleged to prevent the development of preeclampsia, 
the results of several studies cast doubt on their real value. The 
women studied by Kraus and associates (1966) took either a 
placebo or 50 mg of hydrochlorothiazide daily during at least 
the last 16 weeks of gestation. The incidence of preeclampsia 
was 6.67 percent in primigravid women given hydrochlorothi-
azide, as well as in those who took the placebo. Moreover, the 
frequency of hypertension was not altered in multiparous 
women. Collins and colleagues (1985) reviewed the results of 
nine such studies that included more than 7,000 women, and 
they concluded that perinatal mortality was not improved when 
diuretics were given to prevent preeclampsia. The failure of 
natriuretic drugs in the prevention of preeclampsia also raises 
serious doubt about the efficacy of rigid dietary sodium restric-
tion. 
Thiazide diuretics and similar compounds are not used in 
the treatment or prophylaxis of preeclampsia at Parkland Hos-
pital. While there is no clear evidence that they are of any value, 
there is evidence that these drugs can reduce renal perfusion as 
measured by creatinine clearance and more importantly, prob-
ably reduce uteroplacental perfusion as cited above (Gant and 
colleagues, 1975). Thiazides can induce serious sodium and 
potassium depletion, hemorrhagic pancreatitis, and severe 
thrombocytopenia in some newborns. 
OTHER DRUGS 
Wallenburg and co-workers (1986) reported their experiences in 
which they gave either 60 mg of aspirin or placebo to primi-
gravid women at 28 weeks gestation. These women were judged 
to be at high risk for developing preeclampsia because they 
were abnormally sensitive to infused angiotensin II. The re-
duced incidence of preeclampsia in the treated group was at-
tributed to suppression of thromboxane synthesis by platelets, 
with .subsequent endothelial prostacyclin dominance. In a group 
of women with prior bad pregnancy outcomes due to hyperten-
sion and placental insufficiency, Beaufils and colleagues (1985) 
reported that early prophylactic treatment with dipyridamole 
and aspirin reduced their recurrence. They also attributed these 
results to the antiplatelet actions of these drugs. Although these 
reports seem encouraging, more extensive investigations to con-
firm these observations are necessary before they can be recom-
mended for clinical practice. Currently the National Institutes of 
Health is sponsoring a multicenter study designed to investi-
gate this hypothesis. 
OBJECTIVES OF TREATMENT 
The basic management objectives for any pregnancy compli-
cated by pregnancy-induced hypertension are (1) termination of 
the pregnancy with the least possible trauma to the mother and 
the fetus, (2) birth of an infant who subsequently thrives, and 
(3) complete restoration of the health of the mother. In certain 
cases of preeclampsia, especially in women at or near term, 
these three objectives may be served equally well by careful 
induction of labor. Therefore, the most important information 
that the obstetrician has for the successful management of 
pregnancy, and especially pregnancy that becomes complicated 
by hypertension, is precise knowledge of the age of the fetus 
(see Chap. 14, p. 260). 
AMBULATORY TREATMENT 
Ambulatory treatment has no place in the management of 
pregnancy-induced or pregnancy-aggravated hypertension. Ex-
cluding young nulliparas, some women whose systolic blood 
pressure does not exceed 135 mm Hg and whose diastolic pres-
sure does not exceed PD mm Hg, and in whom proteinuria is 
absent, may be managed tentatively at home as long as trie 
disease does not become more severe and tetal growth retarda-
tion is not suspected. Bed rest throughout the greater part ot tne 
day is essential. Moreover, these women should be examined 
twice weekly rather than once weekly, and they should oe 
instructed in detail about reporting symptoms. With minor el-
evations of blood pressure, the response to this regimen is often 
immediate, but the woman must be cooperative and the obste-
trician wary. 
HOSPITAL MANAGEMENT 
The indication for hospitalization of women with pregnancy-
induced hypertension is a sustained elevation in systolic blood 
pressure of 140 mm Hg or above or a diastolic pressure of 90 mm 
Hg or above. For an intelligent continuing appraisal of the se-
verity of the disease, upon admittance to the hospital, a sys-
tematic study should be instituted that includes the following: 
1. An appropriate history and general physical examina-
tion followed by daily search for the development of 
signs and symptoms such as headache, visual distur-
bances, epigastric pain, and rapid weight gain 
2. Weight measurement on admittance and every 2 days 
thereafter 
3. Urine test for protein on admittance and subsequently at 
least every 2 days 
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MANAGEMENT OF PREECLAMPSIA 
For over a century the phrase "toxemia of preg-
nancy" was used to describe hypertensive disorders 
complicating pregnancy. The term was also used for 
a variety of other poorly understood conditions, in-
cluding hyperemesis gravidarum and acute yellow 
atrophy of the liver. Because of this ambiguity, the 
following classification is now preferred. 
Classification of Hypertensive Disorders 
in Pregnancy 
I. Pregnancy-induced hypertension 
A. Preeclampsia 
1. Mild 
2. Severe 
B. Eclampsia 
II. Chronic hypertension preceding pregnancy (any 
etiology) 
IN. Chronic hypertension (any etiology) with super-
imposed pregnancy-induced hypertension 
A. Superimposed preeclampsia 
B. Superimposed eclampsia 
It is apparent that virtually all of the hypertensive 
diseases that occur during pregnancy are included 
in this clinical classification, proposed in 1971. The 
original outline has been modified here by the use 
of the term "pregnancy-induced hypertension." The 
Committee on Terminology of the American College 
pf Obstetricians and Gynecologists has established 
standard definitions for each of these conditions (1). 
Hypertension is defined as a diastolic blood pressure 
ofat least 90 mm Hg or a systolic pressure ofat least 
14(Tmm Hg, or a rise in the former of at least 15 mm 
Hg or in the latter of 30 mm Hg. These blood pres-
sures must be manifested on at least two occasions 
fr hours or more apart. Preeclampsia is the develop-
ment of hypertension with proteinuria (presence of 
300 mgor more of protein in a 24-hour urine collec-
tion or a protein concentration of 1 g or more per 
liter in at least two random urine specimens collected 
6 hours or more apart) or edema (a generalized ac-
cumulation of fluid of greater than 1 + pitting edema 
after 12 hours of bed rest or weight gain of 5 pounds 
or more in 1 week), or both, induced by pregnancy 
after the 20th week of gestation, and sometimes 
earlier, when there are extensive hydatidiform changes 
in the chorionic villi (2). Another rare event may be 
the development of a typical preeclamptic finding 
in the absence of any previous hypertension, which 
may be the consequence of a rare autoimmune re-
sponse caused by the presence of the lupus anti-
coagulant. This lupus anticoagulant may be present, 
in fact, without any of the diagnostic features of lupus 
erythematosus or without a previous history of 
thrombotic episodes (3). Preeclampsia is regarded 
as mild unless one or more of the following signs or 
symptoms are present, in which case it is classified 
as severe: 
• Blood pressure readings, with the patient at bed 
rest, ofat least 160 mm Hg systolic pressure or 110 
mm Hg diastolic pressure on two occasions at least 
6 hours apart (in practice, however, one should 
not wait 6 hours between blood pressure readings 
of greater than 110 mm Hg diastolic pressure 
before diagnosing severe pregnancy-induced 
hypertension and taking appropriate action) 
• Proteinuria levels ofat least 5 g in a 24-hour urine 
collection (or 3+ to4 + based on semiquantitative 
assay) 
• Oliguria (24-hour urinary output of less than 
400-500 ml) 
• Cerebral or visual disturbances such as altered 
consciousness, headache, scotomata, or blurred 
vision 
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• Pulmonary edema or cyanosis 
• Epigastric or right upper quadrant pain, presum-
ably caused by stretching of Glisson's capsule (oc-
casionally the pain precedes hepatic rupture, an 
uncommon but catastrophic complication) 
• Impaired liver function of unclear etiology 
• Thrombocytopenia, postulated to be caused by 
platelet adherence to collagen exposed at sites of 
disrupted vascular endothelium (4) 
Eclampsia is the occurrence of convulsions, not 
caused by any coincidental neurologic disease such 
as epilepsy, in a woman whose condition also meets 
the criteria for preeclampsia Chronic hypertension 
is defined as the presence of persistent hypertension, 
of whatever cause, before the 20th week of gesta-
tion in the absence of hydatidiform mole or exten-
sive molar change, or persistent hypertension beyond 
6 weeks postpartum Superimposed preeclampsia 
or eclampsia is defined as the development of pre-
eclampsia or eclampsia in a woman with chronic 
hypertensive vascular or renal disease (2) 
Pathophysiology 
Effects on the Mother 
Although numerous theories and opinions have 
been advanced to explain the etiology of pregnancy-
induced hypertension, virtually all authorities agree 
on these common features 1) the disease process 
is characterized by hypertension and various degrees 
of impaired tissue perfusion, and 2) for some unique 
and as yet unexplained reason, a pnmigravida has 
the highest risk of developing pregnancy-induced 
hypertension 
There are many potential consequences of preg-
nancy-induced hypertension for the mother, most 
effects, however, can be categorized as cardiovas-
cular, hematologic, and regional perfusion abnor-
malities 
CARDIOVASCULAR EFFECTS 
The primary characteristic of preeclampsia is an ele-
vation in blood pressure Blood pressure is the prod-
uct of cardiac output and peripheral resistance In 
a normal pregnancy, the cardiac output increases by 
30-50%, this increase is maintained in patients with 
preeclampsia (5) The elevation in blood pressure 
seen in pregnancy-induced hypertension is, there-
fore, probably the direct result of a change in 
peripheral vascular resistance 
The exact reasons for increased vascular resistance 
remain a mystery, some pioneering work (6), how-
ever has led investigators to examine the pressor ef-
fects ot angiotensin II in pregnancy A relative refrac-
tory response to the pressor effects of angiotensin I! 
in late normal pregnancy has been observed Addi-
tional studies (7) have indicated that preeclamptic 
patients lose their pregnancy-associated refractori-
ness to angiotensin II Further work (8) has reported 
that women predisposed to pregnancy-induced 
hypertension become progressively more sensitive 
to the pressor effects oi infused angiotensin II after 
18 weeks of gestation This increased sensitivity to 
the pressor effects of angiotensin II, and possibly to 
other pressor agents as well, often results in altera-
tions of regional perfusion, which may lead to the 
other physiologic changes observed with pregnancy-
induced hypertension, such as changes in the hema-
tologic system 
HEMATOLOGIC EFFECTS 
The most frequent hematologic consequence of 
pregnancy-induced hypertension is the constriction 
of plasma volume, which can result in decreased 
regional perfusion and could subject the woman to 
hypovolemic shock if antepartum or postpartum 
hemorrhage occurs These patients are not hypo-
volemic but are volume constricted Thus, the vas-
cular system is not underfilled but is constricted by 
the pressor effects noted above This observation is 
clinically substantiated by the observation of a ris-
ing hematocrit as the severity and duration of preg-
nancy-induced hypertension increases 
Thrombocytopenia is the most frequent coagula-
tion abnormality that occurs in women with preg-
nancy-induced hypertension (4) The frequency and 
severity of this condition is increased with earlier 
onset or in patients with chronic hypertension and 
superimposed preeclampsia The thrombocytopenia 
itself is probably a manifestation of microangiopathic 
hemolytic anemia This entity is characterized by 
hemolytic anemia accompanied by bizarre red 
blood cell morphology and consumption of platelets 
and other coagulation factors It is likely to be the 
consequence of endothelial damage resultmgfrom 
the arteriolar spasm that accompanies pregnancy-
induced hypertension This syndrome is a variation 
of disseminated intravascular coagulation, but the 
full picture of disseminated intravascular coagula-
tion is usually not observed 
REGIONAL PERFUSION ABNORMALITIES 
Renal blood flow is reported to decrease in women 
with pregnancy-induced hypertension This decrease 
in renal plasma flow averages 20%, and glomerular 
filtration rates decrease by,an average of 32% (9) 
There is evidence that hepatic blood flow and perfu-
fusion to the extremities are reduced, but a consen-
sus is lacking in these areas of research. 
Usually cerebral blood flow is unaltered by preg-
nancy-induced hypertension (10). It is important to 
note that hydralazine and magnesium sulfate appear 
to increase cerebral blood flow and oxygen con-
sumption in women with pregnancy-induced hyper-
tension, whereas barbiturates are reported to in-
crease cerebrovascular resistance and decrease ce-
rebral blood flow and oxygen consumption (11). 
Effects on the Fetus 
The decrease in maternal-placental perfusion that 
accompanies maternal vascular spasm in pregnancy-
induced hypertension is believed to account for the 
increased perinatal morbidity and mortality associ-
ated with this disease process. Although several 
methods have been used to measure uteroplacental 
perfusion, all methods thus far used have revealed 
a decrease of approximately 50-70% in uteroplacen-
tal blood flow in women with pregnancy-induced 
hypertension (12). 
The use of diuretics and antihypertensive agents 
does not result in improved uteroplacental blood 
flow in women with pregnancy-induced hypertension 
(12). The failure to increase uteroplacental blood flow 
and to lower perinatal mortality is probably the re-
sult of diuretics further decreasing plasma volume. 
Similarly, antihypertensive therapy in patients with 
pregnancy-induced hypertension has failed to improve 
outcome, probably because uteroplacental blood 
flow is directly related to uterine arterial blood pres-
sure, which may be reduced by this treatment (13). 
Clinical Management 
In the past, essential management included prevent-
ing convulsions, controlling blood pressure, and 
delivering the baby. This is still the best approach if 
preeclampsia occurs when the fetus is mature. When 
the fetus is immature, delivery should be effected if 
there is severe preeclampsia, fetal growth retarda-
tion, or fetal distress. If, however, a patient has mild 
preeclampsia and the fetus is immature and appar-
ently healthy, ambulatory or hospital management 
without delivery is acceptable (Table 1). 
When delivery is indicated, the prevention or treat-
ment of convulsions involves the use of parenteral 
magnesium sulfate, which may be given either intra-
muscularly or intravenously. One method of admin-
istration is as follows. A 20-ml injection of a 20% 
magnesium sulfate solution (4g) is given intravenous-
ly over'? minutes? This is immediately fo!' )wed by 
20 ml of a 50% magnesium sulfate solution, one-half 
(5 g) of which is injected deeply in the upper outer 
quadrant of each buttock (10 gtotal dose). Thereafter, 
10 ml of a 50% magnesium sulfate solution (5 g) is 
injected intramuscularly into alternate buttocks 
every 4 hours (14). Another method of administer-
ing magnesium sulfate involves a similar 4-g intra-
venous loading dose followed by continuous intra-
venous infusion of 1-3 g/h, depending on the inten-
sity of the patellar reflex. For the administration of 
magnesium sulfate to continue, the patient should 
have 1) a patellar reflex; 2) urine flow greater than 
25 ml/h; and 3) respiration greaterthan 12/min (15). 
If magnesium levels are obtained, they should be 4-8 
mg/dl. Magnesium toxicity most often can be re-
versed by the slow intravenous administration of 10% 
calcium gluconate and nasal oxygen. In instances 
in which toxicity cannot be reversed with calcium 
gluconate, respiration must be supported until mag-
nesium levels in plasma are reduced. 
Antihypertensive therapy consists of the intermit-
tent intravenous administration of hydralazine (14). 
In a patient with a diastolic blood pressure of 110 mm 
Hg, 5 mg of hydralazine is given intravenously and 
blood pressure is monitored every 5 minutes. The 
goal of therapy is to reduce diastolic blood pressure 
to the range oi 90-100 mm Hg. 
Vaginal delivery usually can be accomplished by 
initiating labor with intravenous oxytocin. Relatively 
rapid labor may ensue in patients with severe pre-
eclampsia. The final decision for a vaginal versus an 
abdominal delivery, however, is based on an evalua-
tion of all maternal and fetal indications. Diuretics 
and hyperosmotic agents should not be used. 
For a patient who has mild pregnancy-induced 
hypertension with an immature fetus, the goal of 
therapy should be to 1) retard the hypertensive 
process so as not to endangerthe mother orthefetus, 
2) allow time for the fetus to mature and increase the 
potential for neonatal survival, and 3) allowthecer-
vix to ripen and therefore increase the probability 
for a vaginal delivery. Therapy forthese patients can 
be conducted by either ambulatory management or 
hospitalization. Ambulatory management is accept-
able for patients who are compliant, who can have 
frequent office visits including laboratory assess-
ments, and who can perform some form of adequate 
blood pressure monitoring at home. Hospitalization 
should be required for noncompliant patients and 
those who show unsatisfactory progress as out-
patients. In either situation, the following regimen 
should be recommended: 
• Ambulation with modified bed rest in the lateral 
decubitus position 
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TABLE 1. CLINICAL MANAGEMENT OF PATIENTS WITH PREGNANCY INDUCED HYPERTENSION 
Clinical Condition Therapy 
Mild pregnancy-induced hypertension 
and immature fetus 
Compliant patient and improvement 
Noncompliant patient or lack of improvement 
Severe pregnancy-induced hypertension and 
immature fetus in the presence of fetal growth 
retardation or fetal jeopardy 
Severe pregnancy-induced hypertension and 
mature fetus 
Expectant 
1) Ambulatory management 
a See patient twice a week 
b Fetal surveillance* 
c Bed rest 
d Educate about increasing severity of the disease 
e Weight daily 
f Home blood pressure monitoring 
2) Hospitalization 
a Urine protein daily 
b Fetal surveillance* 
c Regular diet 
d No salt restriction 
e Weight daily 
f Blood pressure four times a day 
Definitive 
1) Prevent convulsions (magnesium sulfate) 
2) Control blood pressure (hydralazine) 
3) Deliver by vaginal or cesarean birth, depending upon 
fetal and maternal conditions 
Definitive 
1) Prevent convulsions (magnesium sulfate) 
2) Control blood pressure (hydrazalme) 
3) Deliver by vaginal or cesarean birth, depending upon 
fetal and maternal conditions 
* Fetal surveillance is defined as tests of fetal well being including but not limited to fetal movement charts contraction stress tests nonstress tests and 
biophysical profiles 
• Regular diet 
• B lood pressure measurements four t imes dai ly 
• Weight and ur ine protein recorded two or three 
t imes weekly 
• Creat in ine clearance recorded week ly 
• Fetal survei l lance 
• Serial sonography 
A patient is considered a candidate for induc t ion 
of labor if she has reached 37 weeks of gestation, the 
fetus is mature, and the cond i t i on of the cervix is 
favorable She is also a candidate for induct ion if her 
diastolic b lood pressure cont inues to rise despite 
conservative management A patient w i t h mi ld 
pregnancy- induced hypertension may be fo l lowed 
beyond 37 weeks of gestation if fetal evaluat ion is 
normal and the cond i t ion of the cervix is unfavor-
able Ind iv idual ized t reatment is necessary 
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UTAH VITAL STATITSTIC SUMMARY 
UTAH'S VITAL STATISTICS SUMMARY 
UTAH DEPARTMENT OF HEALTH 
TECHNICAL REPORT NO. 164 BUREAU OF VITAL RECORDS & HEALTH STATISTICS 
DECEMBER 1992 CENTER FOR HEALTH STATISTICS 
FINAL VITAL STATISTICS, JANUARY 1 - DECEMBER 31, 1991 
UTAH'S INFANT MORTALITY RATES DROPPED TO AN ALL-TIME LOW OF 6.2 PER THOUSAND LIVE BIRTHS IN 1991, THE LOWEST IN 
UTAH'S HISTORY. THIS WAS A DECREASE OF 16 PERCENT FROM THE PREVIOUS RECORD LOW RATE OF 7.4 IN 1990. THE NUMBER OF 
INFANT DEATHS DECREASED BY MORE THAN 18 PERCENT FROM 269 IN 1990, TO 222 IN 1991. THE PROVISIONAL RATE IN THE UNITED 
STATES WAS 8.9 IN 1991, A DECREASE BY TWO PERCENT FROM 9.1 THE PREVIOUS YEAR. THIS ALSO WAS THE LOWEST RATE EVER 
RECORDED FOR THE UNITED STATES. 
THERE WERE 36,016 LIVE BIRTHS TO UTAH'S RESIDENTS IN 1991. THIS IS A DECREASE OF LESS THAN ONE PERCENT BELOW THE 
36,253 IN 1990. THE CRUDE BIRTH RATE, THE NUMBER OF RESIDENT LIVE BIRTHS PER 1,000 RESIDENTS, ALSO DECREASED BY LESS 
THAN ONE PERCENT, FROM 21.0 IN 1990 TO 20.3 IN 1991. THE PROVISIONAL BIRTH RATE NATIONALLY WAS 16.2 IN 1991, A THREE 
PERCENT DECLINE FROM THE RATE OF 16.7 IN 1990. 
BOTH THE NUMBER AND RATE OF BIRTHS TO UNMARRIED WOMEN INCREASED BETWEEN 1990 AND 1991. IN 1991, THERE WERE 5,195 
INFANTS BORN TO UNMARRIED WOMEN, AN INCREASE OF ALMOST SIX PERCENT ABOVE THE 4,910 IN 1990. THE RATE OF BIRTHS TO 
UNMARRIED WOMEN INCREASED BY ALMOST SEVEN PERCENT FROM 135.4 IN 1990 TO 144.2 PER THOUSAND LIVE BIRTHS IN 1991. THIS 
IS THE SEVENTEENTH CONSECUTIVE YEAR THIS RATE HAS INCREASED IN UTAH, FROM 38.0 IN 1974 TO 144.2 THIS PAST YEAR. 
NATIONALLY, THERE WERE 270.8 BIRTHS TO UNMARRIED WOMEN FOR EVERY 1,000 LIVE BIRTHS IN 1989, THIS WAS FIVE PERCENT HIGHER 
THAN THE 257.1 IN 1988. 
THE NUMBER AND RATIO OF INDUCED ABORTIONS TO UTAH'S RESIDENTS DECREASED BETWEEN 1990 AND 1991. IN 1991, THERE WERE 
3,759 ABORTIONS REPORTED TO RESIDENTS OF THE STATE. ALTHOUGH MOST OF THESE OCCURRED IN-STATE, 111 WERE REPORTED TO HAVE 
OCCURRED IN OTHER STATES. IN 1990, THERE WERE 4,159 ABORTIONS REPORTED TO RESIDENTS OF UTAH, WITH 99 OF THESE OCCURRING 
IN OTHER STATES. THE NUMBER OF ABORTIONS DECREASED BY ALMOST TEN PERCENT, AND THE ABORTION RATIO DECREASED BY NINE 
PERCENT, FROM 114.7 TO 104.4 PER 1,000 LIVE BIRTHS. NATIONALLY, PRELIMINARY DATA FOR 1989, THE LATEST YEAR AVAILABLE, 
SHOW THERE WERE 345.6 ABORTIONS FOR EVERY ONE THOUSAND LIVE BIRTHS, WHICH IS A DECREASE OF ABOUT TWO PERCENT FROM THE 
352 REPORTED IN 1988. 
IN 1991, THERE WERE 9,576 DEATHS TO RESIDENTS OF UTAH, AN INCREASE OF FIVE PERCENT COMPARED WITH THE 9,135 IN 1990. 
THE CRUDE MORTALITY RATE INCREASED BY ALMOST TWO PERCENT, TO 5.4 PER 1,000 POPULATION, COMPARED WITH 5.3 THE PREVIOUS 
YEAR. THE PROVISIONAL MORTALITY RATE NATIONALLY FOR 1991, 8.5 DEATHS PER 1,000 POPULATION, DECEASED BY SLIGHTLY MORE 
THAN ONE PERCENT FROM THE RATE OF 8.6 IN 1990. 
IN 1991, ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) AND AIDS RELATED DEATHS BECAME THE 12TH LEADING CAUSE OF DEATH 
FOR RESIDENTS OF UTAH, MOVING UP FROM THE 16TH PLACE IN 1990. THE NUMBER OF DEATHS INCREASED BY 24 PERCENT FROM 58 TO 
72 SINCE 1990. NATIONALLY, AIDS ROSE FROM THE 11TH LEADING CAUSE IN 1990, TO THE 9TH LEADING CAUSE IN 1991. THE NUMBER 
OF AIDS RELATED DEATHS NATIONALLY INCREASED FROM AN ESTIMATED 24,120 IN 1990, TO 29,850 IN 1991, ALSO A 24 PERCENT 
INCREASE FOR THE YEAR. 
TABLE 1 
FINAL VITAL STATISTICS, RESIDENTS: UTAH AND UNITED STATES, 1990-91 
EVENTS 
LIVE BIRTHS ( 
DEATHS 
NATURAL INCREASE 
MARRIAGES 
DIVORCES 
BIRTHS TO UNMARRIED WOMEN 
LOW BIRTH WEIGHT, <2,500 GRAMS 
INDUCED ABORTIONS 
FETAL DEATHS 
INFANT DEATHS 
NEONATAL 
POSTNEONATAL 
POPULATION IN MILLIONS 
UUMBER - \ 
' 
X 1991 
36,016 
N^g>76 
^ — 
19,472 
8,700 
5,195 
2,179 
3,759 
198 
222 
109 
113 
1.775 
\^ 
1990 
36,253 
9 , 1 2 5 ^ 
19,427 
8,950 
4,910 
2,070 
4,159 
189 
269 
137 
132 
1.729 
\ 
\ 1991 
J 20.3 
/ 5.4 
14.9 
11.0 
4.9 
144.2 
60.5 
104.4 
5.5 
6.2 
3.0 
3.1 
RATES 
REVISED 
1990 
21.0 
5.3 
15.7 
11.2 
5.2 
135.4 
57.1 
114.7 
5.2 
7.4 
3.8 
3.6 
- -
U. S. RATES 
PROVISIONAL 
1991 
16.2 
8.5 
7.7 
9.4 
4.7 
N.A. 
N.A. 
N.A. 
N.A. 
8.9 
5.4 
3.4 
252.2 
1990 
16.7 
8.6 
8.1 
9.8 
4.7 
270.8 
70.4 
345.6 
7.5 
9.1 
5.7 
3.3 
249.5 
NOTES: POPULATIONS ARE REVISED ESTIMATES BASED ON CENSUS OF POPULATION ON APRIL 1, 1990. ALL 
PREGNANCY OUTCOME RATES AND RATIOS ARE PER 1,000 LIVE BIRTHS. INDUCED ABORTIONS AND FETAL DEATHS 
ARE DEFINED AS RATIOS. FOR THE U.S., THE RATES FOR BIRTHS TO UNMARRIED WOMEN AND LOW BIRTI 
WEIGHT AND THE RATIOS FOR ABORTIONS AND FETAL DEATHS ARE FINAL FOR 1989. N.A. IS NOT AVAILABLE. 
TABLE 2 
ESTIMATED POPULATION, BIRTHS, DEATHS, NATURAL INCREASES, MARRIAGES, DIVORCES AND ANNULMENTS 
BY HEALTH DISTRICT AND COUNTY OF RESIDENCE: UTAH, 1991 
HEALTH 
DISTRICT/ 
COUNTY OF 
RESIDENCE 
TOTAL 
BEAR RIVER 
BOX ELDER 
CACHE 
RICH 
CENTRAL UTAH 
JUAB 
MILLARD 
PIUTE 
SANPETE 
SEVIER 
WAYNE 
DAVIS 
SALT LAKE 
SOUTHEASTERN 
CARBON 
EMERY 
GRAND 
SAN JUAN 
SOUTHWEST 
BEAVER 
GARFIELD 
IRON 
KANE 
WASHINGTON 
SUMMIT 
TOOELE 
UINTAH BASIN 
DAGGETT 
DUCHESNE 
UINTAH 
UTAH COUNTY 
WASATCH 
WEBER-MORGAN 
MORGAN 
WEBER 
UNITED STATES 
ESTIMATED 
POPULATION 
1 JULY 1991 
1,775,100 
110,700 
37,100 
71,900 
1,700 
53,750 
6,000 
11,600 
1,350 
16,900 
15,700 
2,200 
195,000 
747,000 
50,300 
20,600 
10,200 
6,800 
12,700 
87,600 
4,850 
4,100 
21,500 
5,250 
51,900 
16,600 
27,200 
36,600 
700 
12,800 
23,100 
272,000 
10,700 
167,650 
5,650 
162,000 
252,177,000 
BIRTHS 
NUMBER 
36,016 
2,382 
718 
1,639 
25 
910 
89 
210 
15 
305 
261 
30 
3,760 
14,782 
961 
343 
205 
88 
325 
1,635 
77 
76 
448 
89 
945 
282 
479 
711 
12 
246 
453 
6,776 
186 
3,152 
79 
3,073 
4,111,000 
RATE 
20.3 
21.5 
19.4 
22.8 
14.7 
16.9 
14.8 
18.1 
11.1 
18.0 
16.6 
13.6 
19.3 
19.8 
19.1 
16.7 
20.1 
12.9 
25.6 
18.7 
15.9 
18.5 
20.8 
17.0 
18.2 
17.0 
17.6 
19.4 
17.1 
19.2 
19.6 
24.9 
17.4 
18.8 
14.0 
19.0 
16.2 
DEATHS 
NUMBER 
9,576 
581 
213 
361 
7 
435 
58 
80 
17 
147 
111 
22 
730 
4,089 
338 
151 
59 
59 
69 
668 
48 
53 
120 
40 
407 
61 
140 
207 
7 
79 
121 
1,165 
59 
1,103 
36 
1,067 
2,165,000 
RATE 
5.4 
5.2 
5.7 
5.0 
4.1 
8.1 
9.7 
6.9 
12.6 
8.7 
7.1 
10.0 
3.7 
5.5 
6.7 
7.3 
5.8 
8.7 
5.4 
7.6 
9.9 
12.9 
5.6 
7.6 
7.8 
3.7 
5.1 
5.7 
- -
6.2 
5.2 
4.3 
5.5 
6.6 
6.4 
6.6 
8.5 
NATURAL 
INCREASE 
26,440 
1,801 
505 
1,278 
18 
475 
31 
130 
-2 
158 
150 
8 
3,030 
10,693 
623 
192 
146 
29 
256 
967 
29 
23 
328 
49 
538 
221 
339 
504 
5 
167 
332 
5,611 
127 
2,049 
43 
2,006 
1,946,000 
MARRIAGES 
NUMBER 
19,472 
1,342 
242 
1,082 
18 
1,117 
46 
70 
9 
863 
118 
11 
1,099 
10,251 
405 
177 
67 
77 
84 
1,091 
43 
29 
152 
51 
816 
271 
229 
374 
50 
102 
222 
1,600 
112 
1,581 
49 
1,532 
2,371,000 
RATE 
11.0 
12.1 
6.5 
15.0 
10.6 
20.8 
7.7 
6.0 
6.7 
51.1 
7.5 
5.0 
5.6 
13.7 
8.1 
8.6 
6.6 
11.3 
6.6 
12.5 
8.9 
7.1 
7.1 
9.7 
15.7 
16.3 
8.4 
10.2 
71.4 
8.0 
9.6 
5.9 
10.5 
9.4 
8.7 
9.5 
9.4 
DIVORCE & 
ANNULMENTS 
NUMBER 
8,700 
316 
179 
136 
1 
192 
28 
41 
8 
43 
69 
3 
983 
4,063 
210 
108 
30 
53 
19 
482 
26 
13 
117 
21 
305 
72 
133 
144 
0 
40 
104 
1,028 
47 
1,030 
4 
1,026 
1,187,000 
RATE 
4.9 
2.9 
4.8 
1.9 
- -
3.6 
4.7 
3.5 
5.9 
2.5 
4.4 
- -
5.0 
5.4 
4.2 
5.2 
2.9 
7.8 
1.5 
5.5 
5.4 
3.2 
5.4 
4.0 
5.9 
4.3 
4.9 
3.9 
- -
3.1 
4.5 
3.8 
4.4 
6.1 
0.7 
6.3 
4.7 
NOTES: FOR UTAH, RATES ARE PER 1,000 POPULATION; HOWEVER, THEY ARE NOT COMPUTED FOR LESS THAN SEVEN VITAL EVENTS. MARRIAGES ARE RECORDED 
FOR COUNTY OF OCCURRENCE, WHILE DIVORCES ARE RECORDED FOR COUNTY OF RESIDENCE. FOR THE UNITED STATES ALL FREQUENCIES AND RATES ARE FOR 
1991 AND ARE PROVISIONAL. 
INFANT MORTALITY--TOTAL, NEONATAL, POSTNEONATAL, OUT-OF-WEDLOCK, LOW WEIGHT BIRTHS AND ABORTIONS 
BY HEALTH DISTRICT AND COUNTY OF RESIDENCE: UTAH, 1991 
HEATLH 
DISTRICT/ 
COUNTY OF 
RESIDENCE 
TOTAL 
BEAR RIVER 
BOX ELDER 
CACHE 
RICH 
CENTRAL UTAH 
JUAB 
MILLARD 
PIUTE 
SANPETE 
SEVIER 
WAYNE 
DAVIS 
SALT LAKE 
SOUTHEASTERN 
CARBON 
EMERY 
GRAND 
SAN JUAN 
SOUTHWEST 
BEAVER 
GARFIELD 
IRON 
KANE 
WASHINGTON 
SUMMIT 
TOOELE 
UINTAH BASIN 
DAGGETT 
DUCHESNE 
UINTAH 
UTAH COUNTY 
WASATCH 
WEBER-MORGAN 
MORGAN 
WEBER 
UNITED STATES 
TOTAL 
NUMBER 
222 
12 
6 
6 
0 
4 
0 
0 
0 
4 
0 
0 
16 
106 
11 
4 
2 
2 
3 
5 
0 
0 
2 
0 
3 
0 
1 
2 
0 
1 
1 
39 
3 
23 
0 
23 
36,600 
RATE 
6.2 
5.0 
- -
4.3 
7.2 
11.4 
- -
- -
- -
- -
5.8 
- -
7.3 
7.5 
8.9 
- INFANT MORTA 
NEONATAL 
BIRTH 
TO 28 DAY 
NUMBER 
109 
7 
3 
4 
0 
3 
0 
0 
0 
3 
0 
0 
12 
46 
6 
3 
1 
1 
1 
3 
0 
0 
2 
0 
1 
0 
0 
1 
0 
1 
0 
17 
2 
12 
0 
12 
22,640 
LI 1 T 
s 
RATE 
3.0 
2.9 
- -
3.2 
3.1 
- -
- -
- -
- -
- -
2.5 
- -
3.8 
3.9 
5.5 
POSTNEONATAL 
28 DAYS 
TO 1 YEAR 
NUMBER RATE 
113 
5 
3 
2 
0 
1 
0 
0 
0 
1 
0 
0 
4 
60 
5 
1 
1 
1 
2 
2 
0 
0 
0 
0 
2 
0 
1 
1 
0 
0 
1 
22 
1 
11 
0 
11 
13,800 
3.1 
- -
- -
- -
4.1 
- -
- -
- -
- -
- -
3.2 
- -
3.5 
3.6 
3.4 
BIRTHS 
UNMARRIED 
NUMBER 
5,195 
203 
85 
117 
1 
112 
16 
19 
1 
35 
38 
3 
416 
2,603 
281 
73 
37 
40 
131 
186 
4 
8 
42 
13 
119 
20 
98 
135 
0 
41 
94 
469 
19 
653 
4 
649 
1,094,169 
TO 
WOMEN 
RATE 
144.2 
85.2 
118.4 
71.4 
123.1 
179.8 
90.5 
114.8 
145.6 
110.6 
176.1 
292.4 
212.8 
180.5 
454.5 
403.1 
113.8 
105.3 
93.8 
146.1 
125.9 
70.9 
204.6 
189.9 
166.7 
207.5 
69.2 
102.2 
207.2 
211.2 
270.8 
LOW BIRTH WEIGHT 
UNDER 
2,500 GRAMS 
NUMBER RATE 
2,179 
140 
58 
80 
2 
51 
1 
9 
1 
15 
22 
3 
221 
970 
55 
17 
13 
4 
21 
80 
4 
6 
26 
2 
42 
10 
33 
55 
0 
21 
34 
330 
12 
222 
5 
217 
284,391 
60.5 
58.8 
80.8 
48.8 
56.0 
42.9 
49.2 
84.3 
58.8 
65.6 
57.2 
49.6 
63.4 
64.6 
48.9 
58.0 
44.4 
35.5 
68.9 
77.4 
85.4 
75.1 
48.7 
64.5 
70.4 
70.6 
70.4 
INDUCED 
ABORTIONS 
NUMBER RATIO | 
3,759 
124 
29 
95 
0 
42 
2 
7 
1 
20 
9 
3 
310 
2,412 
62 
34 
5 
13 
10 
12 
0 
1 
4 
2 
5 
96 
57 
38 
2 
14 
22 
205 
14 
387 
2 
385 
1,396,658 
104.4 
52.1 
40.4 
58.0 
46.2 
33.3 
65.6 
34.5 
82.4 
163.2 
64.5 
99.1 
147.7 
30.8 
7.3 
340.4 
119.0 
53.4 
56.9 
48.6 
30.3 
75.3 J 
122.8 
125.3 
345.6 
NOTES: FOR UTAH, THE RATES AND RATIOS ARE PER 1,000 LIVE BIRTHS; HOWEVER, THEY ARE NOT COMPUTED FOR FEWER THAN SEVEN EVENTS. THE INDUCED 
ABORTION TOTAL INCLUDES 111 EVENTS TO RESIDENTS OF UTAH WHICH OCCURRED OUT-OF-STATE. FOR THE UNITED STATES, FREQUENCIES AND RATES FOR 
INFANT MORTALITY ARE FOR 1991 AND PROVISIONAL; FREQUENCIES AND RATES FOR BIRTHS TO UNMARRIED WOMEN AND LOW BIRTH WEIGHT AND THE FREQUENCY 
AND RATIO FOR INDUCED ABORTIONS ARE FOR 1989 AND FINAL. 
TABLE 4 
DEATHS BY SELECTED CAUSES AND AGE, RESIDENTS: UTAH, 1991 
I CD CODES 
9TH REVISION CAUSE OF DEATH (9TH REV) RATES 
539.5 
5.1 
4.1 
2.1 
110.4 
1.1 
0.0 
26.0 
19.5 
11.0 
16.3 
4.3 
17.7 
5.2 
ALL 
AGES 
9,576 
90 
72 
38 
1,959 
19 
461 
346 
196 
290 
77 
315 
92 
<1 
222 
1 
0 
2 
2 
0 
0 
0 
0 
0 
0 
1 
0 
1-4 
63 
1 
0 
0 
5 
0 
0 
0 
0 
0 
0 
3 
1 
5-14 
83 
0 
0 
0 
7 
0 
0 
0 
0 
0 
0 
3 
3 
15-24 
202 
0 
1 
0 
9 
0 
0 
0 
0 
0 
0 
3 
3 
25-34 
300 
3 
27 
3 
33 
2 
4 
2 
4 
5 
1 
8 
4 
35-44 
421 
1 
25 
6 
98 
0 
20 
8 
12 
8 
0 
35 
8 
45-54 
466 
5 
13 
2 
148 
2 
41 
19 
28 
9 
3 
31 
3 
55-64 
979 
9 
4 
4 
375 
4 
83 
97 
47 
34 
12 
50 
17 
65-74 
1,942 
22 
2 
7 
564 
5 
122 
122 
54 
85 
28 
79 
25 
75+ 
4,897 
48 
0 
14 
718 
6 
191 
98 
51 
149 
33 
102 
28 
UN-
KNOWN 
1 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
038-
042-044 
001-037.039-041 
045-139 
140-208 
140-149 
150-159 
160-165 
174-175 
179-187 
188-189 
170-173,190-199 
204-208 
200-203 
210-239 
250 
260-269 
280-285 
390-448 
390-398.402,404-429 
390-398 
402,404-
410-414 
410-
411-414 
424-
415-423,425-429 
401-403 
430-438 
434-
430,433,435-438 
440-
441-448 
480-487 
480-486 
487-
490-496 
490-491 
492-
493-
494-496 
531-533 
550-553,560 
571-
580-589 
740-759 
760-779 
767-769 
760-766,770-779 
780-799 
E800-E949 
E810-E825 
E800-E807,E826-E949 
E950-E959 
E960-E978 
E980-E999 
RESIDUAL 
TOTAL. ALL CAUSES 
SEPTICEMIA 
ACQUIRED IMMUNODEFICIENCY SYNDROME 
ALL OTHER INFECTIOUS AND PARASITIC 
DISEASES 
MALIGNANT NEOPLASMS 
MALIGNANT NEOPLASMS OF LIP, ORAL 
CAVITY AND PHARYNX 
MALIGNANT NEOPLASMS OF DIGESTIVE 
ORGANS AND PERITONEUM 
MALIGNANT NEOPLASMS OF RESPIRATORY 
AND INTRATHORACIC ORGANS 
MALIGNANT NEOPLASMS OF BREAST 
MALIGNANT NEOPLASMS OF GENITAL ORGANS 
MALIGNANT NEOPLASMS OF URINARY ORGANS 
MALIGNANT NEOPLASMS OF ALL OTHER 
AND UNSPECIFIED SITES 
LEUKEMIA 
OTHER MALIGNANT NEOPLASMS OF 
LYMPHATIC AND HEMATOPOIETIC TISSUES 
BENIGN NEOPLASMS, CARCINOMA IN SITU 
AND NEOPLASMS OF UNCERTAIN BEHAVIOR AND 
OF UNSPECIFIED NATURE 
DIABETES MELLITUS 
NUTRITIONAL DEFICIENCIES 
ANEMIAS 
MAJOR CARDIOVASCULAR DISEASES 
DISEASES OF HEART 
RHEUMATIC FEVER AND RHEUMATIC HEART 
DISEASE 
HYPERTENSIVE HEART DISEASE, HYPERTENSIVE 
HEART AND RENAL DISEASE 
ISCHEMIC HEART DISEASE 
ACUTE MYOCARDIAL INFARCTION 
OLD MYOCARDIAL INFARCTION AND OTHER 
FORMS OF CHRONIC ISCHEMIC HEART 
DISEASE 
OTHER DISEASES OF ENDOCARDIUM 
ALL OTHER FORMS OF HEART DISEASE 
HYPERTENSION WITH OR WITHOUT RENAL 
DISEASE 
CEROBROVASCULAR DISEASES 
OCCLUSION OF CEREBRAL ARTERIES 
ALL OTHER AND LATE EFFECTS OF 
CEREBROVASCULAR DISEASE 
ATHEROSCLEROSIS 
OTHER DISEASES OF ARTERIES, ARTERIOLES 
AND CAPILLARIES 
PNEUMONIA AND INFLUENZA 
PNEUMONIA 
INFLUENZA 
CHRONIC OBSTRUCTIVE PULMONARY DISEASES 
AND ALLIED CONDITIONS 
BRONCHITIS, CHRONIC AND UNSPECIFIED 
EMPHYSEMA 
ASTHMA 
OTHER CHRONIC OBSTRUCTIVE PULMONARY 
DISEASES AND ALLIED CONDITIONS 
ULCER OF STOMACH AND DUODENUM 
HERNIA OF ABDOMINAL CAVITY AND INTESTINAL 
OBSTRUCTION WITHOUT MENTION OF HERNIA 
CHRONIC LIVER DISEASE AND CIRRHOSIS 
NEPHRITIS, NEPHROTIC SYNDROME, AND 
NEPHROSIS 
CONGENITAL ANOMALIES 
CERTAIN CONDITIONS ORIGINATING IN THE 
PERINATAL PERIOD 
BIRTH TRAUMA. INTRAUTERINE HYPOXIA 
BIRTH ASPHYXIA AND RESPIRATORY 
DISTRESS SYNDROME 
OTHER CONDITIONS ORIGINATING IN THE 
PERINATAL PERIOD 
SYMPTOMS, SIGNS AND ILL-DEFINED CONDITIONS 
ACCIDENTS AND ADVERSE EFFECTS 
MOTOR VEHICLE ACCIDENTS 
ALL OTHER ACCIDENTS AW ADVERSE EFFECTS 
SUICIDE 
HOMICIDE AND LEGAL INTERVENTION 
ALL OTHER INJURIES 
ALL OTHER DISEASES 
9.2 
3.0 
163 
53 
18.2 
1.4 
1.0 
206.2 
154.9 
3.0 
6.8 
90.4 
45.3 
45.0 
3.8 
50.9 
2.8 
38.8 
3.5 
35.3 
4.1 
5.6 
21.9 
21.8 
0.1 
24.1 
1.1 
4.1 
1.8 
17.1 
2.1 
3.0 
4.7 
6.0 
5.4 
3.4 
0.3 
3.1 
9.6 
26.1 
14.6 
11.5 
15.9 
3.4 
2.2 
60.2 
323 
25 
18 
3,660 
2,749 
53 
121 
1,604 
805 
799 
68 
903 
50 
689 
62 
627 
72 
100 
389 
387 
2 
428 
19 
73 
32 
304 
37 
53 
83 
106 
96 
61 
6 
55 
171 
463 
259 
204 
282 
61 
39 
1,069 
0 
0 
0 
2 
1 
0 
0 
0 
0 
0 
0 
1 
0 
1 
0 
1 
0 
0 
3 
3 
0 
0 
0 
0 
0 
0 
0 
0 
0 
1 
60 
59 
6 
53 
66 
10 
1 
8 
0 
3 
2 
11 
0 
0 
1 
5 
5 
0 
0 
0 
0 
0 
0 
5 
0 
0 
0 
0 
0 
0 
2 
2 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
10 
1 
0 
1 
1 
27 
12 
16 
0 
5 
0 
4 
1 
0 
0 
4 
1 
0 
0 
0 
0 
0 
0 
1 
1 
1 
0 
1 
0 
1 
1 
1 
0 
1 
0 
0 
1 
0 
0 
0 
0 
0 
4 
1 
0 
1 
1 
38 
19 
19 
4 
10 
0 
11 
13 
60 
24 
0 
0 
0 
2 
1 
0 
0 
0 
0 
0 
0 
1 
0 
1 
1 
0 
0 
0 
0 
0 
0 
2 
0 
0 
2 
0 
0 
0 
0 
0 
2 
0 
0 
0 
3 
89 
72 
17 
64 
13 
4 
12 
7 
1 
0 
19 
11 
1 
0 
5 
4 
1 
1 
4 
0 
5 
0 
5 
0 
3 
6 
5 
1 
2 
0 
0 
2 
0 
0 
0 
0 
2 
6 
0 
0 
0 
4 
78 
53 
25 
55 
11 
15 
26 
14 
0 
0 
48 
39 
0 
2 
21 
6 
15 
1 
15 
0 
7 
1 
6 
0 
2 
8 
8 
0 
2 
0 
0 
1 
1 
0 
0 
12 
3 
4 
0 
0 
0 
4 
59 
34 
25 
68 
11 
9 
47 
21 
1 
0 
116 
95 
1 
4 
54 
29 
25 
1 
35 
1 
17 
1 
16 
0 
3 
6 
6 
0 
11 
0 
4 
6 
3 
2 
14 
1 
6 
0 
0 
0 
6 
30 
19 
11 
28 
3 
6 
40 
35 
3 
2 
307 
250 
4 
21 
149 
90 
59 
5 
71 
4 
43 
4 
39 
2 
8 
17 
17 
0 
37 
4 
5 
5 
23 
1 
3 
21 
6 
1 
0 
0 
0 
4 
29 
12 
17 
22 
3 
1 
89 
97 
2 
2 
721 
586 
19 
26 
353 
208 
145 
13 
175 
10 
100 
9 
91 
5 
20 
55 
55 
0 
165 
5 
31 
8 
121 
6 
14 
20 
21 
2 
0 
0 
0 
13 
26 
16 
10 
22 
0 
1 
167 
148 
18 
13 
2,436 
1,760 
28 
68 
1,022 
468 
554 
47 
595 
34 
514 
46 
468 
65 
63 
291 
290 
1 
208 
10 
36 
9 
153 
27 
34 
16 
72 
1 
0 
0 
0 
69 
77 
21 
56 
19 
1 
1 
662 
o
o
o
o
o
 
o 
0 
0 
0 
0 
0 
o 
0 
0 
o 
0 
o 
0 
o 
0 
0 
0 
0 
0 
0 
o 
o 
1 
o 
0 
NOTES: MORTALITY RATES ARE PER 100,000 POPULATION. 
AND AIDS RELATED DEATHS AS COOES 042-044. 
IN 1987, THE NATIONAL CENTER FOR HEALTH STATISTICS BEGAN TO CODE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) 
qein 'Alio e>jBi p s 
lS9fr 'ON HWd3d 
aivd 
aovisod -s'n 
3ivy xina 
1069-869(108) 3NOHd3131 
OOz.0-91. IPS HV10 AUG 3 W 1 HVS 
00Z9L X08 O d 
SOI1SI1V1S H11V3H ONV 
SQdO03H 1V1IA dO nV3Hfl9 
H11V3H dO lN3WlfciVd3a 
Tab 6 
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University of Texas Medical School at Houston, Houston, Texas, 
Chief, Obstetrics and Gynecology, Hermann Hospital, Houston, Texas 
ROBERT RESNIK, M.D. 
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CHAPTER 
41 
PREGNANCY-
RELATED 
HYPERTENSION 
JAMES M. ROBERTS, M.D. 
CLASSIFICATION AND 
DEFINITIONS 
The hypertensive disorders of pregnancy 
challenge the medical and obstetric skills of 
the health care team. Decisions as to the 
possible use and appropriate choice of phar-
macologic agents require not only an under-
standing of the pathophysiology of the hyper-
tensive disorders and a recognition of the 
pharmacokinetic changes occurring during 
pregnancy but also an appreciation of the 
possible fetal effects of such therapeutic 
agents. Obstetric management demands metic-
ulous maternal observation and use of tests of 
fetal-placental function and fetal maturity in 
order to weigh maternal risks and the risks to 
the infant of intrauterine versus extrauterine 
existence. 
Recent information has provided new in-
sights into the pathophysiology of the hyper-
tensive disorders of pregnancy and has sug-
gested methods of evaluating and treating the 
patient with these disorders. 
The management of elevated blood pressure 
and the impact of the disorder on the mother 
and her fetus are quite different when hyper-
tension antedates pregnancy from when the 
appearance of elevated blood pressure signals 
the onset of a specific pregnancy-related va-
sospastic condition. An attempt to differen-
tiate these patients has led to several systems 
of nomenclature and classification. The hyper-
tensive disorders of pregnancy were for many 
years called toxemias of pregnancy, a term that 
originally even included hyperemesis gravida-
rum and acute yellow atrophy of the liver. This 
term reflected the opinion that these disorders 
had, as a common etiology, circulating toxins. 
Failure to identify these toxins did not lead to 
a revision of this terminology, signifying the 
continuing confusion that has plagued the tax-
onomy of these disorders. This archaic termi-
nology, which neither describes the disorders 
nor clarifies their etiology, has rightly been 
abandoned. 
One of the difficulties in interpreting studies 
of the hypertensive disorders of pregnancy is 
the inconsistency of terminology (Rippman, 
1969). Several systems of nomenclature are in 
Use around the world. The system prepared by 
the Committee on Terminology of the Amer-
ican College of Obstetricians and Gynecolo-
gists (Hughes, 1972), even though imperfect 
like all such systems, has the advantage of 
clarity and is available in published form to 
investigators throughout the world. This clas-
sification is as follows: 
Chronic hypertension 
Preeclampsia-eclampsia 
Preeclampsia superimposed upon chronic 
hypertension 
Transient hypertension 
Unclassified 
The various classifications are explained in the 
following discussion. 
Chronic Hypertension 
Chronic hypertension is defined as hyperten-
sion that is present and observable prior to 
pregnancy or that is diagnosed before the 20th 
Week of gestation. The Committee has defined 
hypertension as a blood pressure greater than 
140/90 mm Hg. Hypertension diagnosed for 
the first time during pregnancy that persists 
beyond the 42nd day postpartum is also clas-
sified as chronic hypertension. 
Preeclampsia-Eclampsla 
The diagnosis of preeclampsia is determined 
by increased blood pressure accompanied by 
proteinuria, edema, or both. Blood pressure 
must increase by at least 30 mm Hg systolic or 
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15 mm Hg diastolic. If prior blood pressure is 
not known, readings of 140/90 after 20 weeks 
gestation are considered sufficiently elevated 
for diagnosis of preeclampsia. This elevation 
must be present at two measurements taken 6 
hours apart. 
Page and Christianson (1976) advocated the 
use of mean arterial pressure during preg-
nancy. Mean pressures are determined by the 
following relationship: 
Mean arterial pressure = 
Systolic BP + (2 x Diastolic BP) 
3 
which can be simplified for clinical use to: 
Mean arterial pressure = 
Diastolic pressure -f (16 x Pulse pressure) 
The use of mean arterial pressure eliminates 
confusion regarding the significance of diastolic 
or systolic hypertension. For example, if one 
regards a mean arterial pressure of 105 as 
defining risk, this level may be associated with 
diastolic "hypertension" (125/95) or systolic 
"hypertension" (155/80). In addition, mean 
blood pressures are much easier to deal with 
statistically. The obvious disadvantage is that 
obstetricians are not familiar with the use of 
mean pressures. The Committee defines either 
an increase in mean arterial pressure of 20 mm 
Hg or, if a prior blood pressure is not known, 
a mean arterial pressure of 105 mm Hg as 
indicative of hypertension. 
Proteinuria is defined as the excretion of 0.1 
gm/liter of protein in a random specimen or 
0.3 gm/liter in a 24-hour specimen. Interest-
ingly, the Committee did not define the mini-
mum amount of protein excreted in 24 hours 
th&t can be considered diagnostic. On the basis 
of usual urinary output, the minimum would 
be about 0.3 gm/day. Edema is diagnosed as 
clinically evident swelling, but fluid retention 
may also be manifest as a rapid increase of 
weight without evident swelling. 
Preeclampsia has mild and severe forms. 
Severe preeclampsia is diagnosed when the 
following criteria are present: 
1. Bk)od pressure of 160 mm Hg or more 
systolic, or 110 mm Hg or more diastolic, 
recorded on at least two occasions at least 6 
hours apart, with the patient at bed rest. 
2. Proteinuria of 5 gm or more in 24 hours 
(3- or 4-plus on qualitative examination). 
3. Oliguria (500 ml or less in 24 hours). 
4. Cerebral or visual disturbances. 
5. Epigastric pain. 
6. Pulmonary edema or cyanosis. 
Eclampsia is the occurrence of seizures in a 
preeclamptic patient that cannot be attributed 
to other causes. 
Preeclampsia Superimposed Upon 
Chronic Hypertension 
There is ample evidence that preeclampsia 
may occur in women already hypertensive and 
that the prognosis for mother and fetus is much 
worse than with either condition alone. The 
Committee on Terminology recommends that 
the diagnosis be made on the basis of increases 
of blood pressure (30 mm Hg systolic and 15 
mm Hg diastolic, or 20 mm Hg mean arterial 
pressure) together with the appearance of pro-
teinuria or generalized edema. 
Transient Hypertension 
Transient hypertension is the development 
of elevated blood pressure during pregnancy 
or in the first 24 hours postpartum without 
other signs of preeclampsia or pre-existing 
hypertension. 
Unclassified Hypertension 
Information about these disorders is insuffi-
cient for classification. This category should be 
used for a minority of patients with hyperten-
sive disorders of pregnancy. 
Problems with Classification 
The degree of blood pressure elevation that 
constitutes gestational hypertension is contrcT-
versial. Because average blood pressure in 
women in their teens to 2Us is 12U/6U mm HgT 
the standard dennition ot hypertension—bloocT 
' pressure greater than 14U/9U mm Hg—is 
* judged by some investigators to be too high 
XVartran, 1966). There is evidence that the 
rate of perinatal mortality is increased irT 
'women with blood pressures even lower than"" 
140/90 (Page, 1976) ^ -
There are also problems inherent in the use 
of blood pressures measured in the first trimes-
ter to diagnose chronic hypertension or to 
define basal blood pressure for the diagnosis 
of preeclampsia. Blood pressure usually de-
creases early in pregnancy, reaching its nadir 
at about the stage of pregnancy at which 
women usually present for obstetric care (Fig. 
41-1). The decrease averages 7 mm Hg for 
diastolic and systolic readings. In some 
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FIGURE 41-1. Mean blood pressure by gestational 
age in 6,000 white women 25 to 34 years of age who 
delivered single term infants (From Chnstianson 
R Page EW Studies on blood pressure during 
pregnancy Influence of parity and age Am J Obstet 
Gynecol 125 509, 1976 Copyright 1976 by Amen 
can College of Obstetricians and Gynecologists ) 
women, obviously, blood pressure decreases 
more than 7 mm Hg, and in others, the early 
decline and subsequent return of blood pres-
sure to pre-pregnant levels in late gestation 
will be sufficient to diagnose preeclampsia 
There is evidence that women hypertensive 
prior to pregnancy actually have a greater 
decrease in blood pressure in early pregnancy 
than do normotensive women (Chesley and 
Annito, 1947) and thus are even more likely 
to be erroneously diagnosed as preeclamptic 
according to blood pressure criteria Also, the 
diagnosis of chronic hypertension based on the 
failure of blood pressure to return to normal 
by 42 days postpartum can be in error In a 
long-range prospective study by Chesley 
(1956), many women who remained hyperten 
sive 6 weeks postpartum were normotensive at 
long-term follow-up 
Even the triad of proteinuria, edema, and 
hypertension are nonspecific signs, and their 
presence in pregnancy could be due to condi-
tions other than preeclampsia Edema is a very 
physiologic finding present in many normal 
pregnant women The diagnosis of superim-
posed preeclampsia is especially difficult 
Women fulfilling diagnostic criteria for super-
imposed preeclampsia may, indeed, have pre-
eclampsia but in some of these women the 
origin of signs may instead be renal disease, 
either causing the hypertension or secondary 
to it that may comcidentally worsen during 
pregnancv Conversely, many women who ac-
tuall\ develop preeclampsia may not have the 
condition diagnosed This is a special problem 
in women receiving antihypertensive therapy, 
in whom early stages of preeclampsia without 
proteinuria may be masked by therapeutic 
lowering of blood pressure Superimposed pre-
eclampsia is especially difficult to diagnose in 
the hypertensive woman with proteinuria at 
the onset of pregnancy To aid in diagnosis, 
investigators have suggested the use of increas-
ing serum uric acid (Redman et al , 1976a) 
and decreasing creatinine clearance (Roberts 
and Perloff, 1977) as indicators of preeclamp-
sia 
Renal biopsy specimens from women clini 
cally diagnosed as having preeclampsia (blood 
pressure increase and proteinuria) demon 
strate these diagnostic difficulties (Table 41-1) 
(McCartney, 1964a) Of 62 women diagnosed 
as preeclamptic in their first pregnancy, 70 per 
cent had a glomerular lesion believed to be 
characteristic of preeclampsia However, 24 
per cent had evidence of chronic renal disease 
not suspected previously Renal biopsies of 
multiparous women with a clinical diagnosis of 
superimposed preeclampsia demonstrate the 
difficulty of diagnosing this condition Of 152 
subjects, only 3 per cent had the characteristic 
glomerular lesion, but 43 per cent had evidence 
of pre existing renal or vascular disease 
Preeclampsia has a clinical spectrum ranging 
from mild to severe forms and then potentially" 
to eclampsia Affected patients do not "catch ^ 
eclampsia but progress through this spectrum. 
In most cases progression will be slow and the 
TABLE 41-1. Renal Biopsy Findings in Patients with Clinical Diagnosis of Preeclampsia 
BIOPSY FINDINGS 
PRIMIGRAVIDAS 
(N = 62) 
MULTIGRAVIDAS 
(N = 152) 
Glomeruloendotheliosis 
Normal histologic appearance 
Chronic renal disease (chronic GTN chronic pyelonephritis) 
Arteriolar nephrosclerosis 
70% 
5% 
25% 
0 
14% 
(with or without 
nephrosclerosis) 
53% 
21% 
12% 
(Modified from McCartney CP Pitholo ic tl anatomy of acute hypertension of pregnancy Circulation 30(Suppl 1!) V7 1964 b\ 
permission of the American He irt Associ uion Ine ) 
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disorder may never proceed beyond mild pre-
eclampsia. In others, the disease may progress 
jnore rapidly, changing trom mild to severe 
over days to weeks In the most serious cases, 
progression may be fulminant, with mild pre-
eclampsia evolving to severe preeclampsia or 
eclampsia over hours to days In a series of 
eclamptic women analyzed bv Chesley (1978) 
25 per cent had evidence of only mild pre-
eclampsia in the days preceding convulsions 
Thus, for clinical management, we must accept 
the fact that we are overdiagnosing the condi-
tion, because as will be discussed later, a major" 
goal in managing preeclampsia is the preven-" 
tion of eclampsia, primarily through timing ot 
delivery It is also evident, however, that stud-
les of preeclampsia will be confounded by 
inclusion of women diagnosed as preeclamptic 
who actually have another cardiovascular or 
renal disorder Still another problem is that 
some women with pregnancy-specific patho-
physiologic changes identical to those present 
in preeclampsia will not have the specific signs 
of preeclampsia sufficient to satisfy the ACOG 
definition (Gpodhn, 1986) These women are 
nonetheless at increased risk, as are their in-
fants (Weinstem, 1982, Killam et al , 1975), 
and should be managed as is the more typical 
preeclamptic patient 
PREECLAMPSIA-ECLAMPSIA 
In spite of the difficulty of making a clinical 
diagnosis of preeclampsia, there is no question 
that a disorder exists unique to pregnancy and 
characterized by poor perfusion of many vital 
organs, including the fetal-placental unit, and 
completely reversible with the termination of 
pregnancy Pathologic, pathophysiologic, and 
prognostic findings clearly indicate that this 
condition, which we will call preeclampsia * is 
not merely an unmasking ot pre-existing, un-
derlying hypertension Although this fact has 
been well documented for many years, prob-
lems still arise owing to approaches in the 
management of preeclampsia that are based 
solely on principles useful in managing hyper-
tension in nonpregnant individuals The suc-
cessful management of preeclampsia requires 
an understanding of the pathophysiologic 
*It is tempting to use a new label to define this 
vasospastic condition in pregnancy However because 
there are already too many labels and because the diag 
nosis of this pregnancy related condition can be made only 
retrospectively i e when physiologic functions including 
blood pressure return to normal after pregnancy we will 
use preeclampsia realizing its limitations 
changes in this condition and the recognition 
that the signs of preeclampsia—increased 
blood pressure, proteinuria and edema—are 
only signs and not causal abnormalities The 
etiology of preeclampsia-eclampsia is not com-
pletely understood; however, as Zuspan (1978) 
has pointed out, we can manage the condition 
very successfully using the information we do 
have about its pathophysiology, prognosis, and 
natural history 
Clinical Presentation 
The "Typical" Preeclamptic Patient 
Preeclampsia occurs in about 7 per cent of 
pregnancies not terminating in first-trimester 
abortions It would be useful to be able to 
identify the women at greatest risk In pre-
eclampsia as with all diseases there are no truly 
"typical" patients Epidemiologic findings do, 
however, indicate that certain characteristics 
are more common in women who develop 
preeclampsia The most important is nullipar-
ity Preeclampsia is primarily a disease of the 
first pregnancy At least two-thirds of cases 
occur in women during the first pregnancy not 
terminating in a first-trimester loss 
Preeclampsia is thought to be more common 
in women of lower socioeconomic status In 
his study of pregnant women in Aberdeen, 
Scotland, nearly all of whom were delivered 
in hospitals, Nelson (1955) found no relation-
ship of preeclampsia-eclampsia to socioeco-
nomic status In similar studies in Finland 
(Vara et al , 1965) and Jerusalem (Davies 
1970), no relationship was established between 
this factor and the incidence of preeclampsia 
It remains the current clinical impression of 
most individuals caring for pregnant women in 
the United States that preeclampsia is a disease 
of lower-income women This impression ma\ 
be accurate, but it is undoubtedly confounded 
by the relationship of preeclampsia to age, 
race, and parity Eclampsia, on the other hand, 
is clearly a disease of women of lower socio-
economic status (Nelson, 1955, Vara et al , 
1965, Davies, 1970) Eclampsia is preventable 
by careful obstetric observation and delivery 
for severe preeclampsia Therefore, the lack 
of availability and utilization of good-quality 
obstetric care to indigent women is undoubt-
edly a major factor in the increased incidence 
of eclampsia It is interesting to note that in 
past years the clinical impression was that 
preeclampsia-eclampsia was a disease of 
women of higher socioeconomic status (Ches-
ley, 1978) 
There is a relationship between the extremes 
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of childbearing age and the incidence of 
eclampsia and preeclampsia. Because most 
pregnancies, particularly most first pregnan-
cies, occur in young women, most cases of 
preeclampsia-eclampsia occur in this age 
group. However, studies of entire populations 
in Aberdeen, Jerusalem, and Finland do not 
indicate an increased incidence of preeclamp-
sia in young women if parity is considered. In 
all of these studies a higher incidence of pre-
eclampsia was found in older women that was 
not dependent on parity. The information from 
the Collaborative Study in the United States 
(Vollman, 1970) does suggest a higher inci-
dence of preeclampsia in younger women, al-
though Davies (1971) has pointed out the 
deficiencies in this study. It is possible that the 
incidence of preeclampsia may be greater in 
young women in the United States but not in 
other parts of the world; however, even if this 
is true, increased incidence of the youngest 
age groups in the Collaborative Study is not 
nearly as great as that of older patients. 
The relationship of preeclampsia and 
eclampsia to race is equally difficult to evalu-
ate. Data from both the U. S. Collaborative 
Study and the Jerusalem study indicate a re-
lationship to race (Vollman, 1970; Davies, 
1970). The Jerusalem study revealed the strong 
correlation of race and age during pregnancy. 
In the Collaborative Study the incidence of 
preeclampsia was higher in blacks, in whom 
hypertension is generally more common. This 
finding raises the question whether the inci-
dence of preeclampsia is truly race-related or 
whether the finding is an example of the diffi-
culty in differentiating preeclampsia from un-
recognized pre-existing chronic hypertension. 
Chesley has stated that there is no difference 
in incidence of preeclampsia between blacks 
and Caucasians (unpublished observation cited 
by Davies, 1971) 
A characteristic oi preeclampsia-eclampsia 
that is frequently overlooked is the tendency 
of the condition to occur in daughters and 
sisters of women with a history of preeclamp-
sia. In Aberdeen, the incidence of proteinuric 
preeclampsia was found to be four times higher 
in sisters of women who had preeclampsia in 
their first pregnancy than in sisters of women 
who did not (Adams and Finlayson, 1961). In 
a recent study of the same population the 
incidence of preeclampsia was 15 per cent in 
mothers but only 4 per cent in mothers-in-law 
of preeclamptic women (Sutherland et al., 
1981). Chesley and Cooper (1986) evaluated 
preeclampsia in the first pregnancy of sisters, 
daughters, granddaughters, and daughters-in-
law of women who had been eclamptic. The 
incidence of preeclampsia in sisters was 37 per 
cent, in daughters 26 per cent, in granddaugh-
ters 16 per cent, but in daughters-in-law only 
6 per cent. These observed incidences fit 
closely with inheritance of preeclampsia 
through a single maternal gene with the fre-
quency of the putative gene being 0.25. 
Certain medical disorders also predispose to 
preeclampsia. Diabetes is frequently compli-
cated by preeclampsia, with the incidence 
stated to be as high as 50 per cent of diabetic 
pregnancies (Chesley, 1978). Preeclampsia is 
also more common in women with hyperten-
sion antedating pregnancy. In several studies 
the reported incidence is approximately 20 per 
cent (Roberts and Perloff, 1977). 
Certain conditions of pregnancy also in-
crease the risk of preeclampsia. The incidence 
is approximately 30 per cent in women with 
twin pregnancies and is increased regardless of 
parity. In a study by Bulfin and Lawler (1957) 
the incidence was 70 per cent in primiparas 
and 20 per cent in multiparas. Preeclampsia is 
also present in 70 per cent of women with 
large, rapidly growing hydatidiform moles and 
occurs earlier than usual in gestation (Page, 
1939). In fact, in cases of preeclampsia occur-
ring before 24 weeks, hydatidiform mole 
should be suspected and sought. An interesting 
variant of preeclampsia occurs with fetal hy-
drops, although not with erythroblastosis un-
complicated by hydrops; the incidence is high 
(approximately 50 per cent), and preeclampsia 
is not confined to hydrops secondary to isoim-
munization, occurring in one series in nine of 
11 infants with hydrops of nonimmune etiology 
(Scott, 1958). This condition may present early 
in pregnancy and with severe signs and symp-
toms of preeclampsia. Proteinuria is massive, 
and blood pressure elevation and edema are 
marked. In spite of this severity, eclampsia is 
a rare complication. Preeclampsia is also re-
ported to be more common in pregnancies 
complicated by polyhydramnios; however, if 
the association of polyhydramnios with diabe-
tes and multiple pregnancies is accounted for, 
the relationship is not present (Jeffcoate and 
Scott, 1959). 
Signs of Preeclampsia 
The diagnostic signs of preeclampsia usually 
antedate symptoms. The usual sequence of the 
appearance of the signs is edema, followed by 
increased blood pressure and proteinuria; how-
ever, any order of appearance may occur 
(Chesley, 1978). 
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Edema 
Fluid retention can be manifested as a rapid 
gain in weight prior to demonstrable edema. 
A gain of 5 lb in one week is cited as a warning 
sign of preeclampsia. However, rapid weigh: 
gain can occur in pregnancy without pre-
eclampsia, and, in one group of women who 
became eclamptic, only 10 per cent manifested 
this rapid weight gain (Chesley, 1978). Edema 
in preeclampsia is believed to be related in 
part to sodium retention and is thus not limited 
to dependent edema..Edema of the hands and 
face is more likely associated with sodium 
retention and is therefore a more reliable in-
dicator of preeclampsia than is dependent^ 
edema, which may be due to primarily hydro-
static mechanisms. However, sodium retention 
caused by altered glomerular tubular balance 
due to postural decreases in glomerular filtra-
tion is common in normal pregnancy. Edema 
of the hands and face occurs in 10 to 15 per 
cent of women whose blood pressure remains 
normal throughout pregnancy (Thomson et al., 
1967). Edema may be massive, especially in 
severe~preeclampsia, rendering the patient vir~ 
tnally unrecognizable (Fig. 41-2). With such" 
"patients it is important to remember that sub-
stantia} hypoalbuminuria may complicate pre-
eclampsia and contribute to the edema. There-
fore, edema is an early and common sign of 
preeclampsia but is not diagnostic. 
Blood Pressure Change 
Increased blood pressure is required for the 
diagnosis of preeclampsia. As discussed pre-
viously, however, the changes in blood pres-
sure associated with normal pregnancy may 
lead to misdiagnosis. In clinical practice the 
possible impact of preeclampsia on mother and 
fetus warrants such overdiagnosis. From a 
pathophysiologic viewpoint, of primary impor-
tance is poor tissue perfusion secondary to 
vasospasm, which is revealed more clearly by 
blood pressure changes than by absolute blood 
pressure (evefs. Even the relative increase of 
blood pressure does not, however, always cor-
relate well with decreased tissue perfusion and 
subsequent damage. Eclampsia and maternal 
or fetal death can occur in the patient with 
only modest blood pressure elevation. In two 
series, 20 per cent of women with eclampsia 
never had a systolic blood pressure exceeding 
MO mm Hg (Chesley, 1978; Dieckman, 1952). 
Proteinuria 
Among the diagnostic signs of preeclampsia, 
proteinuria accompanied by hypertension is 
the most reliable indicator of fetal jeopardy. 
In two studies of preeclampsia, the perinatal 
mortality rate tripled in women with protein-
uria (McGillivray, 1958), and the amount of 
proteinuria correlated with increased perinatal 
mortality rate and the number of growth-re-
tarded infants (Tervila et al., 1973). If only 
eclampsia is considered—thus excluding cases 
of chronic hypertension misdiagnosed as pre-
Eclampsia—the relationship of proteinuria to 
perinatal mortality is even more striking. In 
the series reported by Nelson (1955) from 
Aberdeen, there were 15 neonatal deaths in 
52 proteinuric women and no neonatal deaths 
in 17 women who became eclamptic but did 
not have proteinuria. In spite of the specificity 
3nd fetal prognostic significance of proteinuria, 
however, we must emphasize that eclampsia 
Qan occur without proteinuria. In one series of 
298 eclamptic patients, 41 per cent did not 
have proteinuria (Naidoo and Moodley, 1980), 
FIGURE 41-2. Facial edema in 
severe preeclampsia. Markedly 
-edematous facies of this se-
verely preeclamptic woman (A) 
are especiaffy evident wfien 
compared with her appearance 
6 weeks postpartum (B). 
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and in a series of eclamptic patients reviewed 
by Chesley (1978) 26 of 199 had either trace 
(16) or no (10) proteinuria prior to seizures. 
Retinal Changes 
Important and consistent signs in preeclamp-
tic patients are retinal vascular changes on 
funduscopic examination. Localized or gener-
alized changes occur in retinal arterioles in at 
least 50 per cent of women with preeclampsia. 
These retinal vascular changes are the clinical 
sign that best correlates with renal biopsy 
changes of preeclampsia (Pollak and Nettles, 
1960). Localized retinal vascular narrowing is 
visualized as segmental spasm, and the gener-
alized narrowing is indicated by a decrease in 
the ratio of arteriolar-venous diameter from 
the usual 3:5 to 1:2 or even 1:3. It may occur 
in all vessels or, in early stages, in single vessels 
(Jaffe and Shatz, 1986). Preeclampsia does not 
cause chronic arteriolar changes; thus the pres-
ence of arteriolar sclerosis detected by in-
creased light reflex, copper wiring, or arterio-
venous nickling indicates pre-existing vascular 
disease. Finnerty (1956) described a character-
istic "retinal sheen" in preeclamptic patients. 
In the author's experience, this finding is pres-
ent in many young patients, pregnant and 
nonpregnant, male and female, and has not 
been a useful sign. 
Hyper-reflexia 
Hyper-reflexia is a sign given a great deal of 
clinical attention. Deep tendon reflexes are 
increased in many women prior to seizures. 
However, seizures can occur in the absence of 
hyper-reflexia (Sibai et al., 1981), and many 
young subjects are consistently hyper-reflexic 
without being preeclamptic. Changes, or lack 
of changes, in deep tendon reflexes are not 
part of the diagnosis of mild forms of pre-
eclampsia. 
Other Signs 
Other signs that occur in preeclampsia less 
commonly are indicators of involvement of 
specific organs of the preeclamptic process. 
Thus, patients with marked edema may have 
ascites and hydrothorax, and those in conges-
tive heart failure have the usual signs—in-
creased neck vein distention, gallop rhythm, 
and pulmonary rales. Hepatic capsular disten-
tion, manifested by hepatic enlargement and 
tenderness, is particularly ominous, as is dis-
seminated intravascular coagulation sufficient 
to result in petechiae or generalized bruising 
and bleeding. 
Symptoms of Preeclampsia 
It is important to remember that the major-
ity of women with early preeclampsia are 
asymptomatic. This lack of symptoms is, in 
fact, an important part of the rationale for 
frequent obstetric visits in late gestation. In 
most cases, increased blood pressure, increas-
ing edema, and proteinuria antedate overt 
symptoms. 
The multitude of symptoms that can occur 
secondary to preeclampsia—especially pre-
eclampsia of increasing severity—are listed in 
Table 41-2. Because preeclampsia is a disease 
of poor perfusion to essentially all tissues, the 
occurrence of symptoms related to many organ 
systems is not surprising. Tightness of hands 
and feet and paresthesias secondary to medial 
or ulnar nerve compression occur because of 
fluid retention. Although these are of concern 
to the patient, who may be quite uncomforta-
ble, they are not of prognostic significance. 
Certain symptoms are, however, indicators of 
the severity of the disease. Symptoms of he-
patic capsular distention are particularly omi-
nous. These include epigastric pain, "stomach 
upset," and pain penetrating to the back. 
Headache and mental confusion indicate poor 
cerebral perfusion and may be precursors of 
convulsions. Visual symptoms ranging from 
scotomata to blindness indicate retinal arterial 
spasm and edema. In evaluation of the patient 
with preeclampsia, these signs of poor perfu-
sion are as important indicators of the severity 
of the disease as the easily quantifiable signs. 
Other symptoms may also be present secon-
dary to the complications of preeclampsia, 
such as congestive heart failure and abruptio 
placentae. 
TABLE 41-2. Signs and Symptoms of 
Preeclampsia-Eclampsia 
Cerebral Headache 
Dizziness 
Tinnitus 
Drowsiness 
Change in respiratory rate 
Tachycardia 
Fever 
Visual Diplopia 
Scotomata 
Blurred vision 
Amaurosis 
Gastrointestinal Nausea 
Vomiting 
Epigastric pain 
Hematemesis 
Renal Oliguria 
Anuria 
Hematuria 
Hemoglobinuria 
804 PART III—SECTION 19: MATERNAL DISORDERS 
(Stallworth et al., 1981), but especially if nor^ 
mal variability was never evident, it should be 
proven by fetal scalp blood sampling that de-
creased variability is not secondary to as-
phyxia. The woman with marked hepatic cap^ 
sular distention should undergo cesarean 
delivery if vaginal delivery is not imminent. 
Even several extra hours may be life-threat-
ening, and none of the palliative therapies 
prevents liver rupture. 
Regional anesthesia offers its usual advan-
tages for vaginal and cesarean delivery but 
does carry the possibility of extensive sympath-
olysis with consequent decreased cardiac out-
put, hypotension, and impairment of already 
compromised uteroplacental perfusion. This 
problem can be avoided by meticulous atten-
tion to anesthetic technique and volume ex-
pansion. Regional anesthesia is not a rational 
means to lower blood pressure because it does 
so at the expense of cardiac output. Likewise, 
although analgesia with narcotics is not con-
traindicated and should be used when neces-
sary, there is abundant evidence that attempt-
ing to manage or prevent eclampsia with 
profound maternaf sedation is dangerous ancf 
ineffective. 
MONITORING OF MOTHER AND FETUS 
MATERNAL MONITORING. There are two 
goals for antepartum monitoring of th^ 
mother. The first is the early recognition of 
the condition, because infants of mothers with 
even mild preeclampsia are at increased risk^ 
and the second is to gauge the rate of progres-
sion of the condition, both to prevent eclamp-
sia by delivery and to determine whether fetal 
well-being can be safely monitored by the usual 
intermittent observations. Ideally, identificaN 
tion of early changes would allow intervention 
prior to the advent of clinical symptoms. He-
modynamic, volume, and biochemical changes 
appear to antedate the diagnostic clinical signs 
of preeclampsia. In the past, lability of blood 
pressure, which is a feature of preeclampsia, 
was suggested as a predictor. However, neither 
stimulation of sympathetic response by thQ 
cold pressor test (Chesley and Valenti, 1958a) 
nor second-trimester blood pressure "spikes"' 
(Browne, 1933) were found to be specific 
enough as predictors. More recently, higher 
early second-trimester blood pressures were 
measured in groups of women destined to have 
diagnostic blood pressure increases in later-
pregnancy (Gallery et aL, 1977). The overlap 
of blood pressure levels between these women 
and women who remained normotensive, how-
ever, was too large to regard this value as a 
useful predictor for individual women. Higher 
brachial artery blood pressure in the supine 
than the lateral position is believed by some 
investigators to predict the development of 
sustained blood pressure increases in late preg-
nancy. Extensive studies of this phenomenon 
do not support the earlier enthusiastic reports 
(Kuntz, 1980). Recently, Sobel and co-workers 
(1980) found that both men and nonpregnant 
women had higher right arm blood pressure in 
the supine position than in the left lateral 
position, the difference being related to the 
distance of the brachial artery above the heart. 
However, the increased blood pressure re-
sponse to angiotensin II (Gant et al., 1973; 
Oney and Kaulhausen, 1982; Nakamura et al., 
1986) in women destined to have elevated 
blood pressure in late pregnancy appears to be 
an accurate predictor, but the test is neither 
simple nor safe enough for extensive clinical 
use. Changes in renal function, serum urate, 
and PSP clearance (Gallery and Gyory, 1979a) 
precede clinical signs of preeclampsia. Also, it 
appears that decreased plasma volume (Arias, 
1975) and subtle coagulation changes are also 
predictors (Redman et a(., 1977a). The usefuf-
ness of these values as clinical predictors in 
patient management remains to be confirmed. 
At present, clinical management is dictated 
by the overt clinical signs of preeclampsia. 
Unfortunately, proteinuria—the most valid 
clinical indicator of preeclampsia—is often a 
late change, sometimes even preceded by sei-
zures, and so is not a useful sign for early 
recognition. Although rapid weight increase 
and hand and face edema indicate the fluid 
and sodium retention characteristic of pre-
eclampsia, they are neither universally present 
nor uniquely characteristic of preeclampsia. 
These signs are, at most, a reason for closer 
observation of blood pressure and monitoring 
of urinary protein. Early recognition of pre-
eclampsia is based primarily on diagnostic 
blood pressure increases in the late second and 
early third trimesters in relation to early preg-
nancy. Using blood pressure changes without 
evidence of proteinuria as an indicator does, 
undoubtedly, result in the diagnosis of pre-
eclampsia in some normal women as well as in 
some with underlying renal or vascular disease. 
Because the goal of early diagnosis is to iden-
tify patients requiring more careful observa-
tion, however, overdiagnosis is preferable to 
underdiagnosis. 
Once the blood pressure changes diagnostic 
of preeclampsia appear, an office examination 
within 24 hours is mandatory, or with selected 
patients, blood pressure and urinary protein 
must be checked at home. These measures are 
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directed at determining the rapidity of pro-
gression of the condition in order to ensure 
that it is not following a fulminant course. 
Frequency of subsequent observations is de-
termined by these initial observations and the 
ensuing clinical progression. If the condition 
appears stable, weekly observations may be 
appropriate. If it appears to be accelerating, 
more frequent observations, perhaps in hos-
pital, are required. The initial appearance of 
proteinuria is an especially important sign of 
progression and dictates frequent observation, 
which is best accomplished in hospital. 
If an increasing rate of deterioration is 
noted, as determined by laboratory findings, 
symptoms, and clinical signs, the decision to 
continue the pregnancy is determined day by 
day. Important clinical signs are blood pres-
sure, urinary output, and fluid retention as 
evidenced by daily weight increase. Laboratory 
studies are performed at intervals of no more 
than 48 hours. These include examination for 
possible activation of the coagulation system 
as determined by platelet count and fibrin split 
products, evaluation of renal function as meas-
ured by urinary protein excretion and serum 
creatinine and urate levels, and determination 
of hepatic dysfunction as evidenced by increas-
ing SGOT and SGPT. In addition, subjective 
evidence of central nervous system involve-
ment, such as headache, disorientation, and 
visual symptoms, and the presence of hepatic 
distention as indicated by abdominal pain and 
liver tenderness are equally important indica-
tors of worsening preeclampsia. 
FETAL OBSERVATION. Tests to assess fetal 
well-being provide information for determin-
ing whether the infant is safer in the uterus or 
delivered. Since the perinatal mortality rate is 
higher for infants of women with even mild 
preeclampsia, it is mandatory to begin moni-
toring the fetal condition in any woman with 
the clinical diagnosis of preeclampsia. If the 
maternal condition is stable, weekly monitor-
ing of the fetus appears to be adequate. The 
etiology of fetal demise is apparently placental 
insufficiency, and therefore biochemical indi-
cations of placental function such as serum 
HPL concentration, and of fetal-placental 
function such as urinary or serum estriol level 
can be used (Fliegner, 1976). However, bio-
physical assessment of the fetus by observa-
tions of periodic changes in fetal heart rate 
and activity and contraction stress testing are 
more direct and accurate indicators of fetal 
condition (Freeman, 1975). Unfortunately, no 
test of fetal well-being is predictive when ma-
ternal condition is rapidly deteriorating. The 
management of the fetus with intrauterine 
growth retardation, a common complication of 
preeclampsia, is discussed in Chapter 31. As-
sessment of amniotic fluid for determination 
of lung maturity aids in decision for delivery 
of the fetus with severe intrauterine growth 
retardation. Jeopardy of fetal well-being rather 
than lung maturity is the fetal criterion for 
determining delivery in a pregnancy with pre-
eclampsia that is remote from term. 
Antepartum Management in 
Preeclampsia 
There is little evidence that therapeutic ef-
forts alter the underlying pathophysiology of 
preeclampsia. Therapeutic intervention is pal-
liative. At best, it may slow the progression of 
the condition, but more likely, it merely allows 
continuation of the pregnancy. Bed rest is a 
usual and reasonable recommendation for the 
woman with mild preeclampsia, although its 
efficacy is not clearly established (Mathews, 
1977). Prophylactic hospitalization with in-
creased bed rest may reduce the incidence of 
preeclampsia for women at high risk as iden-
tified by increased angiotensin sensitivity 
(Hauth et al., 1976). It is unclear, however, 
which of the several behavioral modifications 
involved in hospital residence is important. 
Anecdotal reports of clinical improvement 
with bed rest must be tempered by the recog-
nition of the unpredictable course of pre-
eclampsia. Strict sodium restriction or diuretic 
therapy has no role in the prevention or ther-
apy of preeclampsia. In women with marked 
sodium retention as manifested by significant 
edema, modest sodium restriction may not 
alter the course of the disease but may reduce 
discomfort. Diuretics should not be given, be-
cause these patients already have decreased 
plasma volume and further volume depletion 
could adversely affect the fetus. Attempts to 
modify the progression of the disease by vol-
ume expansion are not conclusive and require 
more complete evaluation before they can be 
considered part of routine antepartum man-
agement (Goodlin et al., 1978). The reduction 
of prostacyclin production in tissues from pre-
eclamptic women has prompted the prophylac-
tic use of aspirin in doses (60 to 150 mg) found 
to reduce thromboxane production while main-
taining prostacyclin production. The results in 
two studies of carefully screened very high-risk 
patients, treated prior to the onset of clinically 
evident disease, have been encouraging (Beau-
fils et al., 1986; Wallenburg et al., 1986). 
Carefully controlled trials of the risk-to-benefit 
ratio of this therapy are required before it can 
be used in the general population of pregnant 
women. 
Prolonged expectant antepartum manage-
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ment of women with severe preeclampsia is 
not practiced in most centers. With improve-
ments in neonatal care, many investigators 
regard delivery of women with severe pre-
eclampsia beyond 30 weeks gestation to be in 
the best interests of not only the mother but 
also the fetus. Antihypertensive therapy is not 
used, because it masks one important clinical 
sign of disease progression and blood pressure 
control does not improve fetal well-being. Di-
astolic pressure of 110 mm Hg and higher, 
which puts the mother at increased risk of 
cerebrovascular accident, indicates delivery 
with control of blood pressure. When gesta-
tional age is critical (between 25 and 30 
weeks), one might consider control of maternal 
blood pressure along with meticulous obser-
vation of maternal and fetal condition. Deliv-
ery is then indicated by worsening maternal 
symptoms, laboratory evidence of end organ 
dysfunction, or deterioration of fetal condi-
tion. Whether this plan of action can effect a 
decrease in perinatal morbidity and mortality 
rates after 30 weeks gestation is not clear. The 
use of this approach with even very immature 
fetuses may only replace a nonviable neonate 
with an extremely premature one, with the 
attendant risks of long-range neurologic dis-
ability. Such an approach should therefore be 
attempted only in centers equipped to provide 
meticulous maternal observation and daily as-
sessment of fetal and maternal condition. 
Intrapartum Management in 
Preeclampsia 
The intrapartum management of women 
with preeclampsia tests the obstetric and med-
ical skills of the health care team. The severely 
preeclamptic or eclamptic woman is acutely ill, 
with functional derangements of many organ 
systems. An appreciation of this situation and 
the availability of methods of accurate mater-
nal monitoring have reduced mortality rates 
from 5 per cent in earlier series to 1 per cent 
or less in recent series. Failure to recognize 
and appropriately manage this grave condition 
probably accounts for most deaths. Also, even 
mildly preeclamptic women may experience an 
acceleration of the process during labor. De-
livery terminates the preeclamptic process, and 
it is tempting to effect immediate delivery, 
frequently by cesarean section. However, 
physiologic abnormalities are not immediately 
corrected by delivery, and adding surgical 
stress to the abnormal physiologic state is not 
desirable. It is possible to partially correct 
many of these abnormalities, and it is imper-
ative to attempt to do so prior to imposing 
surgical stress. If the fetus can be monitored, 
several hours of palliation with vaginal delivery 
are preferable to the added maternal stress of 
operative delivery. 
Baseline information should be obtained to 
determine renal function, coagulation status, 
and liver function. Determination of serum 
protein concentration indicates the choice of 
appropriate fluid administration. Some inves-
tigators advocate the use of intensive cardio-
vascular monitoring, preferably with Swan-
Ganz catheters or with central venous pressure 
catheters in all severely preeclamptic and 
eclamptic women (Chapter 19). Such a practice 
is certainly indicated in oliguric patients whose 
urinary output does not improve with a modest 
fluid challenge. The major problems to be 
managed are those of high blood pressure, 
intravascular volume, and convulsions. Less 
commonly, disseminated intravascular coagu-
lation and myocardial dysfunction will require 
treatment. 
ANTICONVULSANTS 
PROPHYLAXIS. The majority of seizures oc-
cur during the intrapartum and postpartum 
periods, suggesting that these are the periods 
in which the preeclamptic process is most likely 
to accelerate. In many centers outside the 
United States, anticonvulsant prophylaxis is 
not used routinely, but rather is reserved for 
the woman who seems clinically to be at risk 
for seizures. It is not known whether the risk 
for seizures is less in these centers than in 
those in the United States. However, a recent 
review of eclamptic patients from a major 
United States center indicates the hazards of 
this approach (Sibai et al., 1981). None of the 
clinical signs and symptoms considered to be 
prognostic of seizures was absolutely reliable. 
Seventeen per cent of women who had seizures 
did not have headache, 80 per cent did not 
have epigastric pain, and 20 per cent had 
normal deep tendon reflexes (Table 41-6). The 
lack of absolute correlation with proteinuria is 
consistent with the observations by Chesley 
and Chesley (1943) 45 years ago that 24 per 
cent of patients do not have proteinuria prior 
to seizure. 
The prophylactic use of anticonvulsant ther-
apy, which is the approach strongly recom-
mended by most United States investigators, 
will protect most women at risk for seizures 
only if therapy is elected for all women with a 
blood pressure elevation diagnostic of pre-
eclampsia whether or not there are other signs 
and symptoms, including proteinuria. Because 
this approach will certainly include many 
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TABLE 41-6. Frequency of Symptoms 
Preceding Eclampsia 
PATIENTS IN WHOM 
PRESENT 
SYMPTOM (%) 
Headache 83 
Hyper-reflexia 80 
Proteinuria 80 
Edema 60 
Clonus 46 
Visual signs 45 
Epigastric pain 20 
(Adapted from Sibai BM, Lipshitz J, Anderson GD. Dilts PV 
Jr: Reassessment of intravenous MgS04 therapy in preclampsia^ 
eclampsia. Obstet Gynecol 57:199, 1981.) 
women at no risk for seizure, the first require-
ment for anticonvulsant prophylaxis is that the 
agent and its dosage must be extremely safe 
for the mother. The other obvious requirement 
is safety for the infant, not only as a fetus but 
also when, as a neonate with appreciable blood 
levels of the drug, it begins the complex ad-
aptation to extrauterine life. 
In the past, a staggering array of drugs and 
combinations of dn\gs have been used as ther-
apeutic and prophylactic agents for convulsions 
(Studd, 1977). Zuspan (1978) and Pritchard 
and Pritchard (1975), among others, have dem-
onstrated the value of simplifying therapy by 
reducing the number of agents administered. 
Both reports advocate the use of magnesium 
sulfate for anticonvulsant prophylaxis, which 
is clearly the drug of choice for United States 
obstetricians. Other anticonvulsant agents, pri-
marily benzodiazepine derivatives, are used in 
other parts of the world. Investigators world-
wide agree with the principle of simplifying 
therapy by avoiding polypharmaceutical regi-
mens (Studd, 1977). 
CHLORMETHIAZOLE AND BENZODIAZE* 
PINES. The use of large doses of diazepam was 
advocated by some British investigators as an 
effective means of terminating eclamptic sei-
zures and preventing their recurrence (Studd, 
1977). It is now evident that diazepam in these 
dosages results in hypotonia, hypothermia, and 
respiratory depression in a high proportion of 
neonates (Cree et ai, 2973). These effects may 
last for several days owing to the pharmaco-
kinetics of benzodiazepine in the neonate. Lor-
azepam, a long-acting benzodiazepine deriva-
tive, has even more severe fetal effects 
(Whitelaw et al., 1981). In spite of these find-
ings, benzodiazepines continue to be the major 
anticonvulsants used in many centers outside 
the United States. The effects of these agents 
on the neonate would appear to contraindicate 
their use as prophylactic agents. Chlormethia-
zole (clomethiazole) has been advocated for 
prophylactic use in preeclamptic women (Duf-
fus et al., 1969). In one series in which this 
drug was used in combination with diazoxide, 
however, 13 of 21 infants were severely de-
pressed (hypotonia, hypoventilation) for 24 to 
36 hours after birth (Johnson, 1976). 
MAGNESIUM SULFATE. Magnesium sulfate 
offers considerable advantages over the pre-
ceding agents for prophylaxis in preeclamptic 
women. Its pharmacokinetics during preg-
nancy is well established, as are its efficacy 
and safety for mother and fetus. 
Pharmacokinetics, Mechanism of Action, 
and Maternal Side Effects, The volume of 
distribution of magnesium is greater than that 
of sucrose, indicating that the distribution of 
this ion goes beyond extracellular fluid, also 
entering bones and cells (Chesley, 1979). Mag-
nesium circulates largely unbound to protein 
and is almost exclusively excreted in urine. It 
is reabsorbed in the proximal tubule by a 
process limited by transport maximum (Tmax) 
and its excretion increases as filtered load 
increases above the transport maximum (Mas-
sey, 1977). Inpatients with normal renal func-
tion, the half-time for excretion is about 4 
hours (Chesley, 1979). Because excretion de-
pends on delivery of a filtered load of magne-
sium that exceeds the Tmax, the half-time of 
excretion is prolonged in women with de-
creased glomerular filtration rate. The clini-
cally significant results of elevated serum mag-
nesium are related primarily to its membrane 
effects. Magnesium slows or blocks neuromus-
cular and cardiac conducting system transmis-
sion, decreases smooth muscle contractility, 
and depresses central nervous system irritabil-
ity. The results include a desired anticonvul-
sant effect and undesirable effects such as 
decreased uterine and myocardial contractility, 
depressed respirations, and interference with 
cardiac conduction. These effects occur at dif-
ferent serum magnesium concentrations (Table 
41-7). Doses of magnesium sulfate sufficient 
for anticonvulsant therapy cause little change 
in blood pressure. Because the depression of 
TABLE 41-7. Effects Associated with Various 
Serum Magnesium Levels 
SERUM LEVEL 
EFFECT (mEq/liter) 
Anticonvulsant prophylaxis 4-6 
EKG changes 5 ~ 1 0 
Loss of deep tendon reflexes ^ 
Respiratory paralysis ** 
General anesthesia *' 
Cardiac arrest >^ 
Tab 7 
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HELLING V. CAREY 
HELLING 
C i t o u s . \V»i*li 
S3 \Vash.2d 514 
Morrison P. HELLING and Barbara 
Helling, his wife, Petitioners, 
v. 
Thomas F. CAREY and Robert C. 
Laughlin, Respondents. 
No. 42775. 
Supreme Court of Washington. 
Kn Kane. 
March 14, 1!)74. 
Malpractice action against ophthalmol-
ogists in which a patient claimed that she 
suffered permanent visual damage due to 
open angle glaucoma as a result of defend-
ants ' failure to diagnose and treat the con-
dition. The trial court entered judgment 
for defendants following a defense verdict, 
the Court of Appeals, Division I, James, J., 
affirmed, and the patient petitioned for re-
view. The Supreme Court, Hunter , J., 
held that defendants were negligent as a 
mat ter of law in failing to administer a 
simple glaucoma test to the patient despite 
uncontradicted expert testimony that it was 
the universal practice of ophthalmologists 
not to administer glaucoma tests to patients 
under age 40 because the incidence of 
glaucoma at younger ages was so small. 
Reversed and remanded for new trial 
on issue of damages only. 
Utter, J., concurred and filed opinion 
in which Finley and Hamilton, }]., con-
curred. 
Physicians and Surgeons 0=18.80(8) 
Ophthalmologists were negligent as 
matter of law in failing to administer glau-
coma test to patient under age 40, thus 
failing to diagnose condition of primary 
open angle glaucoma, despite uncontradict-
ed expert testimony that it was universal 
practice of ophthalmologists not to test pa-
tients younger than 40 for glaucoma be-
cause of low incidence of condition in 
younger patients. 
v. CAREY Wash. 981 
.. r*m r 2«i :M 
O l u d l . Boyle & Hat t rup . Lee Olwell. 
Seattle, for petitioner. 
Williams, Lanza, Kastner & Gibbs, Hen-
ry K. Kastner. Seattle, for respondent. 
HUXTF.R. Associate Justice. 
This case arises from a malpractice ac-
tion instituted by the plaintiff (petit ioner), 
Barbara Helling. 
The plaintiff suffers from primary open 
angle glaucoma. Primary open angle glau-
coma is essentially a condition oi the eye 
in which there is an interference in the 
ease with which the nourishing fluids can 
flow out of the eye. Such a condition re-
sults in pressure gradually rising above the 
normal level to such an extent that damage 
is produced to the optic nerve and its fi-
bers with resultant loss in vision. The 
first loss usually occurs in the periphery of 
the field of vision. The disease usually 
has few symptoms and, in the absence of a 
pressure test, is often undetected until the 
damage has become extensive and irrevers-
ible. 
The defendants (respondents) , Dr. 
Thomas F. Carey and Dr. Robert C. 
Laughlin, are par tners who practice the 
medical specialty of ophthalmology. 
Ophthalmology involves the diagnosis and 
treatment of defects and diseases of the 
eye. 
The plaintiff first consulted the defend-
ants for myopia, nearsightedness, in 1959. 
At that time she was fitted with contact 
lenses. She next consulted the defendants 
in September, 1963, concerning irritation 
caused by the contact lenses. Additional 
consultations occurred in October, 1963; 
February, 1%7; September, 1967; Octo-
ber. 1%7: May. 1°6S; July. 1%S; August, 
P o S ; September, 1%S; and October, 1968. 
L'nnl the October 196S consultation, the 
defendants considered the plaintiff's visual 
problems to be related solely to complica-
tions associated with her contact lenses. 
On that occasion, the defendant, Dr. Car-
ey, tested the plaintiff 's eye pressure and 
field oi vision for the first time. This test 
indicated that the plaintiff had glaucoma. 
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The plaintiff, who was then 32 years of 
age, had essentially lost her peripheral vi-
sion and her central vision was reduced to 
approximately 5 decrees vertical by l«i de-
grees horizontal. 
Thereafter, in August of 1(,69, after con-
sulting; other physicians, the plaintiff filed 
a complaint against the defendants alleg-
ing, among other things, that she sustained 
severe and permanent damage to her eyes 
as a proximate result of the defendants' 
negligence. During trial, the testimony oi 
the medical exper t for both the plaintiff 
and the defendants established that the 
standards of the profession for that spe-
cialty in the same or similar circumstances 
do not require routine pressure tests for 
glaucoma upon patients under 40 years of 
age. The reason the pressure test for 
glaucoma is not given as a regular practice 
to patients under the age of 40 is that the 
disease rarely occurs in this age group. 
Testimony indicated, however, that the 
standards of the profession do require 
pressure tests if the patient's complaints 
and symptoms reveal to the physician that 
glaucoma should be suspected. 
The trial court entered judgment for the 
defendants following a defense verdict. 
The plaintiff thereupon appealed to the 
Court of Appeals, which affirmed the 
judgment of the trial court. Helling v. 
Carey, Xo. I185-U91S-1 (Wn.App., filed 
Feb. 5, 1973). The plaintiff then peti-
tioned this Court for review, which we 
granted. 
In her petition for review, the plaintiff's 
primary contention is that under the facts 
of this case the trial judge erred in giving 
certain instructions to the jury and refus-
ing her proposed instructions defining the 
standard of care which the law imposes 
upon an ophthalmologist. As a result, the 
plaintiff contends, in effect, that she was 
unable to argue her theory of the case to 
the jury that the standard of care for the 
specialty of ophthalmology was inadequate 
to protect the plaintiff from the incidence 
of glaucoma, and that the defendants, by 
reason of their special ability, knowledge 
and information, were negligent ;n fading 
to give the pressure test to the plaintiff at 
an earlier point in time which, if given, 
would have detected her condition and en-
abled the defendants to have averted the 
resulting substantial los> in her vision. 
We find this to be a unique case. The 
tcstimotn oi the medical experts is undis-
puted concerning the standards of the pro-
fession for the specialty of ophthalmology. 
It is not a question in this case of the de-
fendants having any greater special ability, 
knowledge and information than other 
ophthalmologists which would require the 
defendants to comply with a higher duty of 
care than that "degree of care and skill 
which is expected of the average practi-
tioner in the class to which he belongs, act-
ing in the same or similar circumstances." 
Pederson v. Dumouchel. 72 Wash.2d 73, 79, 
431 P.2d 973 (1967). The issue is whether 
the defendants' compliance with the stand-
ard of the profession of ophthalmology, 
which does not require the giving of a rou-
tine pressure test to persons under 40 years 
of age, should insulate them from liability 
under the facts in this case where the 
plaintiff has lost a substantial amount of 
her vision due to the failure of the defend-
ants to timely give the pressure test to the 
plaintiff. 
The defendants argue that the standard 
of the profession, which does not require 
the giving of a routine pressure test to 
persons under the age of 40, is adequate to 
insulate the defendants from liability for 
negligence because the risk of glaucoma is 
so rare in this age group. The testimony 
of the defendant. Dr. Carey, however, is 
revealing as follows: 
0 . Now, when was it. actually, the 
first time any complaint was made to 
you by her of any field or visual field 
problem : A. Really, the first time that 
she really complained of a visual field 
problem was the August 30th date. 
[1%S] Q. And how soon before the 
diagnosis wa> that? A. That was 30 
days. We made it on October 1st. Q. 
And in your opinion, how long, as vou 
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nor have the whole history and analysis 
and the diagnosis, how long had she had 
this glaucoma? A. I would think she 
probably had it ten years or longer. <J. 
Now, Doctor, there's been some refer-
ence to the matter of taking pressure 
checks of persons over 40. What is the 
incidence of glaucoma, the statistics, 
with persons under 40? A. In the in-
stance of glaucoma under the age of 40, 
is less than loo to one per cent. The 
younger you get, the less the incidence. 
It is thought to he in the neighborhood 
of one in 25,000 people or less. (J. 
How about the incidence of glaucoma 
in people over 40* A. Incidence of 
glaucoma over 40 gets into the two to 
three per cent category, and hence, that 's 
where there is this great big difference 
and that 's why the standards around the 
world has been to check pressures from 
40 on. 
Wash. 983 
f t t o W done - ^ i i x M J j v * ajStandar 
sonab!e^p.niat$^^ 
x com plied with o r n o t ? ^ * 
In The T. J. Hooper. 60 l\2d 757. on 
page 74o (2d Cir. 1932). Justice Hand stat-
ed: 
[ I ]n most cases reasonable prudence is 
in fact common prudence ; but strictly it 
is never its measure ; a whole calling 
ma\ have unduly lagged in the adoption 
of new and available devices. It never 
may set us own tests, however persua-
sive IK it^ u>agex^jTCJnr/i must JnJ lie ' 
J h e ' i n c i d t n c e ' o f glaucoma in one out of 
!5,0o^persons under the age'of 40 ma\ ap-
pear Jqu i te minimal. However, that one 
cpersdtvthe"plaintiff in this instance, is en-
I t i t l ed j to^he^same protection, as a trorded 
iO,'essential for t imeh detec-
JheieVidence of,glaucoma where it 
iheSarrcstedUOvavoid the ,g ra \e and 
•devastating result of this disease. The t o t 
is a simple pressure test, relative!} m e \ -
pensi\ e..„JTherc .ir^no^iuHgnfent factor' in-
>.-,\cnd sax wiwt is required;vthereare\fire- _ , 
"cautions so impcrativc'ithat ez'cnltneir -:<^r^ 
universal disregard will -not excuse their 
^amission. 
(Italics ours.) 
Under the facts of this case reasonable 
prudence required the timely giving ot the 
pressure test to this plaintiff. The precau-
tion of giving this test to detect the inci-
dence of glaucoma to patients under 40 
u a r s of age is so imperative that irrespec-
tive of it- disregard by the standards of 
,thc opthalrnology profession, it is the duty 
of the courts to say what is required to 
'protect patients under 40 from the damag-
ing restilt> of glaucoma. / 
We therefore hold, as a mat ter of law, 
that the reasonable s tandard that should 
h a \ e been followed under the undisputed 
facts of this case was the timely giving of 
this simple, harmless pressure test to this 
plaintiff and that, in failing to do so, the 
Jand there Ts no doubt that by giv-
ing the test the evidence of glaucoma can 
^ d e ^ e d . The giving of the t e s t e s vdefendants were negligent," which proxi-
mately resulted in the blindness sustained 
by the plaintiff for which the defendants 
are liable. 
^^rmlesSxif the physical condition of the 
eye permits. The testimony indicates that 
although the condition of the plaintiff 's 
eyes might have at times prevented the de-
fendants irom ctdnunlstcrinii the pressure 
test, there is an absence of evidence in the 
record that the test could not have been 
timely given. 
There are no disputed facts to submit to 
the jury on the issue of the defendants ' 
liability. Hence, a discussion of the plain-
tiff's proposed instructions would be incon-
sequential in view of our disposition of the 
case. 
The judgment of the trial court and the 
deciMou of the Court of Appeals is re-
(\Vhat usually Ts dohe~may be. evidence of versed, and the case is remanded for a new 
- what "ought to be done, but what ought trial on the issue of damages only. 
Justice Holmes stated in Texas & Pac 
Ry. v. Behymer. 1SV I ' .S. 46S, 470, 23 S.Ct 
622, 623, 47 l..Ed. (>o5 il<>03>: 
9 8 4 ^ ' a s h . 519 PACIFIC REPORTER, 2d SERIES 
H A L E , C. J., and R O S E L L I X L S T A F -
F O R D . W R I C H T and B R A C H T F X -
B A C H . J J . . concur. 
UTTF.R. Associate Justice (concurr ing) . 
I concur in the result reached by the ma-
jority. I believe a creator dut\ of cure 
could be imposed on the defendants than 
was established by their profession. The 
duty could be impused when a disease, such 
as glaucoma, can be detected by a simple. 
well-known harmless test whose results are 
definitive and the disease can be success-
fully arrested by early detection, but where 
the effects of the disease are irreversible if 
undetected over a substantial period of 
time. 
The difficulty with this approach is that 
we as judges, by using a negligence analy-
sis, seem to be imposing a stigma of moral 
blame upon the doctors who. in this case, 
used all the precautions commonly pre-
scribed by their profession in diagnosis and 
treatment. Lacking their t ra ining in this 
highly sophisticated profession, it seems il-
logical for this court to say they failed to 
. exercise a reasonable standard of care. It 
seem to me we are, in reality, imposing lia-
bility, because, in choosing between an in-
nocent plaintiff and a doctor, who acted 
reasonably according to his specialty but 
who could have prevented the full effects 
of this disease by administer ing a simple, 
harmless test and treatment , the plaintiff 
should not have to bear the risk of loss. 
As such, imposition of liability approaches 
that of strict liability. 
Strict liability or liability without fault 
is not new to the law. Historically, it pre-
dates our concepts of fault or moral re-
sponsibility as a basis of the remedy. 
Wigmore, Responsibilitv for Tor t ious 
Acts : Its History, 7 Har .L.Rev. 315, 383, 
441 (1394). As noted in \ \ \ Prosser, The 
Law of Tor t s § 74 (3d ed. 1964) at pages 
5<t7, 508: 
There are main situations in which a 
careful person is held liable for an en-
tirely reasonable mistake. . . . in 
some cases the defendant may be held 
liable, although he is not only charged 
with no moral wrongdoing, but has not 
even departed in any way from a reason-
able standard of intent or care. 
There is *'a strong and growing tenden-
cy, where there is blame on neither side, 
to ask, in view of the exigencies of so-
cial justice, who can best bear the loss 
and hence to shift the loss by creat ing 
liability where there has been no fault." 
i Footnote omitted.) Tor t law has contin-
ual!} been in a state of flux. It is "not al-
ways neat and orderly. But this is not to 
<ay it is illogical. Its central logic is the 
logic that moves from premises—its objec-
tives—that are only part ly consistent, to 
conclusions—its rules—that serve each 
objective as well as may be while serving 
others too. It is the logic of maximizing 
service and minimizing disservice to multi-
ple objectives." Keeton, Is There a Place 
for Negligence in Modern Tor t L a w : , 53 
Va.L.Rev. 886, 897 (1967). 
When types of problems ra ther than 
number* of cases are examined, strict lia-
bility is applied more often than negligence 
as a principle which determines liability. 
Peck. Negligence and Liability Without 
Fault m Tor t Law, 46 Wash.L.Rev. 225, 
239 (1971). There are many similarities in 
this case to other cases of strict liability. 
Problems of proof have been a common 
feature in situations where strict liability is 
applied. Where events are not mat ters of 
common experience, a ju ro r ' s ability to 
comprehend whether reasonable care has 
been followed diminishes. There are few 
areas as difficult for ju ro r s to intelligently 
comprehend as the intr icate questions of 
proof and standards in medical malpractice 
cases. 
In appKing strict liability there are 
many situations where it is imposed for 
conduct which can be defined with suffi-
cient precision to insure that application of 
a strict liability principle will not produce 
miscarr iages of justice in a substantial 
number of cases. If the activity involved 
is one which can be defined with sufficient 
precision, that definition can serve as an 
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accounting unit to which the costs of the 
activity may be allocated with some cer-
tainty and. precision. With this possible, 
strict liability serves a compensatory func-
tion in situations where the defendant is, 
through the use of insurance, the financial-
ly more responsible person. Peck, Negli-
gence and Liability Without Fault in Tort 
Law., supra at 240, 241. 
If the standard oi a reasonably prudent 
specialist is, in fact, inadequate to offer 
reasonable protection to the plaintiff, then 
liability can be imposed without fault. To 
do so under the narrow facts of this case 
does not offend my sense of justice. The 
pressure test to measure intraocular pres-
sure with the Schiotz tonometer and the 
Goldman applanometer takes a short time, 
involves no damage to the patient, and 
consists of placing the instrument against 
the eyeball. An abnormally high pressure 
requires other tests which would either 
confirm or deny the existence of glaucoma. 
It is generally believed that from 5 to 10 
years of detectable increased pressure must 
exist before there is permanent damage to 
the optic nerves. 
Although the incidence of glaucoma in 
the age range of the plaintiff is approxi-
mately one in 25,0**0, this alone should not 
be enough to deny her a claim. Where its 
presence can be detected by a simple, well-
known harmless test, where the results of 
the test are definitive, where the disease 
can be successfully arrested by early detec-
tion and where its effects are irreversible 
if undetected over a substantial period of 
time, liability should be imposed upon de-
fendants even though they did not violate 
the s tandard existing within the profession 
of ophthalmology. 
The failure -of plaintiff to raise this 
theory at the trial and to propose instruc-
tions consistent with it should not deprive 
her of the right to resolve the case on this 
theory on appeal. Where this court has 
authoritatively stated the law. the parties 
are bound by tho^e principles until they 
have been overruled. Acceptance of those 
principles at trial does not. constitute a 
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waiver or estop appellants from adapting 
their'" cau<e on. appeal to such a rule as 
might be declared if the earlier precedent 
is overruled. Samuelson v. Freeman, 75 
\Vash.Aj $04, 'HIM,
 4 ; 4 pjd 4iw, , l% r)„ 
FLYLF.Y and II VMILTuN", If., concur. 
f IE' HUHBiB S U U M > 
S3 Wash.2d 49S 
INTERNATIONAL UNION OF OPERATING 
ENGINEERS LOCAL NO. 286, AFL-
CIO (LOCAL 286),, et al.( Appellants, 
v. 
SAND POINT COUNT h i CUUL.. «~ 
POINT) et al.( Respondents. 
No. 42691. 
Sujuvnn • Court of Washington, 
En Banc. 
March 7, V. )T4. 
Action, was brought by employee rep 
resentatives seeking an injunction requir-
ing golf club operators to engage in collec-
tive bargaining. The Superior Court, King 
County, Shorett , J., entered summary judg-
ment for defendants, and plaintiffs appeal-
ed. The Supreme Court, Rosellini, J., held 
that under statute, golf club operators did 
not have an affirmative duty to bargain 
with representatives of maintenance em-
ployees. 
Judgment affirmed. 
Hale , C. ] d'" rc^n ' ' • ' nied an 
opinion. 
I. Labor Relations C=46 
Purpose of labor statute was to facili-
tate achievement by employees of an effec-
tive bargaining position and not to provide 
for compulsory collective bargaining. 
R C W A 40.52.011 et seq. 
: Lahor Relations C=I76 
Under statute, golf club operators did 
not have an affirmative duty to bargain 
Tab 8 
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Eclampsia 
Marco A. ViUarL., M,D,tm and Baha M. Sibai, M.D. t 
Eclampsia is defined as the development of convulsions oi 
or both, in pregnant patients with signs and symptoms o 
eclampsia. It is mainly a disease of young primigravidas. Eclampsia 
has been reported to occur in 0.05 to 0.2 per cent of all deliveries and 
in 3.6 per cent of twin deliveries.11,23 Maternal mortality rates of 0 to 
14 per cent have been attributed to eclampsia, as have perinatal mor-
tality rates of 10 to 28 per cent. Eclampsia may be prevented by early 
adequate prenatal care and by astute medical judgment. 
PATHOPHYSIOLOGY 
Ecuuiipsia is a syndrome characterized by functional derange-
ment of nearly every organ system. Many hypotheses regarding the 
etiology and pathophysiology of pre-eclampsia and eclampsia have 
been proposed (Table 1), but none as yet has been confirmed conclu-
sively. There is considerable evidence to suggest that the develop-
ment of pre-eclampsia is associated with increased trophoblastic mass 
(hyperplacentosis). This finding might explain the increased inci-
dence of pre-eclampsia in patients with molar pregnancy, multiple 
gestation, and nonimmune hydrops fetalis. In addition, there is an 
increased incidence in patients with underlying renal disease, as can 
be seen in chronic hypertension and lupus erythematosus. 
Uteroplacental ischemia seems to play an important role in the 
etiology of pre-eclampsia and eclampsia. The most widely accepted 
hypotheses suggest an imbalance in the production of the two pla-
cental eicosanoids: prostacyclin and thromboxane. During normal 
pregnancy, the placenta produces equivalent amounts of prostacyclin 
and thromboxane, so that the biologic actions on vascular tone, 
platelet aggregation, and uterine activity will be balanced. However,. 
in pre-eclamptic pregnancy, placental production of these two eico-
* Fellow, Division of Maternal Fetal Medicine, Department of Obstetrics and Gyne-
cology, University of Tennessee, Memphis, Tennessee 
fProfessor, Division of Maternal Fetal Medicine, Department of Obstetrics and Gyne-
cology, University of Tennessee, Memphis, Tennessee 
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Table 1. Mechanisms Suggested as Etiologies of Pre-eclampsia 
Uteroplacental ischemia (uterine stretch) 
Decreased placental perfusion 
Abnormal progesterone metabolism 
Oecieased MCRDS to estradiol 
Immunologic dysfunction 
Primarily a disease of primigravida 
Immunologic complexes in kidney and liver 
Multisystem involvement 
Hematologic abnormalities 
Thrombocytopenia 
Disseminated intiavasculai coagulopathy 
Renal ischemia 
Impaired renal function 
Hypertension 
Proteinuria 
Biochemical abnormalities 
Magnesium metabolism 
Calcium metabolism 
Zinc deficiency 
Dietary factors 
Sodium intake 
Protein intake 
Caloric intake 
Trace metals 
Genetic factors 
Increased incidence in daughters of eclamptic patients 
Increased incidence in gianddaughters of eclamptic patients 
Vasospasm 
Increased sensitivity to vasoactive substances 
Abnormal prostaglandin metabolism 
sanoids is tipped heavily in favor of thromboxane. Therefore, the ac-
tions of thromboxane—increasing vasoconstriction, platelet aggrega-
tion, and uterine activity—will be exacerbated, whereas the actions 
of prostacyclin—promoting vasodilation and inhibiting platelet ag-
gregation and uterine activity—will be diminished.30 
Eclamptic patients exhibit an increased sensitivity to vasoactive 
substances such as angiotensin II and catecholamines. Such patients 
have generalized arteriolar vasospasm resulting in increased periph-
eral vascular resistance and an increased left-ventricular stroke work 
index. Central venous pressure is usually low, and the pulmonary 
capillary wedge pressure is in the low part of the normal range (0 to 7 
mm Hg). The plasma volume is markedly reduced compared with 
that of normal pregnancy (less than 48 ml per kg versus 63 ± 5 ml 
per kg), resulting in hemoconcentration and increased blood vis-
cosity. Renal function is frequently characterized by a reduced glo-
merular filtration rate, decreased renal plasma flow, and reduced 
uric acid clearance. Liver damage is usually an autopsy finding in 
patients who die from eclampsia. The typical lesion is periportal ne-
crosis with hepatocellular damage. 
Several pathologic mechanisms have been implicated as possible 
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Table 2. Possible Etiologic Factors Responsible for Convulsions 
in Eclampsia 
Cerebral vasospasm 
Cerebral hemorrhage 
Cerebral ischemia 
Cerebral edema 
Hypertensive encephalopathy 
Metabolic encephalopathy 
etiologic factors in the development of either convulsions or coma in 
eclamptic patients (Table 2). Although a recent report suggests a pos-
sible association between decreased colloid osmotic pressure and the 
development of seizures in eclamptic patients,6 this idea has not 
been confirmed in a study involving a larger patient population from 
this institution. 
DIAGNOSIS 
Theacriteria for the diagnosis of eclampsia require the develop-
ment,of convulsions in a patient with hvpertension>proteinnria;»*or 
edema,after<the 20th week of gestation or.within ,4& hours post-
partum.^Several risk factors may predispose to eclampsia (Table 3). 
Development of convulsions during pregnancy and the puerperium 
may also be the result of other medical and central nervous system 
disorders (Table 4), which should be considered in the differential 
diagnosis. 
The>clinicaLcourse,of eclampsia is usually gradual and chronip; 
howevei>the*onset of eclampsia.may be abrupt withoutany warning 
signs-or^symptoms, as,occurs in about 15 to 20 percent of casesi*A(i 
the^University-of*Tennessee,- Memphis, > the authors .studied* 2JJB 
eclampticcasesjsabrupt onset.was found in 34 (15.7 percent). 
Abnormahweight gain (with or without clinical edema) in excess 
of^pounds^per^week^during^the^third trimester, may be an eajjly 
warning sign,*but*excessiveiweighhgain or edema during pregnancy* 
is notnecessaryfonthe diagnosis^of eclampsia* In,a, report from-thist 
institution,^}. (33.8 per*cent)*of.the eclamptic patients had convujj 
sions without,edema,-and^intonly 52 (24 per.cent),was generalized 
edema evicjjpnt. 
Table 3. Established Risk Factors for Eclampsia 
Nulliparity 
Multiple gestation 
Molar pregnancy 
Existing hypertension or renal disease 
Previous severe pre-eclampsia and eclampsia 
Nonimmune hydrops fetalis 
Family history of pre-eclampsia or eclampsia 
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Table 4. Differential Diagnosis of Eclampsia 
Cerebrovascular accidents 
Cerebral venous thrombose 
Cerebral arterial occlusion 
Cerebral arteiial embolisn 
Intracerebral hemorrhage 
Hypertensive disease 
Hypertensive encephalopathy 
Pheochromocytoma 
Space-occupying cential nervous system lesioi 
Tumor 
Abscess 
Infectious disease 
Meningit is 
Encephalitis 
Metabolic diseases 
Hypoglycemia 
Hypocalcemia 
Water intoxication 
Epilepsy 
Hypertension is the lialu i i< ot eclampsia. This can be severe 
(above 160 mm Hg systolic or • ive 110 mm Hg diastolic), as shown 
in 42.6 per cent of our series, or mild (140 to 160 mm Hg systolic or 
90 to ] 10 mm Hg diastolic), seen in 20.3 per cent. Income cases,,the^ 
hypertension is relative (120/80 mm Hg). In ;this-situation^hyperten r 
sion is signified by any rise in blood pressure that is 30 mm Hg sys= 
tolic or 15 mm Hg diastolic above mid-trimester blood pressure 
readings.* Most young primigravidas have initial systolic pressures of 
80 to 90 mm Hg and diastolic pressures between 50 and 60,mm Hg 
during the second and early third trimester of pregnancy;-conse-
quently, some of these patients may suffer convulsions with relative 
degrees of hypertension. 
The use of mean ar ter ial p ressure dt :ng w e e k s ^ l 8 , t o 26j 
(MAP-2) to identify patients destined to dev^ op pre-eclampsia has 
been suggested by some authors. We have found that this*blood-* 
pressure criterion is a poor predictor of eclampsia and might give the 
clinician a false sense of security (Table 5)}3 This finding is in agree-
ment with data reported by Moiler and Landmark,15 who found that 
'mly 39 per cent of patients having eclampsia before 37 weeks' and 16 
per cent of those having eclampsia beyond 37 weeks' gestation had an 
elevation of blood pressure 4 days before the first eclamptic seizures. 
The diagnosis of eclampsia is usually associated with significant 
proteinuria (more than 2 + on dipstick). The degree of proteinuria 
may fluctuate widely over any 24-hour period, making quantitative 
24-hour urine determinations more accurate than random assess-
ment. However, the jugsence of proteinuria is not necessary for the 
diagnosis of eclampsia, as about 20 per cent of eclamptic"patients'do 
not have proteinuria (Fig. 1). " """" ~~ " 
Several other Hinical signs and symptoms are potentially helpful 
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Table 5, Maximal Mean Arterial Pressure in Second Trimester in Two 
Groups nf Eclamptic Patients 
GROUP 
Nulliparas 
Margaret-Hagu^ 
EH Crump 
Total 
Multiparas 
Margaret Hague 
EH Crump 
total 
NO. OFPATE-CTS 
8£ 
122 
207 
c 
r 2( 
MEAN 
86.1 
85.9 
86.0 
86.2 
86 9 
86 6 
± 
-+• 
-H 
-*-
•+• 
-h 
± 
S.D. 
6,30 
6T 
6 2 
4 
4 I 
8.0 
PERCENTAGE WITH 
90-94 mm 
28 
20 
23 
a3 
27 
30 
J/g 7*9% - : * ^ 
From Chesley LC, Sibai BM £ ^od pressure in mid-trimester and future eclampsia 
Am J Obstet Gynecol 157:1259, 1QST 
in e i the r es tabl ishing the diagnosis of eclampsia or serving a-
warnings before the onset of convulsions. These include severe and 
pers is tentheadache, blurred vision, photophobia, epigastric pain oi 
right upper^quadrTtTTt pain, and hyperactive deep tendon r e f l e t s 
with clonus* Persistent occipital headache (80 per cent), visual dis-
turbances (40 per cent), and epigastric pain (20 per cent) are the mc-s 
frequent premonitory symptoms before convulsions. l£ 
The onset of convulsions can be antepartum, intrapartum, o 
postpartum. About 50 per cent of cases develop antepartum, 25 p e r 
cent during labor, and the rest in the postpartum period. Most cases 
of antepartum eclampsia develop during the third trimester, a few 
cases occur between 21 and 27 weeks' gestation, and rare cases have 
been reported before 20 weeks* gestation. Figure 2 shows the distri-
bution of gestational age at the time of onset of eclampsia among 216 
cases studied by the authors. The development of eclamptic convul-
* 2 1 . 7 6 * 
40.61% 
29.63% 
_ _^ ~ ~ — I 
ECLAMPSIA W ^ f L J ECLAMPSIA WIT- E L EZ_±M-»3,- ^ T J O U T " j 
SIGNIFICANT Fr^~H'NURIA MODERATE PRC~H r JRIA ^ " ^ ' ~L* * I 
Figure J P r e s e n t of nrofeinui ia in er latnptu »^»»<# n' 
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Figure 2. Distribution of gestational age at the time of onset of eclampsia among 
216 patients. 
sions prior to the 20th week of gestation or more than 48 hours after 
delivery in patients with clinical and laboratory findings consistent 
with pre-eclampsia is termed "atypical eclampsia" by the authors. 
This term has been viewed with skepticism by several other authors 
because they consider that the convulsions are due to another dis-
order. These cases are extremely rare, especially those without asso-
ciated hydropic or molar degeneration of the placenta; therefore, 
most of the time, they may be misdiagnosed as hypertensive enceph-
alopathy or a seizure disorder. Thus, the authors believe that women 
in whom convulsions develop in association with hypertension, pro-
teinuria, and elevated uric acid during the first half of pregnancy 
should be treated as eclamptic.19 ' 
Late-onset postpartum eclampsia is defined as convulsions more 
than 48 hours after delivery.21 Pre-eclampsia is not always recognized 
before the onset of convulsions; consequently, education of physi-
cians, nurses , and pa t ien ts on the subject of late pos tpa r tum 
eclampsia may help identify the patient before the development of 
convulsion. The seriousness of overlooking a persistent postpartum 
blood pressure of 130/80 mm Hg or greater when previous constant 
readings were 100/60 mm Hg intrapartum, or of a patient failing to 
question and report severe headaches for 1 to 3 days or visual distur-
bances in the first week or two postpartum, cannot be overempha-
sized. 
During the past 10 years, 33 cases of late postpartum eclampsia 
(15.2 per cent of our series) have been managed in our institution. 
Some of these patients had pre-eclampsia antepartum or during 
labor. They received intravenous magnesium sulfate during labor and 
for a minimum of 24 hours postpartum. There was clinical evidence 
of improvement in the preeclamptic vrocess in all of them, yet con-
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vulsions developed either during hospitalization or a few days after 
discharge. The other patients had normotensive gestations with 
normal postpartum blood pressures. They had sudden onset of con-
vulsions at home and then were readmitted. Headaches, visual dis-
turbances, or both of 1 to 4 days* duration were reported by all pa-
t ients before the onset of convulsions. Physical and laboratory 
findings immediately after the convulsions were clearly consistent 
with eclampsia in all patients, and brisk diuresis (urine output ex-
ceeding 4 L per day) for about 2 days was the rule in every patient. 
None of them had a history of seizure disorder, and no patient had 
neurologic deficits or seizures on follow-up. 
Late-onset postpartum eclampsia should not be treated solely as 
a diagnosis of exclusion, since immediate medical therapy should be 
instituted for seizure control. Hence, when a postpartum patient is 
admitted with a history of convulsions more than 48 hours after de-
livery and is hypertensive with proteinuria or edema, late-post-
partum eclampsia should be the primary diagnosis while ruling out 
other possible neurologic or metabolic causes (Table 4). 
LABORATORY FINDINGS 
The diagnosis of eclampsia is not dependent on any specific labo-
ratory data. The frequency of abnormal laboratory findings is in-
fluenced by multiple factors such as the presence of associated med-
ical or obstetric complications, quality of obstetric care, and ade-
quacy of compensatory physiologic mechanisms. Serum uric acid is 
elevated (greater than 6.2 mg per dl) in most patients (69 per cent). 
Other renal function tests such as serum creatinine and creatinine 
clearance are abnormal in 50 to 70 per cent of the cases. 
Hemoconcentration (increased hematocrit and reduced plasma 
volume) and increased blood viscosity may be common in eclampsia. 
Thrombocytopenia (platelet count below 150,000 per mm3) is seen in 
15 to 30 per cent of eclamptic patients. The full picture of dissemi-
nated intravascular coagulopathy may be seen in neglected cases or 
in association with abruptio placentae and fetal demise (4.5 per 
cent).22 
Conventional liver function tests such as alkaline phosphatase, 
lactic dehydrogenase, serum transaminases, and bilirubin may be 
elevated in 11 to 74 per cent of eclamptic patients. A syndrome of 
hemolysis, elevated liver enzymes, and low platelets (HELLP syn-
drome) is encountered in about 10 per cent of eclamptic patients, and 
its presence increases the risk of subcapsular hematoma of the liver 
with or without rupture. This syndrome is usually seen late after 
long-standing disease and in patients with associated medical dis-
ease.26 
Cerebral pathology in the form of edema, hemorrhage, or both 
is a common autopsy finding in eclampsia. The diagnosis of eclampsia 
is not dependen t on^ any single clinical or diagnostic neurologic 
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finding. Focal neurologic signs such as hemiparesis or tliose of as-
phyxia are rare. Neurodiagnostic tests such as electroencephalog-
raphy (EEG), computed tomography (CT) scan, lumbar puncture, 
and cerebral arteriography are rarely needed for the diagnosis,25 
The EEG is acutely abnormal in the majority of eclamptic pa-
tients. During eclampsia, the EEG pattern is usually a diffuse slow 
activity (p or 8 waves), sometimes with focal slow activity and occa-
sional paroxysmal spike activity. None of these findings is pathogno-
monic of eclampsia, as similar patterns are usually seen in other con-
ditions such as hypoxia, renal disease, polycythemia, hypocalcemia, 
and water intoxication. Such abnormalities may persist for as long as 
6 weeks postpartum and return to normal within 3 to 6 months there-
after. We studied the E E G findings in 36 eclamptic patients during 
the administration of magnesium sulfate (serum Mg 4.5 to 11.0 mg 
per dl) and after magnesium sulfate had been discontinued (serum 
Mg 1.8 to 2.5 mg per dl).24 Seventy-five per cent of the patients had 
abnormal EEG findings despite adequate serum magnesium levels. 
In addition, the authors found no correlation between the degree of 
maternal blood pressure elevation and the presence of E E G abnor-
malities. 
There are very few data describing the CT scan findings in 
eclamptic patients. The abnormal patterns found are either edema, 
hemorrhage, or reversible diminished density of white matter scat-
tered throughout the brain with or without reduced lateral ventricle 
size. Cerebral arteriography and lumbar puncture should be re-
stricted to the evaluation of patients with focal neurologic deficits or 
late-onset postpartum eclampsia to rule out cerebrovascular pa-
thology such as cerebral vascular accidents (cerebral venous throm-
bosis or intracerebral hemorrhage), cerebral edema, or cerebral in-
fections (meningitis, encephalitis, or brain abscess). 
Magnetic resonance imaging (MRI) is a recently developed 
neuroimaging technique that appears superior to other processes for 
defining intracranial anatomy and pathophysiology. The technique 
provides images in multiple planes, avoids the use of ionizing radia-
tion, and is not associated with any known biohazards. Its application 
in eclampsia has been reported by Crawford and associates,7 who 
found highest sensitivity relative to CT in its ability to detect central 
nervous lesions. If their findings are confirmed by larger studies, 
MRI might prove to be the method of choice in the management of 
this kind of patient, especially the one in whom the diagnosis of 
eclampsia is unclear. 
. MANAGEMEN 
The basic p r inc ip le s in the mp c e m e n t of a n t e p a r t u m 
eclampsia involve the following measin . (1) support of maternal 
vital functions; (2) control of convulsions and prevention of recurrent 
"MMvnk-mns-- i^) rnr rprHni i nl maternal hvnnvnmia or ac idemia: (4) 
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control of severe hypertension; and (5) initiation of the process of 
delivery. 
Eclamptic convulsions constitute a life-threatening emergency. 
The cardinal steps in management are to prevent maternal injury 
during the convulsive episode, such as inserting a padded tongue 
blade between the teeth, and to safeguard against potential maternal 
morbidity following the convulsions. The most urgent part of therapy 
is to ensure maternal oxygenation and to minimize the risk of aspira-
tion. 
The ideal anticonvulsant for pregnancy would be "one which is 
rapidly effective, reliable, has a predictable duration of action, has a 
wide safety margin, and is nei ther depressive nor toxic to ei ther 
mother or fetus."27 Although it falls short of these ideals, parenteral 
magnesium sulfate (MgS04*7 H a O USP) has been the drug of choice 
to control and prevent eclamptic convulsions. The drug does not 
cliuse any significant maternal-neonatal central nervous system de-
pression when used properly. During its administration, the mother 
is awake and alert, and laryngeal reflexes are intact, which helps to 
protect against aspiration. Fetal magnesium levels tend to equilibrate 
with maternal levels after long-term administration; however, neuro-
muscular depression in the newborn is rare with proper use of the 
drug. 
The usual dose of magnesium sulfate given to arrest eclamptic 
convulsions is 4 to 6 gm intravenously over 5 to 10 minutes. This 
dose is followed by one of three commonly used regimens (Table 6). 
If a patient has recurrent convulsions, then another bolus dose of 2 to 
4 gm can be given over 3 to 5 minutes. If convulsions again recur, 
then a short-acting barbiturate such as sodium amobarbital should be 
given in a dose of up to 250 rng intravenously over 3 minutes. An 
occasional patient will have recurrent seizures even with all the 
above measures, necessitating the administration of a paralyzing 
agent as well as intubation. 
Maternal plasma levels of magnesium after parenteral adminis-
tration of magnesium sulfate depend on the volume of distribution 
and renal clearance of the M g + 2 ion. These are usually increased and 
decreased, respectively, during pregnancy, especially in eclamptic 
patients, The usual loading dose of 4 gm intravenously is likely to 
Table 6. Specific Recommended Regimens of Magnesium Sulfate to Treat 
Eclamptic Convulsions 
Pritchards intramuscular regimen 
4 gm IV over 3 - 5 minutes + 10 gm IM as loading dose 
Maintenance dose of 5 gm IM every 4 hours 
Zuspan's intravenous regimen 
4 gm IV over 5 to 10 minutes as loading dose 
Maintenance dose of 1-2 gm per hour 
Sibai's intravenous regimen 
6 gm IV over 10 minutes as loading dose 
Maintenance dose of 2 - 3 gm per hour 
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result in instant maternal plasma M g + 2 levels of 5 to 8 mg per dl. 
This increase is transient, and plasma levels fall rapidly within the 
first 60 minutes. The regimen recommended by Pritchard will ordi-
narily keep maternal plasma M g + 2 levels between 5 and 8 mg per dl. 
The maintenance dose of 1 gm per hour recommended by Zuspan 
will produce plasma levels between 3 and 4 mg per dl, but even the 
dose of 2 gm per hour produces plasma levels below 5 mg per dl in 
about 50 per cent of patients. The recommended therapeutic levels 
of Mg range from 4.8 to 8.4 mg per dl; however, the actual thera-
peutic level is unknown. An occasional patient develops convulsions 
at plasma levels that are well in the therapeutic range. 
Table 7 summarizes the physical findings consistent with ele-
vated serum M g + 2 levels. Additional actions might include a tran-
sient and mild hypotensive effect when magnesium is given as an 
intravenous bolus and mild reduction in uterine activity during active 
labor. In addition, decreased fetal heart rate variability, neonatal 
poor muscle tone, and low Apgar scores are associated with magne-
sium use. Because of the potential for significant morbidity during its 
administration, it is mandatory to examine the patient at regular in-
tervals for evidence of toxicity. Loss of patellar reflexes is the first 
sign of magnesium intoxication; hence, any order for administration 
of the drug should include checking these reflexes before continuing 
the maintenance dose. It is important to keep an ampule containing 1 
gm of calcium gluconate at the bedside for intravenous administra-
tion as an antidote in case of magnesium toxicity. 
The mechanism of anticonvulsant action of Mg*2 is unknown, 
and there is considerable controversy surrounding its peripheral 
versus central nervous system effects. Some authors suggest that 
magnesium sulfate is a poor anticonvulsant on the grounds that it 
controls convulsions by blocking peripheral neuromuscular transmis-
sion by interfering with the liberation of acetylcholine and reducing 
the sensitivity to acetylcholine at the motor end-plate. This view is 
supported by Hilmy and Somjen,10 who induced hypermagnesemia 
sufficient to paralyze skeletal muscles in two men, but they were 
unable to induce significant depression of the central nervous 
system. Based on these findings, they suggested that the central 
nervous system is protected from high levels of serum magnesium by 
a barrier mechanism that keeps the concentration in the brain within 
physiologic limits. On the other hand, large clinical studies using 
magnesium sulfate in patients with severe pre-eclampsia or 
Table 7. Signs of Magnesium Toxicity and Approximate Plasma Levels 
SIGN PLASMA LEVEL (MC/DL) 
Loss of patellar reflex 10-12 
Respiratory arrest 14.6 
Paralysis 15.0 
Cardiac arrest 30 
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eclampsia have suggested that magnesium prevents convulsions 
through a central nervous system effect, because the M g + 2 levels 
reported as being adequate to control convulsions are well below the 
levels needed to produce complete neuromuscular blockade. 
The use of other anticonvulsants such as narcotics, sedatives, 
tranquilizers (phenothiazine), and barbiturates can cause significant 
maternal-neonatal central nervous system and respiratory depres-
sion. Barbiturates and phenytoin are good anticonvulsants when used 
orally to treat epilepsy during pregnancy. Diazepam in high doses (20 
to 50 mg) depresses both mother and fetus, causes loss of beat-to-
beat variability in the fetal heart rate, delays the onset of neonatal 
breathing, and is responsible for neonatal apnea, hypotonia, and poor 
sucking. The use of intravenous phenobarbital has the potential for 
producing laryngospasm as well as circulatory and respiratory de-
pression. In dosages adequate to control seizures, intravenous phe-
nytoin must be administrated slowly (no more than 25 mg per 
minute). Because phenytoin is cleared from the brain rapidly, re-
peated intravenous injections are needed to maintain therapeutic 
levels. In a very recent report by Slater and associates,27 the use of 
phenytoin infusion was adopted to avoid the difficulties mentioned 
above. After an initial loading dose of 750 to 1250 mg, a 25 mg per 
min infusion was started; 12 hours later, a second loading dose of 500 
mg was given. Plasma phenytoin levels in the range of 7 to 20 mg per 
L were obtained with this regimen, and no serious maternal or neo-
natal side effects were observed. 
Correction of Maternal Hypoxemia or Acidemia 
After controlling maternal convulsions, we obtain arterial blood-
gas measurements and a chest radiograph to ensure the presence of 
normal arterial P 0 2 and pH to rule out aspiration. Maternal hypox-
emia or acidemia may result from repeated convulsions and respira-
tory depression from the use of multiple anticonvulsive agents, aspi-
ration, or a combination of these factors. Correction of hypoxemia 
and acidemia is necessary before administering either anesthetic or 
anticonvulsive drugs in order to avoid toxic side effects. 
Control of Severe Hypertension 
The objective of treating severe hypertension is to prevent cere-
brovascular accidents without compromising uteroplacental blood 
flow, which is already reduced in eclampsia. Hydralazine is a safe 
and effective drug for the management of severe hypertension during 
pregnancy. The drug should be administered in intermittent bolus 
injections of 5 to 10 mg every 20 minutes. Frequent close monitoring 
of maternal blood pressure is necessary to titrate the dose of hydral-
azine. The ultimate goal is to keep the systolic blood pressure be-
tween 140 and 150 mm Hg, the diastolic blood pressure between 90 
and 100 mm Hg, or both. 
Labetalol hydrochloride is a new antihypertensive agent that 
might augment the obstetrician's armamentarium.14 It is available for 
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hoih oral and intravenous use and produces nonselective beta-
blockade and postsynaptic alpha-1-blockade, combining the effects of 
propranolol and prazosin. Recent reports suggest the drug also has a 
vasodilator action mediated by beta-2-receptor stimulation. Hemody-
namic studies conflict, but overall, it appears that labetalol decreases 
systemic vascular resistance with little or no change in cardiac 
output. The drug was introduced in Europe in 1975 but did not re-
ceive Food and Drug Administration approval in the United States 
until 1984. Serious rare side effects have not yet been quantified. 
Other potent antihypertensive medications such as sodium ni~ 
troprusside or nitroglycerin are rarely needed in eclampsia. Di-
uretics are not indicated except in the presence of pulmonary edema. 
Process of Delivery 
Delivery of the fetus and the placenta is the primary treatment 
of eclampsia. Once convulsions and severe hypertension are well 
controlled and the patient has been stabilized, preparation for de-
livery should be initiated. All patients should have continuous fetal 
heart rate and uterine activity monitoring during labor. Severe fetal 
bradycardia and late decelerations are frequent during and immedi-
ately after eclamptic convulsions, which may be secondary to ma-
ternal hypoxia and acidosis.17 Adequate correction of such conditions 
is commonly followed by gradual recovery of the fetal heart rate pat-
tern. If labor is not well established and no fetal malpresentation or 
distress is noted, intravenous oxytocin may be used to induce labor in 
all patients beyond 32 weeks' gestation irrespective of the extent of 
cervical dilatation or effacement. A similar approach is used for pa-
tients at less than 32 weeks if the cervix is favorable for induction. All 
other patients are usually stabilized with magnesium sulfate and then 
delivered electively by cesarean section. This approach is based on 
previous experience of a high incidence of intrapartum complications 
such as abruptio placentae and fetal distress in eclampsia developing 
before 32 weeks* gestation. 
Maternal analgesia can be provided by the intermittent use of 
small intravenous doses (25 to 50 mg) of meperidine. Local infiltra-
tion anesthesia with pudendal block may be used in most cases for 
vaginal delivery. A balanced general anesthesia can be used for ab-
dominal deliveries, but probably the anesthesia of choice is epidural. 
It must be emphasized that epidural anesthesia in such patients re-
quires the availability of central hemodynamic monitoring and per-
runnel with special expertise in obstetrical anesthesia. Also, the use 
of conduction anesthesia is contraindicated in patients with thrombo-
cytopenia or prolonged bleeding time (greater than 12 minutes). 
There has been controversy regarding the use of epidural anesthesia, 
with some authors being against its use because of the potential ma-
ternal hypotension and reduced uteroplacental blood flow, but 
others report no adverse maternal or fetal outcome.9 
All patients should have laboratory evaluation of urine protein 
nwl specific eravifrv, creatinine, electrolytes, platelet count, and liver 
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enzymes. The patient should be monitored closely during labor and 
delivery, with special attention to fluid intake and output. Urinary 
output should be monitored every hour, and fluid administration 
should not exceed 150 ml per hour. Parenteral magnesium sulfate 
should be continued through labor and delivery and for at least 24 
hours postpartum. If the patient has oliguria (less than 100 ml per 4 
hours), the rate of fluid infusion and the dose of magnesium sulfate 
should be reduced. 
After delivery, the patient should be monitored, including eval-
uation of reflexes, in the recovery room for at least 24 hours, during 
which time maternal vital signs and intake and output should be 
monitored hourly. Some of these patients may require invasive he-
modynamic monitoring during labor and postpartum. Most patients 
will show evidence of resolution of the disease process within 24 
hours after delivery. However, some patients may require intensive 
monitoring, including the administration of magnesium sulfate, for 2 
to 4 days after delivery. Such patients are at risk for development of 
pulmonary edema from fluid overload and compromised renal func-
tion. 
Some authors recommend the use of short-term phenobarbital 
w h e n p a r e n t e r a l magnes ium is d i s con t inued in hospi ta l ized 
eclamptic patients during the immediate postpartum period. This 
recommendation would appear to be reasonable in view of the per-
sistent EEG abnormalities in some of these patients. However, such 
therapy will prevent early ambulation, and its efficacy has not been 
studied in a controlled manner. In addition, some internists and neu-
rologists prescribe long-term anticonvulsive therapy (as for epilepsy) 
for the majority of patients with postpartum eclampsia. This therapy 
is unwarranted, because most patients will have normal EEGs within 
6 weeks after delivery. Most patients will be normotensive at the 
time of discharge from the hospital, and no patient should have any 
neurologic deficit at that time. 
Some patients continue to have severe hypertension, whic1 
be controlled with a variety of drugs. Such patients should b* 
evaluated within 1 week after discharge from the hospital. Mo 
them will be normotensive on follow-up, at which time antihyper-
tensive medication can be discontinued. 
PERINATAL O U T C O M E 
,Eclampsia|is|r£|Significant cause of both maternal and perinatal? 
deadifMHfmofBiHity worldwide. Most of the maternal deaths are as-
sociated with complicated or mismanaged cases of eclampsia. Poten-
tial maternal complications are summarized in Table 8. Some of them 
are iatrogenic (pulmonary edema or aspiration), whereas others are 
unavoidable (retinal detachment). Abruptio placentae is the most fre-
quent complication; intracerebral hemorrhage i^  the m n ^ sorinn*: 
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Table 8. Maternal Complications in Eclampsia 
Abruptio placentae 
Disseminated intravascular coagulopathy 
Intracerebral hemorrhage 
Pulmonary edema 
Aspiration pneumonia 
Acute renal tubular necrosis 
Retinal detachment 
Ruptured liver 
Transient cortical blindness 
The reported perinatal mortality rate varies between 10 and 28 
per cent. For fetuses alive on admission to perinatal centers, the neo-
natal mortality rate is about 4 per cent.23 Most of the perinatal deaths 
are related to prematurity, severe growth retardation, asphyxia, and 
the increased incidence of abruptio placentae. 
Factors relating to the perinatal mortality rate in eclampsia were 
examined by L6pez-Llera and associates12 in 327 infants born of 
eclamptic Mexican women. The most important factor was the de-
gree of fetal viability when the patient developed eclampsia. The 
mortality rate in the 162 fetuses born to women with antepartum 
eclampsia (mean gestational age 34.5 ± 4 weeks) was 37.0 per cent 
compared with 12.2 per cent for the 107 fetuses born to women with 
intrapartum eclampsia (mean gestational age 38.6 ± 3 weeks). When 
fetuses weighing less than 1000 gm were excluded, the fetal deaths 
were 22.2 per cent for women with antepartum eclampsia compared 
with 6.5 per cent for women with intrapartum eclampsia. The cor-
rected neonatal mortality rate was 9.6 per cent in the women with 
antepartum eclampsia compared with 6 per cent in women with in-
trapartum eclampsia. Women who had eclampsia without any under-
lying medical condition had a perinatal mortality rate (16 per cent) 
half that of women with eclampsia who had chronic hypertension 
(34.9 per cent) or underlying renal disease (46.2 per cent). When 
fetuses weighing less than 1000 gm were excluded, the corrected 
fetal mortality rate in eclamptic women without any underlying med-
ical condition was 6.7 per cent compared with 20.5 per cent in 
eclamptic women with chronic hypertension and 23.1 per cent in 
those with underlying renal disease. Corrected neonatal mortality 
rates were 6 per cent for the eclamptic women without an underlying 
medical condition, 9.7 per cent for the eclamptic women with 
chronic hypertension, and 26.3 per cent for eclamptic women with 
underlying renal disease. Most of the increase in the perinatal mor-
tality rate in these women with chronic hypertension was attributable 
to loss of fetuses weighing less than 1000 gm. 
Of interest were the findings of infants with re tarded fetal 
growth as determined from standards derived by Gruenwald and 
based on British data.8 Before 35 weeks* gestation, 4.3 per cent of 
fetuses had a birthweight two or more standard deviations below the 
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British mean. This increased to 13.9 per cent for fetuses delivered 
after 35 weeks' gestation. Retarded growth prior to 35 weeks' gesta-
tion was associated with a markedly increased fetal death rate. After 
35 weeks ' gestation, fetuses at or below two standard deviations 
below the mean had five times the death rate of fetuses at or above 
the mean. This study points out the increased death rate in under-
grown fetuses. 
Abruptio placentae is a significant risk in women who develop 
eclampsia before delivery. Pritchard and associates17 reported a 5.5 
per cent incidence of abruptio placentae in women who develop 
eclampsia before delivery. This was the contributing factor in the 
death of three stillborn fetuses that weighed 2080, 2470, and 2670 
gm. Abdella and associates1 reported abruptio placentae in 13 of 55 
women (23.6 per cent) with eclampsia prior to delivery at the Univer-
sity of Tennessee, Memphis. The birthweights for these 13 fetuses 
were 1239.6 ± 601 gm with a mean gestational age of 29.9 ± 5.2 
weeks. There were three stillbirths and three neonatal deaths, for a 
perinatal mortality rate of 46 per cent. In addition, two other reports 
have given rates of 60 per cent and 100 per cent in women who had 
eclampsia and developed abruptio placentae. 
Prematurity and intrauterine growth retardation (IUGR) are sig-
nificant problems in the fetuses of eclamptic women. Sibai and asso-
ciates27 reviewed the outcome of the 68 women with eclampsia and 
fetus alive on admission to the hospital for the period of August 1, 
1977, to December 31, 1981. Forty of the fetuses were less than 37 
weeks' gestation with a mean gestational age of 32.4 ± 2 . 2 weeks and 
a mean weight of 1496 ± 456 gm. Twelve of the preterm infants were 
small for gestational age (SGA) at birth. Twenty-six of the 40 infants 
were delivered by cesarean section, with fetal distress being the indi-
cation in 17 of the 26 (65.4 per cent). In comparison, cesarean section 
was performed in 7 of the 28 women in the term group. 
NEONATAL OUTC OME 
These same factors complicating the perinatal outcome are re-
sponsible for the increased neonatal morbidity in infants of eclamptic 
mothers. Such complications, although more common in preterm an-
tepartum eclampsia, occur as well as in eclampsia developing after 36 
weeks' gestation. 
Lopez-Llera and Herndndez1 3 reported higher neonatal loss and 
an increased incidence of fetal growth retardation in both antepartum 
eclampsia and eclampsia developing early in pregnancy (27 per cent). 
Brazy and associates2 reported a high incidence of retarded fetal 
growth (39 per cent below the 10th percentile and 96 per cent below 
the 15th percentile) in 28 infants of severely hypertensive preg-
nancies, eight with eclampsia. In addition, 29 per cent of the infants 
were SGA, showing an evident symmetrical growth retardation. The 
same authors reported a high incidence of perinatal asphyxia, low 
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Apgar scores, i hematologic abnormalities in infants of hyperten-
sive mothers c ipared with a matched group of infants of normoten-
sive mothers. Some of the hematologic abnormalities were an in-
creased incidence of thrombocytopenia, leukopenia, neutropenia, 
and disseminated intravascular coagulopathy. The authors suggested 
the presence of a common pathologic process (a humoral substance) 
leading to the abnormal hematologic findings in both mother anc 
infant. 
The neonatal outcome in 72 infants of eclamptic mothers hac 
been recently reported by Sibai and cowoikers 22 Forty of the 7l2 
infants (56 pei cent) were premature, and in 9 of these 40, the ptej; 
nancy was complicated by abruptio placentae. Twelve of the 40 pie-
matuie infants were SGA. Interestingly, none of the 32 mature in-
fants had evidence of fetal growth retardation. Additionally, giowth 
letardation was symmetrical in all seven infants of mothers who had 
eclampsia before 32 weeks ' gestation. Hence , there is no head 
sparing when eclampsia develops early in the third trimestei 
L O M T E R M NEONATAL OUTCOME 
Sibai and associates followed 28 premature infants and 14 full-
term infants of eclamptic mothers for up to 50 months.22 Eight of the 
12 infants who were SGA by weight at birth showed catch-up growth 
at an average of 20.6 months (range 2 to 48 months). In all, only two 
of the infants remained growth retarded by weight, height, and head 
circumference; both were mentally retarded. A total of three infants 
had seiious neurologic deficits resulting in cerebral palsy and mental 
ietardation on follow-up evaluation. General health continued to be a 
problem for the premature infants during the first year of life, and 
several had repeated hospitalizations for either pulmonary or neuro-
logic complications. 
The information presented illustrates the importance of neonatal 
and obstetric intensive-care facilities in the management of eclamptic 
patients. If these facilities are not readily available, physicians con-
sen t ing eclampsia should be familiar with the guidelines for appro-
pi iate maternal transportation (Table 9). 
Table 9, Guidelines for Transport of F ^nts u i i » 
1 Consultation with physician at perinatal center prior to transpc 
2 Maternal records sent with patient 
3 Stal)ili7e patient regarding blood pressute anil contiol of convulsion* » • • • • i it 
4 Patient given adequate magnesium sulfate pnor to transport either -i *-• 1 IV i\ 1 r i 
1M simultaneously or 6 gm IV over 15 minutes and 4 gm in 250 *> I 1 e 
given at 125 ml per hour 
^ Patient sent in an ambulance with medical personnel in attendance 
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PREVENTION 
jgEcIampsisTisT generally considered a preventable compl ica t ion^ 
I p r e g n a n c ^ T ^ 
wlowef^ift^incidence.^However, some patients develop eclarriraid 
^braptlyTwithout warning signs or symptoms. ~**H* 
^ .^ l l^ u s p a ?A^ e ^^y e s i t t ^ a t ' r ^ e f severefform^of,pre£ebl^psiarshould:bQ> j^pFewntablcrB5rappropriate prenatal care.31 He "al^c^ntehd3ffhat 
convulsions^should not occurence the woman with^pfeTeclampls^is 
J a d m i t t e d , to the J hosp i ta l . /The - same ' au tho r s t ressesnhat iwhej j j 
^p^lnnip'iin dnf*Tfcnfmnri it iVhflc^ise of- fa i lure to-diagnose^pr^ 
^eclampsia, lack of surveillance of women at risk for pre-eclampsia*an 
^eclampsia, and inadeauate trpafm^nf r*«r»o *^*** ^ ~1«—~:~ jl---i—i-._, .vx^uuvv yrj. >Tv/mou at nais, iur pre-eciampsiatand 
"'^'eclampsia, and inadequate treatment once, pre-eclampsia deve lops 
~The low incidence of eclampsia in women managed with early long* i n e low incidence ot eclampsia in women managed with early long*7 term hospitalization for mild pre-eclampsia has been documented bv 
others. All factors that may have been involved in the development 
of eclampsia are summarized in Table 10. Although a large numbej^pf# 
cases^of, eclampsia are avoidable, there are some cases that»seeny 
nonpreventable; factors associated with these cases are shownMn^ 
Table H * 
Because various dietary and biochemical factors have been re 
lated to the etiology of pre-eclampsia and eclampsia (Table 12), se-
eral investigations are being addressed to the use of such association^ 
in developing a preventive method. However, there is no clear evi 
dence to suggest that either of these regimens reduces the incidence 
of eclampsia. 
There is some information from case reports and two recerr 
clinical studies that low-dose aspirin reduces the incidence of pre-
eclampsia and thus eclampsia. This subject was recently reviewed h\ 
Wallenburg and associates.29 The data relating to effectiveness in tin-
prevention of eclampsia are sparse and inconclusive. 
Calcium supplementation during pregnancy has become the 
most recent promising step in pre-eclampsia prevention. Villar and 
coworkers28 strongly suggest an association between the administra-
tion of calcium and the reduction of elevated blood pressure during 
pregnancy. Using doses of as much as 1.5 gm per day after the 26th 
gestational week, those authors were able to reduce the incidence of 
pregnancy-induced hypertension. 
Table 10. fP^bWKs^iateWbith Eclampsy 
Physician^rror JL ^ 
~"
j
"* Iriadequit^prenatal^r 
__ Jire 
kFailure of diagnosis*or*tr i nent 
Patient error 
No prenatal care 
Failure to keep pienatal appointments 
Failure of magnesium sulfate therapy 
Convulsions while receiving magnesium sulfate 
Magnesium levels helovv therapeutic range 
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Table 11. ^Factors in Unavoidabl&Eclampsia 
Abrupt onset 
Late postpartum onset 
Convulsion despite magnesium sulfate levels in therapeutic range 
Mild pre-eclampsia with good response and normal blood piessure after 
hospitalization 
Early onset (before 21 weeks) 
Unfortunately, the benefits of either low-dose aspirin or nutri-
tional supplementation are not definite. Further large multicenter 
trials are required. 
COUNSELING WOMEN AND RELATIVES OF WOMEN 
WITH ECLAMPSIA 
Chesley and associates followed women who deve loped 
eclampsia at the Margaret Hague Hospital from its opening on Oc-
tober 15, 1931, through 1951.5 They traced all but three of the 
women who survived to 1974. The average annual death rate was 
5.11 per 1000, with 31 deaths in the 187 white women who had 
eclampsia during pregnancy. This was not significantly different from 
the number of deaths expected. However, 33 of 59 white women who 
had eclampsia as multiparas had died at an average rate of 21.3 per 
1000, which was significantly higher than the number of deaths ex-
pected (11.6 per thousand). Twenty-nine per cent of the remote 
deaths were the result of cardiovascular-renal disease in the women 
who had eclampsia when nulliparas compared with 82 per cent in the 
women who developed eclampsia as multiparas. 
The prognosis for future pregnancies was good. Another 409 
pregnancies occurred in the 158 women in whom eclampsia devel-
oped during their first pregnancy. One fifth of all pregnancies in 34.5 
Table 12. Drugs and Dietary Factors Being Tried for Prevention 
of Pre-eclampsia 
Pharmacologic manipulation 
Diuretics 
Antithrombotic agents 
Low-dose aspirin 
Dipyridamole 
Heparin 
Dietary manipulation 
Low-salt diet 
Iligh-protem diet 
Nutritional supplementation 
Calcium 
Magnesium 
Zinc 
Fish oil 
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per cent of the women resulted in pre-eclampsia. When pre-
eclampsia was present in a subsequent pregnancy, it was usually 
mild. Eleven of the women had pre-eclampsia classifed as severe. 
Three of these women developed eclampsia for an overall incidence 
of 0.9 per cent for pregnancies beyond 20 weeks' gestation, iipmgg^ 
gfc Chesley^and ^associates*aIso#evieweditheMncidence*of^rel« 
^eclafnpsia^in^the first pregnancies of daughters of eclamptic*wtimerfrfM 
^Preeclampsia developed in 63 of the 257 pregnancies (24.9 p e r ' 
"cent). Eclampsia occurred in seven of these pregnancies (2.7 per 
cent). The outcome of the first pregnancy carried to viability of sisters 
of eclamptic women was reviewed. Pre-eclampsia occurred in 54 (37 
per cent) of first pregnancies, and six women (4.1 per cent) devel-
oped eclampsia. It is interesting that five other sisters who delivered 
at other hospitals also developed eclampsia. Seventy-five of the first 
pregnancies of the daughter-in-law of eclamptic women have also 
been reviewed. Pre-eclampsia occurred in six (8 per cent). The out-
comes of these pregnancies are summarized in Table 13. 
~~ JThe Jong-term efFects„oCeclampsiavOnsmaterrial|bl6od pressure 
_ _ ^ have.been,summarized by Chesley and associates.5 The averageTnci^S 
^ K «dence^dftchronic^hy^^ 
J ^ o w e d f o r 6 weeks'to 44 years was 23.8 per cent.' The^authbrs^rdeX^ 
L amineii 197 mostly white women who had had eclampsia when^pri^ miparous'aWn?average *of*33 years'(range 1 to 43 years), iThe^ incidence of diastolic pressure 100 mm Hg or greater was 21.8 per 
cent among patients having one subsequent viable pregnancy. How-
ever, the incidence was 10 per cent among patients who remained 
normotensive in all pregnancies and 45 per cent among patients 
having hypertension in at least one subsequent pregnancy. This ob-
served incidence of hypertension was not higher than that expected 
in a population of similar age and race. The incidence of diabetes at 
an average follow-up of 25 years was 8.3 per cent, which was 2.5 
times the expected incidence. 
i* Recently, jjSibai andvassociates^analyzed^thefsubsequent p r e g ^ 
nancy outcomes and remote "prognosis in 406 young (11 to 25 years)]* 
women who had had either severe pre-eclampsia (n = 287) or 
Table 13. Risk of Eclampsia in Relatives of Women with Eclampsia 
NO. WITH PRE-ECLAMPSIA ECLAMPSIA 
RELATIONSHIP TO PREGNANCIES 
ECLAMPTIC WOMEN > 2 0 WEEKS N % N % 
Eclamptic women 
(all future pregnancies) 340 70 20.6 3 0.9 
Sister (all future pregnancies) 147 54 37.6 6 4.1 
Daughter (first pregnancy) 257 63 24.9 7 2.7 Daughter-in-law 
(first pregnancy) 75 6 8 0 
Modified from Chesley LC, Annittp JE, Cosgrove RA The familial factor in toxemia 
of pregnancy. Obstet Gynecol 32-303. 1968 
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eclampsia (n = 119) during their first pregnancies compared with a 
group of 409 young (12 to 25 years) women who remained normoten-
sive throughout their first pregnancies.20 Each patient had at least 
one subsequent pregnancy (range 1 to 11). The pre-eclamptic or 
eclamptic group had a total of 815 subsequent pregnancies, whereas 
the normotensive group had a total of 966 pregnancies. The pre-
eclamptic and eclamptic group had significantly higher incidences of 
both mild and severe pre-eclampsia in second pregnancies (Table 14). 
Within this group, patients who had had pre-eclampsia or eclampsia 
at 30 weeks' gestation or earlier had a significantly higher incidence 
of pre-eclampsia in their second pregnancies than those who had 
onset of pre-eclampsia after 30 weeks' gestation. The incidence of 
pre-eclampsia in the second pregnancy in these patients was 76 per 
cent, whereas it was 38 per cent in those who had had pre-eclampsia 
or eclampsia at 37 weeks' gestation or later. 
Table 15 compares the incidence of pre-eclampsia in subsequent 
pregnancies (excluding second pregnancies) in the two groups. 
Again, the pre-eclamptic or eclamptic group had significantly higher 
incidences of both mild and severe pre-eclampsia. Within this group, 
the incidence of pre-eclampsia in subsequent pregnancies was signifi-
cantly higher in those who had pre-eclamptic second pregnancies (68 
per cent) than in those who had normotensive second pregnancies 
(12 per cent). Table 16 presents the subsequent pregnancy outcome 
in the two groups of patients. It is obvious that the pre-eclamptic and 
eclamptic group had significantly more obstetric complications in 
their subsequent pregnancies than the normotensive group. Further-
more, the higher perinatal mortality rate in that group was mainly 
related to the higher incidence of both premature delivery and 
abruptio placentae. 
All patients were followed up for a minimum of 2 years (range 2 
to 24) and 90 patients in the pre-eclamptic group and 138 in the nor-
motensive group were followed 10 years or longer. There was no 
significant difference in the incidence of diabetes in the two groups 
Table 14. Incidence of Pre-eclampsia in Second Pregnancies in Women 
Normotensive (N = 409) or Pre-eclamptic-Eclamptic (N = 406) in 
First Pregnancy 
Mild pre-eclampsia 
Severe pre-eclampsia 
Eclampsia 
Total 
NORMOTENSIVE 
N 
10 
19 
2 
31 
% 
2.4 
4.6 
0.6 
7.6 
PRE-ECLAMPTIC-
ECLAMPT1C 
N % 
79 19.5 
105 25.9 
6 1.4 
190 46.8 
From Sibai BM, El-Nazer A, Gonzalez-Ruiz AR: Severe pre-eclampsia-eclampsia in 
young primigravidas: subsequent pregnancy outcome and remote prognosis. Am J Obstet 
Gynecol J55.I0I2, 1986. 
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Table 15. Incidence of Pre-eclampsia in Third or Subsequent 
Pregnancies in Women Normotensive (N = 557) or Pre-eclamptic-
Eclamptic (N = 406)* in First Pregnancy 
PRE-ECLAMPTIC-
NORMOTENSIVE ECLAMPTIC 
N %
 N % 
Mild pre-eclampsia 12 2.2 28 6.8 
Severe pre-eclampsia 28 5.0 50 12.2 
Eclampsia 3 
Total 0.5 7 1.7 43 7.7 85 20.7 
•Number of subsequent pregnancies. 
From Sibai BM, El-Nazer A, Gonzalez-Ruiz AR: Severe pre-eclampsia-eclampsia in 
young primigravidas: subsequent pregnancy outcome and remote prognosis. Am J Obstet 
.Gynecol 155:1012, 1986. 
(1.7 per cent in the pre-eclamptic and eclamptic group versus 1.5 per 
cent in the normotensive). However, the respective incidences of 
diabetes were 5.6 per cent and 3.5 per cent among patients followed 
10 years or longer. The overall incidence of chronic hypertension was 
significantly higher in the pre-eclamptic and eclamptic group (14.8 
per cent versus 5.6 per cent). In the group followed less than 10 
years, the incidence was 4.4 per cent versus 1.5 per cent. However, 
in the subgroup that was followed 10 years or longer, the incidences 
of chronic hypertension were 51 per cent and 14 per cent. This dif-
ference is very impressive considering that these two groups had 
similar maternal age and duration of follow-up. It is apparent that the 
risk of chronic hypertension in the pre-eclamptic and eclamptic 
group becomes impressive after 10 years of follow-up. 
Table 16. Pregnancy Outcome in All Subsequent Pregnancies 
of Women Normotensive (N = 966)* or Pre-eclamptic-Eclamptic 
(N = 815)* in First Pregnancy 
PRE-ECLAMPTIC-
NORMOTENSIVE ECLAMPTIC 
N %
 N % 
Pre-eclampsia 
Abruptio placentae 
Perinatal mortality 
SGA infants 
Preterm (<37 weeks) 
74 
7 
29 
32 
91 
7.7 
0.8 
3.0 
3.3 
8.4 
275 
21 
48 
58 
122 
33.7 
2.5 
5.9 
7.1 
15.0 
*Total number of pregnancies. 
From Sibai BM, El-Nazer A, Gonzalez-Ruiz AR: Severe pre-eclampsia-eclampsia in 
young primigravidas: subsequent pregnancy outcome and remote prognosis. Am J Obstet 
Gynecol 155:1013, 1986. 
SUMMARY 
The incidence of eclampsia has decreased over the past two de-
cades. Proper prenatal care with early identification and hospitaliza-
tion of patients with mild pre-eclampsia is responsible for this reduc-
tion. Modifications of current obstetrics teachings designed to 
heighten awareness of the risk of both midtrimester and late-post-
partum eclampsia could further reduce its occurrence. However, 
there will always be a small number of women in whom eclampsia is 
not preventable. Eclamptic patients should be counseled regarding 
the increased risk of pre-eclampsia or eclampsia in their sisters and 
daughters as well as their increased risk for both recurrence of the 
disease and perinatal death in subsequent pregnancies. 
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Q 
A 
evaluated 
Q 
A 
Q 
A 
Q 
excessive 
abnormal 
Well, she eventually had eclampsia, didn't she? 
But after her presentation with that, she was 
and was normotensive. 
After her— 
When I evaluated her, she was normotensive. 
Would you agree that she had a sudden weight gain? 
Yes. 
The next sentence here, two down, says, "Sudden and 
weight gain is attributable almost entirely to 
fluid retention and is demonstrable, as a rule, 
before visible signs of nondependent edema, such as, swollen 
eyelids and puffiness of the fingers." Do you agree with 
that? 
A 
Q 
preeclamp. 
lacking." 
A 
Q 
Yes. 
Paragraph 10, right in the middle, says, "In early 
sia, proteinuria may be minimal or entirely 
Do you agree with that? 
I agree. 
I thought you told me earlier that proteinuria must 
be present to have preeclampsia. 
A 
Q 
Correct. 
Well, this says that proteinuria does not have to 
be present, it may be minimal or entirely lacking in early 
preeclamp sia. 
MR. WILLIAMS: You're misquoting or quoting out of 
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context. This text clearly identifies the criteria for 
making the diagnosis. 
Q 
It says, 
(By Mr. Sykes) Go ahead and answer the question. 
"In early preeclampsia, proteinuria may be minimal 
or entirely lacking." 
A 
Q 
says, "In 
I don't know what early preeclampsia is. 
Look at paragraph 11. In the bold print there it 
women who develop eclampsia, severe headache almost 
invariably precedes the first convulsion." Do you agree with 
that? 
A 
sive. 
Q 
I do, but all eclamptic women are also hyperten-
Do you admit that Tony and Brenda told you that she 
was having severe headaches? 
A 
Q 
A 
Q 
aches? 
A 
Q 
with the 
factors? 
A 
Q 
No. 
Severe headaches on June 15th, 1989? 
No. 
They didn't tell you she was having severe head-
No. 
Look at paragraph 15, if you would. Do you agree 
last sentence talking about major predisposing 
Do you agree with that statement? 
I do. 
Did you ask at any time, either in your forms or 
200 
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Clinical significance of elevated mean arterial pressure in the 
second trimester 
Leon C. Chesley, PhD, and Baha M. Sibai, MD 
Brooklyn, New York, and Memphis, Tennessee 
Several reports suggested using the mean arterial blood pressure during the second trimester to predict 
the future development of preeclampsia. The value of a second-trimester mean arterial blood pressure 
^90 mm Hg was reviewed in 39,876 reported cases of preeclampsia and 207 cases of eclampsia. The 
sensitivity ranged from 0% to 92% and the specificity vaned from 53% to 97% The predictive value of a 
positive test ranged from 0% to 43% and the predictive value of a negative test ranged from 76% to 98%. 
The predictive value of a positive test was not greatly higher than the incidence of hypertension in the 
•.whole population studied in the majority of the reports. There was a strong association of higher 
^second-trimester mean arterial blood pressure in nuliiparous women with eclampsia who had transient 
hypertension in later gestations and ultimately developed chronic hypertension The data suggest that one 
sign of future chronic hypertension, that is, transient hypertension, is often predicted by high 
second-trimester mean arterial blood pressure, which may have the same significance. We think that if 
Increased second-trimester mean arterial blood pressure levels predict anything, it is transient 
hypertension rather than preeciampsia-eclampsia. (AM J OBSTET GYNECOL 1988;159:275-9.) 
Key words: Second-trimester mean arterial blood pressure, preeclampsia, transient 
hypertension 
-In 1963, Fallis and Langford' reported that primi-
gravid women developing "toxemia" in the third 
trimester had had higher blood pressures earlier in 
pregnancy when compared with women who remained 
normotensive. The observation lay dormant for more 
than a decade, until given impetus by Page and 
Christianson2 in 1976. In an analysis of data derived 
from 14,833 pregnancies managed in the Kaiser-
Permanente Health Plan, they found that the average 
mean arterial pressure in the second trimester had 
some predictive value for the later development of pre-
eclamptic and nonpreeclamptic hypertensions in the 
third trimester, in that the incidences of those compli-
cations were augmented progressively with increasing 
levels of second-trimester mean arterial blood pressure, 
Wltri
 sharp increases at levels of ^ 9 5 mm Hg 
rrovi the Department of Obstetrics and Gynecology, State University 
°f \'ew York Downstate Medical Center, and the Division of 
Maternal-Fetal Medicine, University.of Tennessee, Memphis 
Reprint requests Baha M Sibai, MD, Division of Maternal-Fetal 
Medicine, 800 Madison Ave , Memphis, TN 38163 
Several later studies have purported to show that 
preeclampsia often can be predicted from average 
second-trimester mean arterial blood pressure levels of 
2*90 mm Hg, although with high percentages of false-
positive and false-negative results.37 Table I summa-
rizes the sensitivity, specificity, and predictive values of 
second-trimester mean arterial blood pressure as re-
ported in a total of 39,600 cases plus 276 unpublished 
cases The sensitivity ranges from 20% to 92% in the 
reported studies, but it was 0% in the unpublished data 
of Chesley The specificity varies from 53% to 97% 
depending on the size and characteristics of the patients 
studied The predictive value of a positive test ranges 
from 6 4% to 43% and the predictive value of a negative 
test ranges from 76% to 98%. It is important to note 
that the predictive value of a positive test was not greatly 
higher than the incidence of hypertension in the whole 
population studied in the majority of the studies. 
In a retrospective analysis of average and maximal 
second-trimester mean arterial blood pressure and 
maximal diastolic pressure in the second trimester, 
275 
276 Chesley and Sibai 
Table I. Summary of literature concerning predictive value of blood pressure in second trimester 
Authors 
Fallis and Langford1 
Page and 
Christianson2 
Friedman and 
Neff3* 
Quass et al.4 
Phelan5 
Oney and 
Kaulhausen6 
Moutquin et al.7 
Chesley (unpub-
lished data) 
No. of cases 
113 
14,833 
22,582 
801 
96 
200 
808 
175 
174 
Parity 
Nulliparous 
All panties 
All panties 
All panties 
Nulliparous 
Nulliparous 
Nulliparous 
Nulliparous 
Multiparous 
Mean arterial 
pressure 
>9Q mm Hg 
41 
2014 
8807 
207 
7 
85 
9 
Pi e eclampsia 
39 
399 
888 
1 213 
15 
21 
46 
3 
2 
Sensitivity 
(%) 
82 
43 
64 
65 
20 
90 
56-71 
0 
Specifiaty 
(%) 
88 
87 
62 
88 
95 
62 
66-78 
97 
Predict! 
Positive 
(%) 
78 
8.6 
6 4 
15 
43 
20 
11-14 
0 
ve value 
Negative 
(%) 
90 
98 
98 
70 
87 
98 
96-98 
99 
*The data of Friedman and Neff are for maximal second-trimester mean arterial blood pressure. 
we8 found but little relation to the later development 
of eclampsia in 207 nulliparous women, and 20 mul-
tiparous women from two different eras, geogra-
phic regions, and racial distributions. Average second-
trimester mean arterial blood pressure levels of ^90 
mm Hg have been observed in only 22% of the nullip-
arous women and 30% of the multiparous women. 
Maximal second-trimester mean arterial blood pressure 
levels of 2*90 mm Hg had occurred in 34% of the nul-
liparous women and 35% of the multiparous women, 
incidences slighdy lower than the 39% seen by Fried-
man and NefP in the whole population of 22,983 
women for whom relevant information was available in 
the Collaborative Perinatal Project; that is, the women 
later developing eclampsia cannot be identified in the 
population by maximal second-trimester mean arterial 
blood pressure. No nulliparous woman had a maximal 
second-trimester diastolic pressure as high as 90 mm 
Hg and only 8.7% had pressures 2*80 mm Hg. 
The inefficacy of second-trimester mean arterial 
blood pressure in the prediction of eclampsia prompts 
a closer look at the data advanced as supporting its 
value in the prediction of preeclampsia (almost always 
of mild degree). Here the diagnostic criteria for mild 
preeclampsia are crucial. 
Problems In diagnosis of preeclampsia 
Page and Christianson2 found incidences of protein-
uria, preeclampsia, and nonpreeclamptic hypertension 
to be 1.8%, 2.7%, and 2.7%, respectively, among their 
14,833 women. The identical incidences of preeclamp-
sia and hypertension seem to indicate that the three 
groups are mutually exclusive. They wrote that the di-
agnosis of preeclampsia "was based upon the combi-
nation of hypertension with proteinuria and/or gen-
eralized edema" but gave no indication of how many 
had had proteinuria. Accepting their diagnoses, it ap-
pears that the predictive value of average second-
trimester mean arterial blood pressure levels of 2*90 
mm Hg is better for hypertension alone than for pre-
eclampsia; the respective sensitivities are 6 1 % and 43%, 
the respective specificities are 94% and 87%, the re-
spective positive predictive values are 13.1% and 8.6%, 
and the respective negative predictive values are 98% 
and 99%. 
Friedman and NefP published relevant data for 
22,582 pregnancies in the Collaborative Perinatal Proj-
ect but used the maximal rather than the average 
second-trimester mean arterial blood pressure as a pre-
dictor. Their data together with those of Page and 
Christianson2 comprise 37,415 pregnancies and ac-
count for 94% of all cases reported. With maximal 
second-trimester mean arterial blood pressure levels 
2*90 mm Hg, for hypertension alone (transient hyper-
tension) and for hypertension with proteinuria (pre-
eclampsia?), the respective sensitivities were 78% and 
64%, the respective specificities were 63% and 62%, the 
respective predictive values of a positive test were 
10.4% and 6.4%, and the respective predictive values 
of a negative test were 98% and 98%. 
Quass et al.,4 who included women of all panties, 
made the diagnosis of preeclampsia in 213 of their 801 
patients but remarked that 88% of them were assigned 
a gestosis index of 1 or 2. That strongly implies that 
mild rises in blood pressure may have been the only 
basis for the diagnoses; that is, most of the women had 
transient hypertension rather than preeclampsia. 
Oney and Kaulhausen6 found that 42% of 200 nul-
liparous women had an average second-trimester mean 
arterial blood pressure of 2*90 mm Hg, but only 32% 
of that group developed later hypertension. Eight-were 
classified as pregnancy-induced hypertension and 19 
Volume 159 
Number 2 
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Table II . Average mean arterial pressures in second tnmestei ol nulhpaious eclamptic women in relation 
to recurrence of hypertension in subsequent pregnancies 
Average second-tnvwslei 
mean arterial blood 
pressure (mm Hg) 
Margawl Hague series j 
Subsequent ptepuninrs 
No. of women No of pi egnanncs 
Ihptttnni, i * 
// < 
————— 
\ n of women 
E H. dump series 
Subsequent pregnancies 
No of p i egna ncies 
Hype* tension* 
n % 
55-64 
65-74 
75-84 
85-89 
5:90 
Total 
2 
4 
14 
20 
6 
46 
2 
9 
22 
29 
23 
85 
0 
0 
3 
() 
4 
13 
IM 4 
M) 
(><> 0 
2S J 
4 
12 
33 
2<> 
\b 
91 
7 
24 
59 
46 
30 
166 
0 
1 
8 
9 
10 
28 
8 3 
24.2 
34.6 
62.5 
30.8 
•In at least one later pregnancy. 
were termed preeclampsia. Only two of the 115 with 
average second-trimester mean arterial blood pressure 
<90 mm Hg developed preeclampsia. Their false-
negative rate is far below any other reported. The au-
thors wrote that the blood pressures had been mea-
sured after the women had lain supine for 10 minutes. 
Hence the higher second-trimester mean arterial blood 
pressure levels might be attributable to the supine 
pressor response that sometimes predicts pregnancy-
induced hypertension. The 42% of patients with 
second-trimester mean arterial blood pressure levels 
2*90 mm Hg is far greater than the 13.6% reported by 
Page and Christianson or by any other investigator. 
• In the classification of the American Committee on 
Maternal Welfare9 and in Nelson's classification,10 which 
b widely used in the British Commonwealth and else-
where, the diagnosis of preeclampsia can be made on 
the sole basis of rises of blood pressure, without pro-
teinuria or edema. The diagnosis is erroneous as often 
as not in primigravid women and usually is so in mul-
tiparous ones. The Committee on Classification of the 
American College of Obstetricians and Gynecologists" 
sought to improve the accuracy of the diagnosis of pre-
eclampsia by relegating mere rises in blood pressure to 
a new category designated transient hypertension 
Sometimes transient hypertension is mild, incipient 
preeclampsia but often, perhaps more often, it is latent 
^essential hypertension brought to light by pregnancy 
The clinically oriented classification of the Commit-
tee on Classification does not require proteinuria for 
the diagnosis of preeclampsia because it usually is of 
late onset in the course of the disorder, so late indeed 
that the onset of convulsions may precede its appear-
ance. The committee's criteria permit the diagnosis of 
preeclampsia on the basis of acute hypertension to-
gether with edema of the hands or face in the latter 
»aif of pregnancy-, but such edema is common in nor-
mal pregnancy and-some women with transient hyper-
tension must have such normal edema and be misdi-
agnosed as having preeclampsia, j 
Dextei dnd Weiss'Jexamined~TDOconsecutive women 
late in normal pregnancies and found digital or facial 
edema, or both, in 64%. They were looking specifically 
for edema and may have observed it in instances that 
would escape detection in routine antepartum clinics. 
Perhaps a more practical example would be in the data 
of the Collaborative Perinatal Project, where significant 
edema of the hands or face, or both, without protein-
uria at any time, had been recognized at some stage of 
pregnancy in 11,516 of 38,636 (30%) women. The fre-
quencies were 39% in white women and 23% in black 
subjects n 
In day-to-day management, acute hypertension and 
edema in pregnancy must be regarded and treated as 
preeclampsia, but in studies of preeclampsia more rigid 
criteria are essential. Although often of late onset, pro-
teinuria is the hallmark of preeclampsia and the char-
actenstic renal lesions of the disorder are rarely found 
in the absence of proteinuria.14 Many of the diagnoses 
of preeclampsia in the relevant publications seem to 
have been made in women without proteinuria. 
Although preeclampsia does occur in multiparous 
women, that diagnosis is usually erroneous, as dem-
onstrated b\ findings in renal biopsy specimens. Fisher 
et al ' retrospectively compared clinical diagnoses with 
anatomic findings and "although most of the patients 
have been considered preeclamptic prior to biopsy only 
55% of them had the renal lesion of preeclampsia. . . ." 
Of the 104 nulliparous women, 79 had the pure lesion 
and eight others had it superimposed on nephroscle-
rosis or other renal disease; thus, 85% had anatomic 
substantiation of the diagnosis and 15% did not. 
Among the 72 multiparous women, 17 had the pure 
lesion of preeclampsia and nine others had it super-
imposed on nephrosclerosis or other renal diseases, 
thus, the clinical diagnosis of preeclampsia was not Sup-
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ported anatomically in 64% of cases; 37 (51%) had only 
the lesions of nephrosclerosis or other renal diseases 
and 8 (11%) had no renal lesion. 
Gleicher et al,'6 compared clinical presentation and 
pregnancy outcome between 46 primiparous and 53 
multiparous women with hypertensive disorders of 
pregnancy. They found clear differences between the 
two groups regarding time of onset of hypertension 
(early in gestation in the multiparous women) and the 
impact of maternal disease on fetal growth and devel-
opment. They concluded that these differences suggest 
different pathophysiologic features as the underlying 
cause of hypertension in primiparous and multiparous 
women. 
It has been suggested that an average second-
trimester mean arterial blood pressure of ^ 9 0 mm Hg 
has a good predictive value for future development of 
preeclampsia. In their landmark study, Langford and 
Watson recorded blood pressures of nulligravid high 
school girls and analyzed them in relation to blood pres-
sure observed throughout first pregnancies occurring 
months to a few years later. Patients with "mild pre-
eclampsia" had had higher pressures before concep-
tion, at every stage in pregnancy, and at io\k>w-up.TYie 
study was based on first pregnancies of 186 women with 
preeclampsia and 400 women without, with similar in-
cidences of proteinuria, usually negative or present 
only in trace amonts. The weight gains and incidences 
of edema were similar in the two groups. The authors 
wrote: "The diagnosis of preeclampsia appeared to be 
based entirely on BP." In a word, most of the "pre-
eclamptics" had had transient hypertension rather than 
preeclampsia and the second-trimester mean arterial 
blood pressure levels of =^90 mm Hg had predicted 
transient hypertension. 
Average second-trimester mean arterial blood 
pressure and future pregnancies 
Transient hypertension has a high rate of recurrence 
in pregnancies, and it seems probable that it provides 
the basis for the diagnosis of preeclampsia in many 
multiparous women. If progressively higher levels of 
second-trimester mean arterial blood pressure predict 
transient hypertension, then they may also predict re-
currence of hypertension in later pregnancies. We have 
tested that hypothesis by relating second-trimester 
mean arterial blood pressure in eclamptic pregnancies 
to the nature of subsequent gestations, as shown in 
Table II. 
Among the women having had eclampsia in the Mar-
garet Hague Maternity Hospital, in Jersey City, N.J., 
during the years 1931 through 1951, 47 nuliiparous 
eclamptic women have had later pregnancies. Recur-
rent hypertension, usually mere rises in blood pressure 
without proteinuria or edema (transient hypertension), 
was observed in nine of 40 (22.5%) women whose av-
erage second-trimester mean arterial blood pressure 
levels had been <90 mm Hg and in four of the six 
whose second-trimester mean arterial blood p c e ^ v ^ 
levels had been >90 mm Hg during the eclamptic tes-
tation. Among the women having had eclampsia in 
Memphis, Tennessee, during the years 1977 through 
1987, 91 nuliiparous eclamptic women have h.ul later 
pregnancies. Recurrent hypertension was observed in 
18 of 75 (24%) whose average second-trimester mean 
arterial blood pressure levels had been <90 mm Hg 
and in 10 of the 16 whose second-trimester mean ar-
terial blood pressure levels had been ^ 9 0 mm Hg dur-
ing the eclamptic gestation. It is interesting to note that 
the incidence of recurrent hypertension in subsequent 
gestations increases with increasing second-trimester 
mean arterial blood pressure levels during the eclamp-
tic gestation. When data from both studies are pooled 
together, the presence of second-trimester mean arte-
rial blood pressure ^ 9 0 mm Hg during the eclamptic 
gestation is associated with a significantly higher in-
cidence of hypertension in subsequent pregnancies 
(p = 0.02, odds ratio 2.5:1). 
Average second-trimester mean arterial blood 
pressure and future chronic hypertension 
Among the 81 nuliiparous eclamptic women surviv-
ing pregnancy in the Margaret Hague Hospital, aver-
age second-trimester mean arterial blood pressure val-
ues ^ 9 0 mm Hg were associated with an increased 
incidence of chronic hypertension at follow-up of 23 
to 43 years. Hypertension was found in 13 of the 59 
(22%) whose average second-trimester mean arterial 
blood pressure value had been <90 mm Hg as com-
pared with nine of 22 (41%) whose levels had been 2*90. 
If the dividing line is to be set at 85 mm Hg, the in-
cidences are 13% and 38%, respectively, for second-
trimester mean arterial blood pressures <85 and ^85 
mm Hg (p < 0.02, odds ratio 4 .1 : 1). 
Unifying concept 
It has long been recognized that persons destined to 
develop essential hypertension characteristically ha\e 
blood pressures slightly increased over age-specific a\-
erages for some years before the onset of sustained 
hypertension and possibly even in early childhood. The 
higher pressures occur throughout pregnancy, includ-
ing the second trimester. Is it not reasonable to suggest 
that one sign of future chronic hypertension, ie, tran-
sient hypertension, is often predicted by high second-
trimester mean arterial blood pressure levels and that 
both predict future essential hypertension, although 
with some degree of fallibility? The data in Tables I 
and II are consistent with that concept. We suggest that 
second-trimester" mean arterial blood pressure may 
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The sperm penetration assay: Can it discriminate between 
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The sperm penetration assay with zona-free hamster ova is widely used to evaluate male infertility 
Despite a growing body of literature about this assay, its results remain difficult to interpret To evaluate 
the clinical usefulness of this test, we reviewed the world s literature about this assay and analyzed the 
test's performance Its sensitivity ranges from 0 00 to 1 00 and specificity ranges from 0 95 to 1 00 for 
diagnosing male infertility For predicting in vitro fertilization failures, its sensitivity varies from 0 00 to 0 78 
and specificity ranges from 0 51 to 1 00 The reproducibility of this assay is not clear, and there is little 
standardization of methods between laboratories Until the validity and reproducibility of the sperm 
penetration assay have been established, this expensive test should probably not be used to evaluate 
infertile couples (AM J OBSTET GYNECOL 1988,159 279-86 ) 
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ABSTRACT 
Acute increases in blood pressure of pregnant women must be regarded and 
treated as preeclampsia, for if the patient really has preeclampsia it may 
progress in severity and lead to eclampsia or even death. In collecting cases 
for the study of preeclampsia the working diagnosis cannot be accepted; far more 
rigid criteria must be used because hypertension is common to several other 
unrelated disorders. Erroneous diagnoses lead to erroneous conclusions. 
Examples cited concern (A) the renal distal tubular reabsorption of free water 
during osmotic diuresis in hydropenia, (B) the concept that preeclampsia causes 
chronic hypertension in women who otherwise never would have developed it, and 
(C) the concept that higher levels of the mean arterial pressure in the second 
trimester (MAP - 2) predict preeclampsia. Many women bearing the diagnosis of 
mild preeclampsia really have transient hypertension, which appears to be latent 
essential hypertension brought to light by pregnancy. Transient hypertension 
often is predicted by higher levels of MAP - 2; it had a high rate of recurrence 
in later pregnancies and often predicts ultimate chronic hypertension. 
About a quarter of women with eclampsia have had apparently mild or even 
barely diagnosable preeclampsia until the onset of convulsions. Dieckmann (8) 
reported that about 22% of eclamptics had not had recorded systolic pressures 
exceeding 140mm Hg before seizures and that about 12% of that subgroup died of 
eclampsia. The experience of the Margaret Hague Maternity Hospital, in Jersey 
City, N.J., was similar during the 19 years that I spent there. Moreover, 
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proteinuria often is a late sign in the course of preeclampsia and may not appear 
before convulsion in perhaps 5% to 10% of cases; in Sibai's (21) series of 67 
cases of eclampsia, 21% had had no proteinuria prior to convulsion, and 21% had 
had diastolic pressures below 90 mm Hg. One of Eden's (10) criteria for severe 
eclampsia is the absence of edema. 
These observations mean that in the day-to-day clinical management, any 
rise in blood pressure in the latter half of pregnancy must be regarded and 
I I treated as preeclampsia, with a potential for progression to eclampsia and even 
1 -f _ ». 
\ I to death. 
Tf 
I The clinical working diagnosis must not be accepted in publishing studies of preeclampsia, for it is err neous in at l ast half of cases and everal 
/ disorders are lumped together under the name "preeclampsia", especially "mild 
\ preeclampsia". 
In most classifications, including those of the American Committee on 
Maternal Welfare (9) and Nelson (18), which is widely used in the British 
Commonwealth and elsewhere, the diagnosis of preeclampsia can be and is made on 
the sole basis of rises in blood pressure, without proteinuria or edema. The 
Committee on Terminology of the American College of Obstetricians and 
Gynecologists (14) sought to improve the accuracy of the diagnosis of 
preeclampsia by setting aside mere rises in blood pressure in a new class called 
transient, gestational, or late hypertension. Transient hypertension is defined 
as rises in blood pressure in late pregnancy or early puerperium, without 
significant proteinuria or edema, and a return to normotension within 10 days 
after delivery./For the diagnosis of preeclampsia, the Committee requires the 
acute onset of hypertension after the 20th week of gestation together with 
^f'\\j proteinuria or edema (facial, digital, or generalized), or both. In their 
/ clinically oriented classification, they do not require proteinuria because it 
\ often is of late onset. 
Edema is not a good criterion because it is so common in normal pregnancy. 
Dexter and Weiss (7) examined 100 consecutive women in the third trimester of 
normal pregnancies and observed facial or digital edema, or both, in 64. They 
were looking for edema specifically and may have observed it in instances that 
would have escaped casual examination. A more relevant datum might be in the 
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Collaborative Perinatal Project; Vollman's (22) analysis showed 39% of 17,698 
white women and 22% of 20,938 black women to have had edema of the hands or face, 
or both during pregnancy. 
Transient hypertension is called preeclampsia in most classifications and 
there is no evident reason why it should not be accompanied by the normal, 
physiologic edema of pregnancy but when it is, the erroneous diagnosis of 
preeclampsia is likely to be made in accordance with the criteria proposed by 
the Committee on Terminology. Although transient hypertension sometimes is 
incipient preeclampsia, and sometimes the reappearance of frank hypertension that 
abated in midpregnancy, probably it more often is a manifestation of latent 
essential hypertension unmasked by pregnancy. O'Sullivan's (19) follow-up 
studies have shown that the majority of women with gestational diabetes 
eventually develop overt diabetes, even though their glucose tolerance tests had 
reverted to normal after delivery. There is good evidence to support the 
hypothesis that transient hypertension in pregnancy often predicts ultimate 
essential hypertension. 
To cite only one of several studies, in 1936 Herrick and Tillman (13) 
reexamined 188 women with what is now called transient hypertension; at an 
average of 7.5 years after pregnancy, half were hypertensive; 33% had retinal 
angiosclerosis; 55% were not yet aged 40, which means that more would become 
hypertensive; significantly, 88% of those having had later pregnancies had had 
recurrence of hypertension during their later gestations. The frequent 
recurrence of transient hypertension has been the basis for many erroneous 
dignoses of preeclampsia in multiparas. 
Probably all of us interested in hypertensive pregnancy look to the Chicago 
Lying-in Hospital as the paragon, so recognized for more than half a century. 
The staff there has assessed the reliability of their clinical diagnoses of 
preeclampsia and I cite two papers. Fisher et al (11) blindly reviewed renal 
biopsies that had been obtained from many of their hypertensive patients between 
1958 and 1976, and then compared the anatomic findings with clinical diagnoses. 
They wrote: "Although most of the patients had been considered preeclamptic 
prior to biopsy only 55% of them had the renal lesion of preeclampsia". That 
does not seem to mean that many preeclamptics do not have the lesion, for 40% 
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of all patients had the lesions of chronic renal disease without the preeclamptic 
changes: glomerulonephritis, nephrosclerosis, interstitial nephritis, 
pyelonephritis, and a scattering of several others. The hypertension, 
proteinuria, and edema associated with renal diseases, singly or in combinations, 
had simulated preeclampsia. 
The consequence of erroneous diagnosis must be erroneous conclusions, as 
exemplified in a paper by McCartney et al (17). They assessed the renal tubular 
handling of water during osmotic diuresis and hydropenia in 22 women with the 
clinical diagnosis of preeclampsia, but obtained renal biopsies from each. Only 
six of the 22 had the renal lesion cf preeclampsia; six had chronic 
glomerulonephritis, five had nephrosclerosis, and five had no renal lesion. The 
tubular handling of water was different from group to group and if the overall 
findings had been based upon the clinical diagnoses, the erroneous conclusions 
would have been that there is a wide range, averaging out close to normal in 
preeclampsia. Actually the women with proved preeclampsia had a depressed rate 
of glomerular filtration, but an increased tubular capacity (T^Q) for the 
reabsorption of solution free water: 7.5 ml/lOOml of glomerular filtrate as 
compared with 5.3 ml in normal pregnant women. An earlier study (2) in women 
with clinical diagnoses of preeclampsia had come to the opposite conclusion, that 
there is a renal concentrative defect in preeclampsia. 
The almost innumerable follow-up studies of women thought to have had 
preeclampsia led to the erroneous conclusion that preeclampsia could and often 
did cause hypertension in women who otherwise never would have had it. That view 
has been disputed and, I hope, discredited in an earlier review (3). Since 
publication of the review, Fisher, Luger, Spargo and Lindheimer (11) reexamined 
53 women who had had preeclampsia as proved by renal biopsies and found that the 
prevalence of hypertension (9.5%) at follow-up was slightly lower than that in 
matched, unselected women in the National Health Survey (10%). They also had 
matched the preeclamptic women with others having had normotensive pregnancies; 
in that group the prevalence of hypertension at follow-up (0.5%) was only 1/20 
of that expected. Thus, as had been suggested by Chesley, Annitto, and Cosgrove 
(4), pregnancy is a screening test for future essential hypertension: 
normotensive pregnancies predict a low likelihood, and transient hypertension 
MILD PREECLAMPSIA 7 
a high probability of ultimate hypertension. Preeclamptic and eclamptic 
hypertension is an intercurrent disorder that predicts nothing, although the 
women will have a higher prevalence of later hypertension than will those having 
had normotensive pregnancies. That is not because preeclampsia-eclampsia causes 
chronic hypertension but because the women have not been screened, whereas 
normotensive pregnancies have selected out women at low risk for essential 
hypertension. 
Studies of "mild preeclampsia" seem to have led to another erroneous 
concept, namely, that higher blood pressures within the normal range in the 
second trimester are predictive of later preeclampsia. Mean arterial pressures 
are calculated by adding 1/3 of the pulse pressure to the diastolic reading and 
it has been alleged that levels of 90 or higher in the second trimester (MAP -
2) often precede preeclampsia (almost always mild), with a sensitivity ranging 
from 20% to 90%, specificity from 62% to 95%, and a positive predictive value 
from 6.4% to 78% (6). Chesley and Sibai (5) put the concept to the acid test 
in a retrospective analysis of MAP - 2 in the eclamptic pregnancies of 207 
nulliparas. They found no predictive value and that the distribution of the 
levels of MAP - 2 were not much different from that in whole populations of 
pregnant women. 
In seven papers purporting to show a predictive value for MAP - 2, 39,608 
women were screened. Fortunately, Page and Christianson (20), with 14,833 women, 
specified the numbers who developed preeclampsia and of those who developed 
hypertension alone (transient hypertension ?), as did Friedman and Neff (12) with 
22,852 women. Page and Christianson used the average MAP - 2 whereas Friedman 
and Neff used the maximal MAP - 2 and specified separately the numbers developing 
hypertension with and without proteinuria. The two series represent 94.5% of 
all cases. Clearly, most of the published data point to the higher levels of 
MAP - 2 as being a better predictor of what usually is transient hypertension 
than of "true" preeclampsia. Table I, based upon the data of Page and 
Christianson, shows that the sensitivity, specificity, and positive predictive 
value of the average MAP - 2 aro better for hypertension alone than for what they 
call preeclampsia. Similarly, Table 1 shows the same thing for the maximal MAP -
2. 
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TABU I 
Predictive Values of the Average MAP 2 in 14,833 Women 
Oerived from Data of Page and Christianson (20) 
Predictive Values 
Diagnosis Sensitivity Specificity Positive Negative 
Preeclampsia 43% 87% 8.1% 98% 
Hypertension 61% 94% 13.1% 99% 
alone 
TABLE 2 
Predictive Values of the Maximal MAP - 2 in 22,582 
Women Derived from the Data of Friedman and Neff (12) 
Predictive Values 
Diagnosis Sensitivity Specificity Positive Negative 
Hypertension 
with 
Proteinuria 65% 62% 6.4% 98% 
Hypertension 
alone 78% 63% 10.4% 98% 
Transient hypertension has a high rate of recurrence in later pregnancies 
and it probably is the usual basis for the misdiagnosis of preeclampsia in 
multiparas. Also, transient hypertension often predicts ultimate chronic 
hypertension (2, 3, 13). For those reasons, Chesley and Sibai (6) tested the 
relation between levels of MAP - 2 in eclamptic pregnancies of nulliparas and 
(A) the recurrence of hypertension in later pregnancies and (B) the prevalence 
of hypertension at from 23 to 43 years after eclampsia. Figure 1 shows increases 
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Average MAP-2 in eclamptic pregnancies of nulliporas 
F1g. 1. Relationship between MAP - 2 in eclamptic pregnancies of 
nulliparas and (A) recurrence of hypertension 1n at least one of 
later gestations (triangles and broken line) and (B) ultimate chronic 
hypertension (circles and solid line). 
in the recurrence of hypertension in later pregnancies and in the prevalence of 
later chronic hypertension with each increment in MAP - 2. 
For the recurrence of hypertension, the difference between incidences with 
M A P - 2 below and above 90 has a Chi2 of 18.0, p<0.001. Using 85 as a dividing 
line, the development of ultimate chronic hypertension has a Chi2 of 5.92, 
p<0.02. 
Langford and Watson (16) published an epochal study that seems to have 
escaped the attention of many obstetricians. They recorded the blood pressures 
of nulligravid high school girls and analyzed their first pregnancies occurring 
months to a few years later; there were 400 normotensive gestations and 186 in 
which the obstetricians had made the diagnosis of preeclampsia. Proteinuria 
usually was absent or present in only trace amounts and the incidences and 
degrees of proteinuria and edema were similar in the two groups, as were the 
gains in weight. The authors wrote: "The diagnosis of preeclampsia appeared to 
be based entirely on BP". That is, many probably had transient hypertension 
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rather than preeclampsia. The patients with "preeclampsia" had had higher blood 
pressures before conception and at every stage of pregnancy (MAP - 1 and MPA -
2), and at follow-up than did those with normotensive pregnancies. 
It has long been known that persons who develop essential hypertension 
characteristically have blood pressures in the upper range of age-specific 
normals before the onset of hypertension, perhaps with such levels even in 
childhood (15). Women in the childbearing age who are destined for essential 
hypertension might then be expected to have increased blood pressures within the 
"normal range" before conception, to carry the higher pressures through pregnancy 
(higher levels of MAP - 2), to develop transient hypertension, and ultimately 
to become chronically hypertensive. Thus, higher levels of MAP - 2 and transient 
hypertension appear to be stages in the natural history of essential 
hypertension. Inasmuch as future hypertensives are not immune to preclampsia, 
higher levels of MAP - 2 may predict preeclampsia in them, purely by chance. 
Of course, we should study incipient and mild preeclampsia, but how are 
we to identify it and exclude simulating disorders? Ernest Page used to talk 
about founding a journal to be called Recent Setbacks in Medicine; he had a 
specific contributor in mind, but I am sure that he would have agreed that many 
of the contemporary papers on mild preeclampsia belong there. 
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Pregnancy Outcome as Related to 
Hypertension, Edema, and Proteinuria 
Toxemia of pregnancy, although recognized 
to be a devastating condition in terms of its 
effects on both mother and fetus, is at best 
ill-defined. The diagnostic criteria have been 
vague and arbitrary in all the systems of 
classification devised thus far. Not only are 
such criteria poorly defined, but they also 
tend to be inconsistent in their application to 
clinical situations, and therefore are inade-
quate for continued use. It was felt necessary 
to try to determine instead the specific 
adverse effects of the clinical diagnostic 
components of toxemia, namely blood 
pressure, proteinuria, and edema, concen-
trating especially on the potentially dele-
terious results associated with combinations 
of these factors and their patterns of change 
during the course of pregnancy. In this way, 
Supported by funds from Contract NOI-NS-3-2320 
from the National Institutes of Health, U.S. Public 
Health Service. The Collaborative Study of Cerebral 
Palsy, Mental Retardation and Other Neurological and 
Sensory Diseases of Infancy and Childhood is supported 
by the National Institute of Neurological Diseases and 
Stroke. The following institutions participate: Boston 
Lying-in Hospital; Brown University; Charity Hospital, 
New Orleans; Children's Hospital of Buffalo; Children's 
Hospital of Philadelphia; Children's Medical Ccn-
lcr, Boston; Gofumbia University; Johns Hopkins 
University; University of Minnesota; Medical College 
o f
 Virginia; New York Medical College; Pennsylvania 
Hospital; University of Oregon; University of Ten-
nessee; and the Perinatal Research Branch, National In-
stitute of Neurological Diseases and Stroke. 
one might be able to develop objective, 
meaningful, and critical criteria for making 
appropriate diagnoses of significant disease. 
Such a study has been undertaken and is 
currently in progress, utilizing data collected 
for the Collaborative Project of the NINDS, 
under whose auspices it has been pursued ac-
tively. 
DATA BASE 
The Collaborative Study of Cerebral Palsy, 
Mental Retardation and Other Neurological 
and Sensory Disorders of Infancy and Child-
hood is a joint endeavor of 14 medical 
centers and the Perinatal Research Branch 
of the NINDS. Its prime objective is to de-
termine relationships between factors that 
affect women during pregnancy and the 
development of neurological and sensory 
disorders in their offspring. To this end, 
since 1957 a total of 58,806 obstetrical 
patients have been studied on a prospective 
basis. 
The relevant data were collected on struc-
tured and prccoded study forms by specially 
trained, highly skilled interviewers and 
examiners. A wide range of information was 
recorded, including history of x-ray ex-
posure, drug intake, minor and major ill-
nesses, socioeconomic and genetic back-
ground, physical examination on each visit, 
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various laboratory studies, labor and de-
livery events in great detail, examination of 
the placenta, etc. Moreover, the neonate was 
studied extensively, beginning with Apgar 
scoring and information concerning the 
onset of respiration and resuscitation. 
Pediatric examinations, together with rele-
vant laboratory determinations, were carried 
out at specified intervals. A psychological 
examination was conducted at eight months 
of age for the assessment of the child's 
mental and motor development. A neu-
rological examination was performed at the 
age of one year. The speech, language, and 
hearing status was determined at three years. 
A detailed Stanford-Binet intelligence test 
was carried out at age four to assess the fine 
and gross motor development. A behavioral 
profile was included at this time, also. 
Another neurological examination was done 
at age seven. A psychological evaluation was 
also carried out at this time, using the 
Wechsler Intelligence Scale for Children and 
the Bender Visual Motor Gestalt Test. 
Throughout this time, periodic interval his-
tories were obtained. Detailed descriptions of 
the collaborative project, its functional 
components, data collection forms', and 
population characteristics have been 
published previously (1,2). 
Our data base was selected from the 
enrolled study population to include only 
those with single, viable pregnancies who 
registered prior to 28 weeks* gestational age 
and had a sufficient number of antepartum 
visits (four or more) to permit us to inves-
tigate the relevant clinical variables. Patients 
were excluded from the data base if they had 
a multiple pregnancy, no antepartum care, 
an abortion, or a hydatidiform mole, or if 
the date of their last menstrual period was 
unknown; in addition, data were excluded 
on pregnancies after the gravida's first 
registered study pregnancy. This procedure 
yielded 38,636 gravidas for study. For them 
there were 269,668 blood pressure recordings 
and like numbers of proteinuria, edema, and 
weight observations for analysis. 
Early in the course of our study, it became 
essential to determine the reliability of the 
available data. A series of editing operations 
was undertaken, together with error analysis, 
which revealed a high level of accuracy in 
the data file under surveillance, with error 
rates of 1% or less, based on 14,245 verified 
items. 
Of considerable interest to us, as others 
had found before, was the recognition that 
the blood pressure data represented a dis-
continuous variable throughout its range, 
with a pooling of the readings primarily at 
the zero end-digit values. Thus, we felt jus-
tified in grouping the blood pressure readings 
into 10 mm Hg incremental groups centered 
at the zero end-digit figure, i.e., 55-64, 65-
74, etc. 
As for the pressure distribution according 
to gestational age (Fig. 1), it was observed 
that the discontinuous distribution of 
pressure recordings persisted, but with a 
characteristic shift to lower readings as preg-
nancy advanced into the second trimester 
and with a return toward higher readings in 
late pregnancy. A plot of cumulative 
pressure frequencies for each week of gesta-
tion (Fig. 2) defined the zones of pressure, 
for purposes of appropriate grouping, as well 
as logical intervals of gestational age accord-
ing to the homogeneity demonstrated for the 
pressure readings during those intervals. 
Thus, we obtained a utilitarian (rather than 
arbitrary) series of epochs of gestational age 
in week intervals (a) 13-16, (b) 17-23, (c) 
24-27, (d) 28-32, (e) 33-34, (/) 35-36, (g) 
37-38, and (h) 39-41. This arrangement pro-
vided a coding for blood pressure readings 
by the gestational epoch in which the record-
ing was obtained for the purpose of designat-
ing patterns of sequential change with 
advancing pregnancy. 
Since the blood pressure readings did not 
follow a continuous distribution but were, in 
fact, naturally clustered around the zero end-
digit values, they were to some degree al-
ready grouped. A further condensation into 
10 mm Hg incremental groups simplified the 
£- S 
DiASTOUC BLOOD PRESSURE READINGS, mm. Hg 
Figure I Distnbution of diastolic blood pressure recordings in 2 mm Hg increments for each 2-week gestational 
age interval from 12 weeks to term. Note the zero end-digit clustering and the trend toward lower pressure distribu-
tion as pregnancy advances, as term approaches, the distribution returns to that observed in early pregnancy 
to te 
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Figure 2 Distribution of diastolic pressure recordings by gestational age epoch. The cumulative percentages of all 
recordings obtained during each week of gestational age arc plotted to illustrate trends with advancing pregnancy 
*nd to form the basis for meaningful gestational age epoch divisions. 
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analysis of dynamic trend patterns of blood 
pressure. However, the issue was then raised 
of how efficient this grouping was in terms 
of the loss of information. The efficiency was 
assessed by taking the ratio of the variance 
of the grouped data to the variance of the 
ungrouped data. For data with a gaussian 
(normal) distribution, the theoretical optimal 
efficiency for five groups is 92.01% (3). Our 
data showed very nearly optimal efficiency 
rates for each gestational age epoch. 
The outcome factors which were investi-
gated included 12 scored items: (a) fetal 
death, (b) neonatal death, (c) perinatal 
mortality, (d) depressed one-minute Apgar 
score (less than 6), (e) depressed five-minute 
Apgar score (less than 6), (/) low fe-
toplacental weight ratio (less than 5), (g) low 
birth weight (less than 2500 g), (h) abnormal 
eight-month Bayley mental score (less than 
56), (0 abnormal eight-month Bayley motor 
score (less than 20), (J) abnormal eight-
month global evaluation, {k) abnormal one-
year neurological examination, and (/) defec-
tive four-year intelligence quotient (less than 
70). Subsequently, the small-for-gestational-
age-infant was designated as one who fell 
below the fifth percentile of his/her appro-
priate birth weight distribution, which was 
produced for each gestational age and for 
two races (white and black). Similarly, a 
birth-weight score was established for each 
infant as the standardized deviation from the 
mean (the deviation expressed in units of 
standard deviation); again, the distributions 
were stratified jointly by race and duration 
of pregnancy at delivery. The most critical 
outcome factors among these 14 items, with 
regard to the effects of the risk factors under 
surveillance, included fetal death (and as a 
consequence, perinatal mortality), low birth 
weight, smallness-for-gestational-age, and 
abnormal four-year intelligence quotient. In 
this chapter, because of space constraints, 
we will concentrate primarily on fetal death 
data. 
ANALYTIC A P P R O A C H E S 
Single-Factor Effects by Epoch 
The data base was partitioned into 40 cells 
for studying blood pressure according to the 
gestational-age epoch (five diastolic pressure 
groups in 10-mm Hg increments in each of 
eight gestational-age epochs during which 
the recordings were obtained). The numbers 
of subjects in these cells ranged from 224 to 
10,139. Where there was more than one 
reading in a given epoch, only the maximum 
was considered. Within each cell, the popu-
lation was studied to determine the various 
outcome incidence rates. Fetal mortality, for 
example, was seen to rise abruptly in each of 
the epochs in association with diastolic 
pressure levels exceeding 84 mm Hg (Table 
1). The relative overall mortality levels fell 
progressively with advancing gestational age 
on the basis of the self-selecting nature of the 
data; those women who delivered previable 
or premature infants earlier in pregnancy 
could no longer present pressure recordings 
as term approached. Similar trends were en-
countered for neonatal death, perinatal 
mortality, neonatal depression at one and 
five minutes, low birth weight, and small-
ness-for-gestational-age. Long-term adverse 
Table 1: Rates of Fetal Mortality (per 1000) for 
Diastolic Blood Pressure by Gestational 
Age 
Diastolic Blood Pressure, mm Hg 
Gestational 
Age (Weeks) <65 65-74 75-84 85-94 95+ 
13-16 
17-23 
24-27 
28-32 
33-34 
35-36 
37-38 
39-41 
9 
8 
6 
6 
6 
7 
2 
4 
8 
8 
8 
7 
6 
4 
5 
5 
12 
11 
10 
8 
6 
6 
4 
3 
13 
12 
9 
9 
8 
6 
5 
5 
18 
16 
26 
21 
19 
16 
9 
9 
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Table 2: Rates of Fetal Mortality (per 1000) for 
Degree of Proteinuria by Gestational 
Gestatior 
Age (Wei 
13-16 
17-23 
24-27 
28-32 
33-34 
35-36 
37-38 
39-41 
Age 
i s l 
eks) 
<• 
None 
13 
*5^  
6 
5 
4 
Proteinuria 
Trace 
9 
\ 1 4 
11 
10 
8 
10 
1+ 2 ^ 
30 0 
10 37 
,14 26 
6 40 
10 44 
16 17 
11 25 
6 41 
3-h 
(0)« 
71 
71 
58 
56 
24 
19 
22 
4+ 
(0) 
(0) 
(91) 
(176) 
(200) 
45 
(0) 
(71) 
a
 Parentheses indicate rates based on a small 
sample size. 
effects did not seem to be associated with 
high levels of diastolic pressure; on the 
contrary, only the very lowest levels seemed 
to be related to poor long-term results. This 
is a matter for consideration elsewhere. 
Similarly, proteinuria of 2+ or greater 
was associated with an adverse outcome for 
each gestational age epoch under sur-
veillance (Table 2). This relationship held for 
essentially all the outcome factors studied. 
The apparent influence of edema on out-
come was negligible, as determined by his-
tory or by physical examination. Also, the 
maternal weight change did not appear to af-
fect the outcome appreciably. It was 
recognized that this approach did not take 
into account potentially confounding factors 
having to do with the coexistence of other 
deleterious effects and the possibility that the 
various subgroups were not constituted 
homogeneously insofar as patient makeup 
(actuarial as well as obstetrical) was 
concerned. 
Doublet Combinations 
In order to approach the dynamic study of 
the effects of blood pressure on the outcome 
of pregnancy, our first thrust was to inves-
tigate doublet groupings based on blood 
pressure transitions between adjacent epochs 
of gestational age. A total of 175 such 
groupings existed (35 epoch-pressure cells 
for epochs 1-7, inclusive, multiplied by the 
five possible blood pressure level transitions 
in the next succeeding epoch). The data 
derived from analyses of outcomes in each of 
these cells showed that a pairwise transition 
involving a jump of three levels upward (for 
example, a rise in diastolic pressure from the 
65-74 mm Hg level to the 95 + mm Hg level) 
had an adverse effect in general (Table 3). 
More important, specific sequences of 
diastolic pressure change could be shown to 
be deleterious. By virtue of the fact that 
some of the pattern cells contained relatively 
few cases, so that the outcome data derived 
therefrom were not likely to be meaningful 
from the statistical point of view, the data in 
each cell were subjected to a "filtering" 
process for the purpose of establishing 
relevance and appropriately suppressing any 
potentially spurious or chance observations. 
This operation permitted us to simplify the 
evaluation involving the data obtained from 
the doublet (and later the triplet) sequences 
by tabulating only those doublet sequences 
which were based on data showing statis-
tically significantly increased or decreased 
rates of abnormal outcome (p < 0.01). It 
was felt that they might serve tentatively for 
purposes of prognostication. In all, 45 dou-
blet sequences of diastolic pressure were 
identified as being particularly hazardous in 
terms of fetal and infant outcome. Most of 
these sequences involved high levels (over 84 
mm Hg) in one or both members of the pair. 
As for proteinuria, it was clear that its ab-
rupt appearance—that is, a positive shift of 
two or more levels (for example, from nega-
tive to 1+ or from trace to 2+)—was 
associated with increased stillbirth rates, as 
well as other short- and long-term adverse 
outcomes. Ninety significant doublets of 
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Table 3: Effect on Fetal Mortality Rates of Direction and Degree of 
Diastolic Change by Gestational Age 
Gestational 
Epoch Pairs 
(Weeks) 
13-16 to 17-23 
17-23 to 24-27 
24-27 to 28-32 
28-32 to 33-34 
33-34 to 35-36 
35-36 to 37-38 
37-38 to 39-41 
- 3 
0 
20 
54 
0 
11 
18 
0 
?< 
- 2 
22 
24 
17 
16 
9 
19 
5 
lirwise 
- 1 
29 
22 
13 
16 
10 
10 
6 
Transit 
No 
ion in Pressure Levela 
Change 
25 
21 
18 
13 
13 
11 
11 
+ 1 
31 
25 
18 
15 
13 
10 
10 
4-2 
26 
26 
16 
7 
15 
9 
14 
4-3 
71 
31 
23 
9 
25 
22 
8 
"Observations grouped in 10mm Hg increments: +1 indicates a positive 
jump to the next higher pressure level between gestational age epochs; 4-2 a 
jump of two levels, upward, etc. 
proteinuria were identified. Comparable 
pairwise transitions of edema showed little in 
the way of a reliably consistent effect, al-
though 28 significant patterns were found. 
The paired interepochal weight change had 
no material influence, but large weight losses 
were associated with increased fetal 
mortality, as shown in 42 pattern pairs. 
Sequence Patterns 
The same operational principle was applied 
to the study of triplet combinations in dy-
namic sequences of diastolic blood pressure 
levels. In all, there were 750 groupings (30 
epoch-pressure cells for epochs 1-6, mul-
tiplied by five possible blood pressure level 
transitions in the next succeeding epoch, and 
by five again for the possible transitions in 
the third epoch of the triplet sequence). The 
previously described statistical filtering 
process identified 108 triplet sequence pat-
terns of diastolic pressure which could be 
considered as indicators of fetal risk. Simi-
larly, there were 176 triplet sequences of pro-
teinuria, 43 of edema, and 179 of weight 
change. 
It soon became clear that the prospect of 
investigating all possible sequences involving 
up to eight epochs was unworkable. The 
numbers of permutations of blood pressur 
patterns increased exponentially for each ac 
ditional epoch examined, and all possibi 
combinations and permutations totaled ovc 
2 million sequence patterns. The problem 
therefore, was approached more empirically 
From a detailed listing of all patterns ot 
served to be actually associated wit 
specific, unfavorable outcomes, it was sec 
that the number of possible theoretical pa 
terns at risk could be reduced considerable 
The complexity of the analysis was reduce 
further, in order to-make the data mo-
meaningful for practical utilization I 
clinical situations, by studying only sequent 
patterns for the last five gestational ai 
epochs, beginning at the 28th week. While! 
total of 7776 such patterns were theoretical 
possible for diastolic blood pressure, on 
1669 were actually encountered; son 
represented in terms of patterns we; 
particularly sparse in the number of subjec 
recognized. All sequencing possibil i ty 
including quadruplet and quintuplet grou 
ings, totalling 3334 subsets, were studied. 
A total of 46 actual high-risk diastolic s 
quence patterns significantly associated wi 
perinatal mortality were uncovered by stat 
tical analysis. It should be emphasized t j | 
the study of these specific patterns includ 
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a provision for determining the gestational 
age at delivery and was confined to observa-
tions made from 28 weeks to delivery, exclu-
sive of observations made during labor. 
When similar procedures were carried out 
on proteinuria sequences, 26 patterns signifi-
cantly associated with perinatal mortality 
were found. Edema sequences yielded 39 and 
weight change 118 additional pattern com-
binations. Thus, in spite of our efforts to 
reduce the inherent complexity of the investi-
gation, we were still left with more than 5 
million theoretical pattern combinations to 
consider in our search for a clinical 
constellation of risk factors involving just 
these four parameters (there are about 
5,504,000 possible combinations involving 46 
pressure, 26 proteinuria, 39 edema, and 118 
weight change patterns). Moreover, this 
investigation in no way considered other 
variables that might be relevant and 
contributory. 
Cluster Analysis 
Large numbers of high-risk patterns were 
seen to occur, each of which had a relatively 
low incidence and accounted for only a small 
number of affected fetuses. The task of 
grouping them meaningfully in order to sim-
plify and classify diagnostic criteria for use 
by the practicing clinician seemed im-
practical, therefore, by the approach 
described above. Moreover, the summary 
variables we used (that is, epoch-specific 
maximum blood pressure, edema, pro-
teinuria, and weight recordings and their 
various changes) may well have missed or 
suppressed much detailed information in the 
visit-by-visit observations, particularly with 
regard to rapid fluctuations at various times 
during pregnancy. Accordingly, we cm-
barked on exploratory analyses in which a 
large number of derived blood pressure, 
edema, proteinuria, and weight variables 
wcre examined. These analyses covered as 
completely as possible the material judged 
potentially significant by the use of combina-
tions of measurements from the available 
data. The variables fell into three main 
groups: (a) level variables, measurements of 
absolute values by epoch (mean, maximum, 
minimum, first, last), and (b) change varia-
bles, measurements of change in magnitude 
or rate (range, maximum rate of increase, 
etc.), and (c) shape variables in terms of 
specified patterns of change with advancing 
gestational age. Thus, a total of 196 varia-
bles were identified which might conceivably 
be related to the disorder under study. These 
variables included relevant actuarial data on 
race, age, and parity, and fetal variables 
dealing with gestational age, birth weight, 
placental weight, outcome, and the birth 
weight score, as defined earlier. 
Cluster analysis was used to identify 
analytic variables which were so highly 
similar in information content, that when 
studying just one of them, one would be us-
ing information on all of those with com-
parable degrees of similarity. Thus, for 
example, a very compact cluster of weight 
variables allowed us to conclude with some 
assurance that we could discard all but one 
weight variable for future analysis without 
any appreciable loss of information. 
The reduced set of variables was then 
used in other cluster analyses, using several 
subsets of gravidas, in an effort to discover 
natural subgroups of gravidas with distinc-
tive profiles that could be related to the inci-
dence of outcome abnormalities. The 
clustering of gravidas based on their blood 
pressure variables was carried out. It was 
found that several of the variables seemed to 
carry relatively little information; for 
example, a set of variables that were stan-
dard deviations of determinations within 
epochs and over the course of pregnancy 
(which may be taken as measures of lability) 
conveyed very little that was not also 
contained in the average rates of change. 
Clusters of cases with low maxima and small 
ranges were associated with low rates of ab-
normality, and clusters with high levels 
(maxima) or large variability (ranges) were 
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associated with high abnormality rates. Pat-
terns of blood pressure change over the 
course of pregnancy were sought, particu-
larly those related to a high risk of abnormal 
outcome. High blood pressure levels with 
and without extreme variability were found 
to have high abnormality rates. We also 
found clusters of blood pressure patterns 
over the course of pregnancy that could be 
characterized as (a) relatively constant and 
low, (b) high and variable, and (c) low in 
early epochs and higher later. We did not 
observe any association between high abnor-
mality rates and specific patterns of change. 
The possibility remained that there were 
regularities in our data that we missed or 
that there were patterns of blood pressure 
change in pregnancy that our data did not 
reflect (for example, phenomena involving 
blood pressure changes on the scale of a few 
days). Despite an exhaustive effort to find 
such regularities, employing a number of dif-
ferent techniques, none was revealed. 
Linear Discriminant Analysis 
We have utilized linear discriminant analysis 
to identify potential combinations of risk 
factors among the variables under study, 
taking into account the potentially con-
founding variables, such as the actuarial 
variables of age, race, and parity, as well as 
the institution in which the observations were 
made. This technique permitted us to 
identify variables that contribute informa-
tion significant for identifying fetuses and in-
fants with the potential for an adverse out-
come from unaffected ones. 
It was determined that age, race, parity, 
institution (with the exception of a single 
unit), maternal weight and edema did not 
provide significantly more information re-
lated to distinguishing unaffected survival 
from fetal death (or other outcomes studied 
in like manner) than was provided already by 
such clearly verified factors as maximum 
proteinuria and diastolic blood pressure, as 
observed during or after the 28th week of 
pregnancy. It was verified clearly that 
neither edema nor maternal weight change 
contributed meaningfully to the adverse out-
come. Moreover, there appeared to be only 
negligible confounding effects from the ac-
tuarial and institutional variables. 
Analysis of Rate Ratios 
Diastolic pressure and proteinuria levels 
were examined simultaneously to determine 
which combinations yield the highest inci-
dence of adverse outcomes. When the levels 
were examined without regard for the gesta-
tional age at which the observations were 
made or for the delivery date, it became 
quite clear that each was associated inde-
pendently with adverse outcomes and were 
synergistic (Table 4). Compared to patients 
with diastolic pressures of 75-84 mm Hg and 
no proteinuria, fetal death rates, for example, 
increased about fourfold in conjunction with 
diastolic pressures of 95 mm Hg or greater 
(and proteinuria less than 2-f) and increased 
by the same amount in association with 2+ 
proteinuria or more (but with diastolic 
pressures of under 95 mm Hg). Pressures of 
95 mm Hg or more which occurred in con-
junction with proteinuria of 2+ or more 
showed fetal mortality rate ratios far exceed-
ing the sum of their independent rate ratios 
(almost tenfold). Indeed, "subliminal" levels 
of both factors (that is, levels that were not 
associated with a recognizably increased risk 
when observed alone) which occurred in com-
bination yielded elevated mortality data as ( 
well. This phenomenon was seen in gravidas 
with 1-f proteinuria and diastolic levels of 
85-94 mm Hg, who had a fourfold increase in 
fetal deaths. Rate ratio zones thus were iden-
tifiable, based on levels of relative hazard as 
related to various proteinuria-diastolic! 
pressure combinations, and these remained 
remarkably intact when the independent ef-
fects and synergistic effects were examinee 
according to the time during pregnancy a* 
which the observations were made. 
A continuum of hazard is seen to begin a | 
a low level in the reference group (diastolic 
pressure 75-84 mm Hg with no proteinuria 
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Table 4: Rate Ratios for Fetal Death by Diastolic/Pressure and Proteinuria 
Combinations 
Proteinuria 
None 
Trace 
1-h 
2 + 
3-f 
4 + 
Total 
<65 
2.5° 
2.2 
1.0 
0.0 
0.0 
0.0 
2.0 
Diastolic Blood Pressure (mm 
65-74 
1.5 
1.3 
0.9 
5.3" 
6.7a 
0.0 
1.3 
75-84 
^ h 0 1 _ 
1.2 
1.0 
3.1° 
0.0 
0.0 
1.0* 
85/94 
iW 
1.5 
3.8° 
0.0 
36 
0.0 
1.5 
95-104 
3.1° 
2.8° 
4.3° 
9.0° 
18.6° 
23.1° 
3.7° 
Hg) 
105 + 
3.3° 
4.5° 
10.1° 
11.1° 
20.2° 
17.9° 
6.1° 
Total 
I.O* 
1.1 
1.4 
2.7° 
5Aa 
6.6° 
° Statistically significant,/? < 0.01. 
b
 Referent rate 0.62%. 
c
 Referent rate 0.86%. 
d
 Referent rate 0.68%. 
and to rise multidirectionally to compose 
three moderately high mortality areas and 
one severe mortality area. Four groups were 
identifiable, as follows: (a) Gravidas present-
ing with the single factor of a diastolic 
pressure elevation of 95 mm Hg or greater 
were associated with a moderate increase in 
the incidence of adverse effects on the fetus 
(rate ratio for fetal mortality, 4.1). (b) 
Gravidas manifesting comparable magnitude 
of mortality were associated with the single 
factor of proteinuria of 2+ or greater (rate 
ratio 4.0). (c) Gravidas shown to possess 
synergistic combinations of the two factors 
(diastolic pressures of 85 mm Hg or greater 
together with proteinuria of 1+ or greater) 
provided the greatest hazard to their unborn 
offspring (overall rate ratio, 7.2). (d) The 
fourth group is composed of gravidas with 
low diastolic blood pressures (less than 65 
rnm Hg and without proteinuria) who have 
significantly high rates of fetal loss (rate 
fatio 3.0). While it is clear that the infants of 
these gravidas experience significant excess 
mortality, it is hypothesized that this syn-
drome represents a condition separate from 
">e hypcrtensive-proteinuric state which we 
*** ttudying here. 
vii Wili ** notcd that the group with thc 
**I&est excess mortality (group 3, above) in-
cluded gravidas with less intense clinical 
risk factors (diastolic blood pressure of 85-
94 mm Hg and proteinuria of 1 + ), in whom 
the fetal peril was shown to equal that of 
patients with diastolic pressures exceeding 94 
mm Hg and proteinuria of 2+ or more. 
Thus, this group may be considered to be 
composed of three subdivisions: (a) those 
with a diastolic blood pressure of 85 mm Hg 
or more with 2+ proteinuria or greater, the 
subset at highest risk (rate ratio, 9.6); (b) 
cases with diastolic pressures of 95 mm Hg 
or greater and 1+ proteinuria (rate ratio, 
8.0); (c) patients with borderline pressures of 
85-94 mm Hg and borderline proteinuria of 
1+ level (rate ratio, 5.1). Together, these 
three subdivisions represent a moderately 
homogeneous group of gravidas whose 
fetuses have a very great chance of being 
damaged. 
Group 1 (hypertension only) comprised 
5.2% of the study population but encom-
passed 10.4% of all fetal deaths. Group 2 
(proteinuria only) included 1.9% of the 
patients and 3.6% of the deaths. Group 3 
(hypertension plus proteinuria) accounted 
for 4.3% of the gravidas and an impressive 
14.7% of the fetal deaths. The fourth group 
(low diastolic pressures, without proteinuria) 
constituted 3.0% of the gravidas studied and 
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4.4% of the fetal deaths. Thus, one-third of 
all fetal deaths were accounted for by these 
four* groups of definable disorders, even 
though the women in these groups all 
together comprised only one-seventh of the 
whole study group. 
Similar analyses of rate ratios for com-
binations of diastolic pressure by weight 
change, diastolic pressure by edema, pro-
teinuria by weight change, proteinuria by 
edema, and weight change by edema con-
firmed the earlier conclusions, based on the 
aforementioned analytic techniques, that 
neither edema nor weight change (other than 
weight loss) affected the outcome in such a 
way as to make these variables useful for the 
purpose of identifying gravidas at risk of a 
potentially adverse fetal outcome. 
SUMMARY 
Clinical variables of blood pressure, pro-
teinuria, edema, and maternal weight have 
been studied extensively, with particular 
reference to associated adverse fetal and in-
fant outcomes. The levels of these variables, 
as well as their relative patterns of change 
with advancing pregnancy, were investigated 
by several analytic methods. It was de-
termined that diastolic blood pressure and 
proteinuria, alone and in combination, pro-
vided sufficient information about their ef-
fect on fetal and infant outcomes to enable 
us to create an empirical classification of 
^gravidas whose fetuses were probably at risk. 
_The results must be considered preliminary 
4n viciwl^f^thefact tFat the wofiris stilHn 
^progress. " " ^ 
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DISCUSSION 
DR. R. A. CHEZ: YOU stated that the weight 
gain factor was not significant. Could you elabo-
rate on this? 
DR. FRIEDMAN: We were unable to show any 
effect of excessive weight gain. On the other hand, 
when we analyzed weight loss, we noted clear 
relationships to unfavorable outcome. <T~ 
D R . C H E Z : Were you referring to total weight 
gain during the gestat ion or i n j ^ m c j i t a l weight 
incrcases^xspecial ly those occurring over a short 
period of t ime. 
D R . F R I E D M A N : Incremental . 
D R . N . S . A S S A L I : It seems odd that one has to 
analyze o u t c o m e to define the disease , and I was 
wondering about the rationale of such an ap-
proach. A s an example , you included "small-for-
gestat ional-age" babies as a criterion for defining 
preeclampsia, yet preeclampsia is an acute disease 
which occurs in the last trimester and does not 
produce (as far as I know) a small-for-gesta-
tional-age baby. The latter is characterist ic of 
chronic hypertensive disease. I wonder if y o u were 
really able to separate acute preeclampsia and 
chronic hypertensive diseases . 
D R . F R I E D M A N : I agree that a small-for-gesta-
tional-age baby usually indicates the presence of 
long-standing hypertension, but it is also seen 
with acute toxemia . From our point of view, we 
were looking for means whereby w e would be able 
to determine signals that would predict those 
patients who would b e c o m e hypertensive. W c felt 
that by using o u t c o m e we would not fall into the 
trap that everyone who has preceded us (including 
ourselves) has fallen into; that is , wc would not 
utilize any preconcept ions and merely determine 
criteria based on bad effects . This is a well-
recognized device in screening programs. That is 
what wc were trying to d o — s e t up a means 
whereby the disease could be determined to exist 
on the basis of a conste l lat ion of factors that 
heretofore had not been recognized. But, note^ 
that we were unable to find any constellation of 
(cither acute or) rapid changes that were critical 
in defining the disease. 
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IN THE THIRD JUDICIAL DISTRICT COURT FOR SALT LAKE COUNTY 
STATE OF UTAH 
BRENDA RIVERA, 
Plaintiff, 
v. 
CLAYTON S. WILDE, M.D., 
Defendant. 
ANTONIO R. RIVERA, by and 
through his Guardian Ad Litem 
TONY RIVERA, also known as 
Antonio R. Rivera, 
Plaintiff, 
v. 
CLAYTON S. WILDE, M.D., 
Defendant. 
AMENDED FINDINGS OF FACT AND 
CONCLUSIONS OF LAW 
Civil No. 900902630 
Judge Michael R. Murphy 
Civil No. 910907496 
The above-entitled matter having come on for trial before 
the Honorable Michael R. Murphy, one of the judges of the above-
entitled court, on the 22nd day of September, 1992, Plaintiff 
Brenda Rivera having been present in person and represented by 
her attorneys of record, Robert B. Sykes, James D. Vilos and 
Tamara J. Hauge of and for Sykes & Vilos, Defendant having been 
present in person and represented by his attorneys of record, 
Elliott J. Williams and Bruce H. Jensen of and for Williams & 
Hunt, the Court having received the Stipulation of the parties 
that the claims of Plaintiff Antonio R. Rivera shall be decided, 
as to a finding of liability, upon the evidence presented and the 
judgment of the Court as to the claims of Plaintiff Brenda 
Rivera, having heard the testimony of the witnesses, having 
reviewed the exhibits entered into evidence, having heard the 
arguments of counsel, having considered proposed findings and 
conclusions submitted by the parties and the memoranda of counsel 
submitted therewith, and with good cause appearing therefore, 
does now enter its: 
FINDINGS OF FACT 
1. In early February 1989, Plaintiff Brenda Rivera sought 
the services of Defendant, a specialist in obstetrics and 
gynecology, to care for her in conjunction with her first 
pregnancy. At the time, Plaintiff was 25 years old. 
2. At the time of Plaintiffs first pre-natal visit to 
Defendant on March 1, 1989, Defendant determined on the basis of 
Plaintiff's medical and family history and physical examination 
that she was a low risk obstetrical patient, that the estimated 
gestational age of the fetus was 11 % weeks, and that the 
estimated date of confinement (for delivery) was September 17, 
1989. Defendant provided information to Plaintiff and her 
husband about what they could expect during the pregnancy and 
assured them that they could, and should, call him anytime they 
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had any concerns or problems. During her pregnancy, Plaintiff 
had the following blood pressure and weights at the times 
indicated 
Date Weeks Weight B.P. (Systolic/ 
Diastolic) 
98/64 
110/72 
120/68 
(110/88 
110/84 
LllO/80 
3/1/89 
4/24/89 
5/22/89 
11% 
19 
24-5 
157 
170 
173 
6/15/89 26 181 
3. Plaintiff was seen monthly by Defendant for routine pre-
natal care. During these visits she complained to Defendant about 
persistent headaches, which were relieved with Tylenol, and 
nausea and vomiting. These symptoms are common during pregnancy 
and Defendant reassured Plaintiff and her husband that she should 
soon begin to feel better. 
4. On June 12, 1989, Plaintiff's husband spoke with 
Defendant's nurse by telephone and reported that Plaintiff was 
experiencing some swelling in her feet and legs after being on 
them all day. After questioning him about other complaints and 
learning of none, the nurse recommended that Plaintiff elevate 
her legs as much as possible and increase her water intake. If 
her condition worsened she was to come in before her next 
scheduled visit. 
5. When Plaintiff visited Defendant on her next scheduled 
visit on June 15, 1989, the estimated gestational age of the 
fetus was 26 weeks. Plaintiff's blood pressure was measured as 
110/88 and a urine test revealed no protein in her urine. 
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Defendant repeated the blood pressure measurement, which was 
found to be 110/84, and rechecked the urine specimen to confirm 
the absence of proteinuria• 
6. During that visit, Plaintiff repeated her complaints of 
having headaches, which were still relieved with Tylenol, and 
some nausea and vomiting. She also complained of some fatigue. 
The symptoms of which Plaintiff complained were consistent with a 
flu-like illness that many of Defendant's patients had recently 
reported. At the request of the Plaintiff's husband, Defendant 
also carefully examined Plaintiff's feet, ankles, legs and face 
and found no pathologic edema. Defendant instructed Plaintiff to 
take breaks at work so that she could have her legs elevated, to 
rest and keep off her feet when at home and to take care of 
herself. Defendant told Plaintiff that she should start feeling 
better in a few days, but, if she did not or got worse, she 
should come in to be checked. Defendant asked Plaintiff to come 
back for another pre-natal visit in two weeks, rather than at the 
regular interval of one month. Plaintiff's blood pressure was 
taken a third time and was measured at 110/80. During this 
office visit the Defendant considered the possibility of pre-
eclampsia and upon examination and evaluation ruled out the 
diagnosis of pre-eclampsia in accordance with the accepted school 
of thought to which he adhered. 
7. Plaintiff experienced an eclamptic seizure on June 23, 
1989. She had no contact with Defendant between the time of the 
last office visit on June 15, 1989, and the eclamptic seizure. 
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8. Plaintiff and Defendant called expert witnesses to 
provide testimony in support of their respective positions. The 
Plaintiff's expert, Dr. Maclyn Wade, had limited obstetrical 
experience and his testimony was equivocal, unpersuasive and 
lacking in credibility. Dr. Wade gave away on cross-examination 
most of the points he made on direct and redirect examination. 
9. The expert testimony adduced during trial and the 
medical literature to which reference was made by the witnesses 
clearly established that there is no uniform standard of care 
followed by all competent practitioners, but rather a cacophony 
of opinion, on the subject of the criteria for diagnosing pre-
eclampsia. 
10. Based upon the expert testimony and medical literature 
presented, the Court finds that Defendant's treatment of 
Plaintiff complied with an acceptable school of thought which is 
within the standard of care. It was appropriate for Defendant to 
adopt and adhere to the school of thought that: (1) defines pre-
eclampsia as a blood pressure of equal to or greater than 140/90 
in the presence of proteinuria; and (2) considers edema (even of 
the face and hands) and weight gain as so common in pregnancy 
that they are useless for the diagnosis of pre-eclampsia. 
11. The school of thought Defendant followed in his 
diagnosis and treatment of Plaintiff is well-supported in the 
medical literature and by competent and qualified experts as an 
approved method of diagnosis and treatment recommended and 
followed by a respectable portion of the medical community in the 
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specialty of obstetrics and gynecology. The Plaintiff has not 
demonstrated by a preponderance of the evidence with credible 
expert testimony that the school of thought Defendant followed is 
unaccepted, insufficient or unsafe. 
12. During Defendant's examination and evaluation of 
Plaintiff on June 15, 1989, the possibility of pre-eclampsia was 
raised, but there was nothing in Plaintiff's medical or family 
history, course of pregnancy, complaints, or examination and test 
findings which was diagnostic of pre-eclampsia or developing pre-
eclampsia. To the contrary, Plaintiff did not have hypertension 
or proteinuria. Her symptoms of headache, nausea, and vomiting 
were not caused by pre-eclampsia or developing pre-eclampsia. 
The amount of edema and weight gain observed was not unusual. 
Moreover, the risk of pre-eclampsia and/or eclampsia is extremely 
low in gravid patients at 2 6 weeks gestational age. 
13. Defendant acted appropriately on June 15, 1989, in 
changing his usual procedure and instructing Plaintiff to return 
in two weeks rather than the usual four week interval. The 
standard of care did not require Defendant to take any further 
action or to have the patient return sooner than two weeks. 
14. Plaintiff has failed to meet her burden of proof to 
establish a claim for medical malpractice or negligence against 
Defendant and the more credible evidence received convinces the 
Court that Defendant clearly complied with an applicable and 
acceptable standard of medical care in his treatment and care of 
Plaintiff during her pregnancy. 
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15. Plaintiff suffered eclamptic seizures on June 23, 1989. 
The eclampsia caused Plaintiff physical and mental injuries. The 
Court makes no findings on the categories or items of damage. 
From the foregoing Findings of Fact, the Court now enters its: 
CONCLUSIONS OF LAW 
1. In order to recover upon a claim for medical 
malpractice, Plaintiff has the burden of proving by a 
preponderance of the evidence that Defendant deviated from the 
standard of care applicable to physicians specializing in 
obstetrics and gynecology practicing in Salt Lake City, Utah, or 
similar communities, in 1989, and that said deviation from the 
standard of care was a proximate cause of the injuries and 
damages claimed by Plaintiff. 
2. Plaintiff Brenda Rivera has failed to meet her burden of 
proof on the elements of her medical malpractice claim against 
Defendant and Defendant is therefore entitled to a judgment in 
his favor of no cause of action upon the claims of Plaintiff 
Brenda Rivera and, based upon the Stipulation of the parties 
herein, and with good cause appearing, is further entitled to a 
judgment in his favor of no cause of action upon the claims of 
Plaintiff Antonio R. Rivera. 
5. Defendant is entitled to be awarded his Court costs 
incurred herein. 
DATED this ' ^ day of lu-^ -*- , 1993. 
' BY THE COURT: 
h^^l/2 
MICHAEL R. MDRPHY 
District Court Judge 
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APPENDIX 13 
VIOLATIONS OF STANDARD OF CARE 
CHART USED AT TRIAL 
VIOLATIONS OF STANDARD OF CARE 
Dr. WUde - 6-15-89 
I. FAILURE TO RECOGNIZE CONSTETXATION -
 of 
signs and symptoms (s/s) that would alert reasonable OB/GYN to existing or developing 
preeclampsia (P.E.), 
A. HIGHER RISK 
- 1st pregnancy 
- family hx of hypertensive disorders 
— mother: hypertension (HTN) 
— sister: stroke 
— sister: pregnancy-induced hpt (PIH) or P.E. 
- lower socio-economic class 
B. DANGEROUS DIASTOLIC BLOOD PRESSURE fDBP) 
- increasing trend in DBP 
- acute increase (t) in DBP 
— > 15 mm Hg t (actually, t of 24) 
C. WEIGHT GAIN - SIGNIFICANT 
- 8 lbs. in Vh weeks 
- rapid 
D. EDEMA (swelling 
- face 
- generalized 
E. HEADACHES - SEVERE 
- persistent 
- unresponsive to tylenol 
F. NAUSEA AND VOMITING 
- still having at 3rd trimester 
n . IMPROPER DTAGNQSIS (dxl 
A. Used "research dx" 
- "must have BP of 140\90" (SBP/DBP) 
- "must have proteinuria" 
B. Should have used: "clinical dx" (treating) 
- constellation of s/s 
- acute HTN = t > 15 mm Hg DBP 
- edema, non-dependent (face), or generalized 
- proteinuria not necessary 
ffl. FAILURE TO TREAT 
A. Needed close observation 
- come back: 24 - 48 hours 
- not two weeks 
- frequent BP and proteinuria readings g 
- increased vigilance due to risk factors I 
m I 
B. Not "continue working" as custodian 
C. Should have ordered 
- bed rest (+ hospitalize if no improvement), px 
- hospitalization (until stable) 
IV. FATT JIRF, TO EXPLAIN AND WARN 
A. Explanation of s/s of P.E. 
B. High DBP = significant P.E. risk 
- "Dangerous" condition 
C. How to avoid future injury 
- progression of symptoms 
- call immediately if s/s worsen 
D. Allayed fears: "just pregnant" 
in 
